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ABSTRACT

THE CURIOUS CASE OF NAD-CLEAVING NUDIX HYDROLASES
by
Atreyei Ray
The University of Wisconsin- Milwaukee, 2019
Under the Supervision of Professor David N. Frick
Nudix proteins are members of a large family of homologous enzymes that hydrolyze
nucleoside diphosphates linked to other compounds (x). These enzymes have catalytic activity on
a wide range of substrates such as dNTPs (both canonical and their oxidized forms), nucleotide
sugars, alcohols, dinucleoside polyphosphates, dinucleotide cofactors, and nucleoside
diphosphates linked to RNA. The bacterial genome encodes around 13, while the human genome
encodes for 22 such nudix proteins.
The E. coli genome encodes for a mutT mutator gene, the progenitor of the family
expressing the MutT pyrophosphohydrolase (NudA) protein (Treffers et al., 1954; Bhatnagar et
al., 1988). The enzyme was found to hydrolyze both canonical and mutagenic nucleoside
triphosphates, most commonly the toxic form of dGTP, 8-oxo-dGTP, preventing its
misincorporation during DNA replication (Maki et al., 1992). Nudt1 is its functional homologue
in humans and plays a vital role in removing mutagenic dNTPs to prevent A:T to C:G transversion,
by hydrolyzing the 8-oxo dGTP to 8-oxo dGMP (Nakabeppu, 2001). The E. coli NudC and its
functional homolog in humans, Nudt12 are members of the NADH diphosphatases of the Nudix
hydrolase superfamily, cleaving the pyrophosphate bond in their nucleotide substrates, such as
such as NADH, NADPH, NADP+, ADP-ribose and AppA to yield two nucleoside
monophosphates. Isomeric forms of NADH were discovered as a substrate for the enzyme,
ii

renalase (Beaupre et al., 2015). For the first time, experiments in this thesis tests the
‘housecleaning’ activity of NudC and Nudt12 on these toxic isomers of their nascent substrate.
Since the early discovery of the Nudix hydrolase class of proteins, several members have
been reported to have mRNA decapping activity. The E. coli RppH (NudH) nudix enzyme removes
pyrophosphate from the 5’-end of RNA while the yeast Dcp2 (Nudt20) nudix protein was the first
eukaryotic mRNA decapping enzyme discovered to remove m7GDP from canonically capped
mRNA (Wang et al., 2002). Nudt3 has also been demonstrated as an mRNA decapping enzyme
(McLennan et al., 2006; Song et al., 2013; Kiledjian et al., 2016). Nudt16 has been reported to
have 5’-end U8 snoRNA decapping activity (Grzela et al., 2018). With the recent discovery of the
cofactor nicotinamide adenine dinucleotide (NAD+) as a transcriptional modification of
prokaryotic mRNA (Chen et al., 2009), it has been suggested that NudC is involved in RNA
decapping, eventually triggering its decay (Cahová et al., 2014). Its functional homolog in mouse,
Nudt12 has also been shown to decap both canonical and ncinRNA (non-canonical initiating
nucleotide) in vitro (Grudzien-Nogalska et al., 2017). Evidence for direct interaction between these
decapping Nudix hydrolases and their oligonucleotide substrates is yet to be shown. For the first
time, we report binding between DNA/RNA and Nudix decapping proteins, and serendipitously
discover that the human Nudt12 protein exclusively binds RNA and not DNA, preferring to bind
in vitro transcribed NAD+-capped RNA.
Although the decapping activity of NudC (Cahová et al., 2014) and Nudt12 (GrudzienNogalska et al., 2019) on NAD+-capped RNA has previously been shown using TLC, we used a
more analytical approach to confirm these results using LC/MS. The preference of these proteins
to cleave NADH-capped RNA over NADH was also observed during these experiments.

iii

It has been hypothesized that the NAD+ on the terminal end of both prokaryotic and
eukaryotic RNA stabilizes the nucleic acids as the 7mG cap does for eukaryotic mRNAs.
NAD+/NADH are widely studied, important coenzymes, involved in many critical biological redox
reactions. Oxidized NAD, NAD+ accepts two electrons while its reduced form, NADH donates
two electrons to a variety of substrates. Kinetics of NAD+/NADH redox reactions can easily be
measured because NADH absorbs light at 340 nm but NAD+ does not. In this thesis, we explored
the hypothesis that ncinRNA might play a more obvious chemical role in the cell, by participating
in cellular redox reactions. To test if ncinRNA can be functional in redox reactions, T7 RNA
polymerase was used to synthesize RNA in vitro, initiating with the ncin: NAD+, NADH, NADP+
and NADPH. After analyzing the nature of the RNA using agarose gel electrophoresis, gel
extraction and LC/MS, we compared the ability of the RNAs to reduce pyruvate and oxidize lactate
in reactions catalyzed by the E. coli, rabbit muscle and bovine heart L-lactate dehydrogenase
(LDH). LDH is a well-characterized redox enzyme, with strict substrate specificity, discriminating
between NADH and the very similar NADPH. As suspected, LDH did not oxidize either NADPH
or NADPH-capped RNA. However, LDH oxidized both NADH and NADH-capped RNA and
reduced NAD+ and NAD+-capped RNA. This is the first study to show a clear biochemical role
for ncinRNA, suggesting that ncinRNAs may be participants in cellular chemical reactions.
ncinRNAs might therefore form a new and interesting class of key ribonucleoproteins or even
ribozymes capable of catalyzing redox reactions.
This thesis aims to the address the elusive physiological role of NADH-cleaving Nudix
hydrolases. For the first time, we report a distinct biochemical purpose for the existence of
ncinRNAs in vivo involved in redox reactions.
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Chapter 1 Introduction

The Nudix (nucleoside diphosphates linked to another moiety x) proteins are a superfamily
of pyrophosphohydrolases characterized by the conserved amino acid sequence commonly
referred to as the NUDIX box GX5EX7REVXEEXGU, where X is any amino acid and U is a
hydrophobic residue. Since its discovery, the Nudix superfamily has been divided into classes
based on their substrate specificity (Srouji et al., 2017) having activity over a range of substrates
such as deoxynucleotides, nucleotide sugars, dinucleoside polyphosphates and dinucleotide
coenzymes.
The E. coli genome encodes for a mutT mutator gene, the progenitor of the Nudix family
expressing the MutT pyrophosphohydrolase (or NudA) protein (Treffers et al., 1954; Bhatnagar et
al., 1988). This enzyme can catalyze the hydrolysis of both canonical and mutagenic nucleoside
triphosphates, most commonly the toxic form of dGTP: 8-oxo-dGTP, preventing its
misincorporation during DNA replication (Maki et al., 1992). Soon after, the E. coli genome was
discovered to encode for NudC (Frick & Bessman, 1995), its functional homolog in yeast NPY1
(AbdelRaheim et al., 2001) and Nudt12 in humans (Abdelraheim et al., 2003). These proteins were
classified as members of one such subclass of the Nudix family, that cleave dinucleotides, such as
NADH, NADPH, NADP+, ADP-ribose and AppA to yield two nucleoside monophosphate. This
subclass of Nudix proteins is found to have a marked preference for the reduced form of NAD+,
NADH. It should be noted that for the regeneration of NADH, the cell spends a couple of ATP
molecules; first an AMP moiety is transferred from ATP to nicotinate ribonucleotide to form
desamido-NAD+ and then in the reduction of NAD+ to NADH. Why the genome would express a
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protein that hydrolyzes not only an important cofactor in cellular metabolism but also an energy
rich molecule has been a concern.
Initially, it had been hypothesized that NudC may be a ‘housecleaning enzyme’, cleansing
the cell of potentially deleterious metabolites (Bessman et al., 1996). With Beaupre BA et al.’s
unique discovery in 2015, of the role that the human enzyme renalase may play in vivo, a similar
hypothesis for the ‘housecleaning activity’ of NADH-cleaving Nudix hydrolases on toxic isomeric
forms of β-NAD(P)H molecules was tested. Experiments set up to support this hypothesis will be
discussed in Chapter 5.
Several techniques can be used to look at interactions between fluorescent molecules.
Fluorescence Ratiometric assays (Lakowicz, 2010) are based one such method, involving changes
in the spectrum of a substrate upon enzyme action. FR techniques may be used to be study Nudix
cleavage of NADH, because the spectra of NADH and NMNH differ. This new assay will be
discussed in Chapter 6.
The human genome encodes for 22 nudix proteins. Nudt20, more commonly referred to as
Dcp2, was the first human mRNA decapping enzyme to be discovered (Wang et al., 2002). It
removes the m7G cap from the 5’-end of eukaryotic mRNA, orthologous to the yeast Dcp2. The
diphosphoinositol polyphosphate phosphohydrolase Nudt3 has also been demonstrated as an
mRNA decapping enzyme (McLennan et al., 2006; Song et al., 2013; Kiledjian et al., 2016).
Another human nudix enzyme, Nudt16 has been reported to have 5’-end U8 snoRNA decapping
activity (Grzela et al., 2018). Both Nudt16 and Nudt20 hydrolyzes the α-β-phosphate bond of the
mRNA cap, whereas Nudt3 can hydrolyze either α-β- or β-γ-phosphates with similar activity
(Grudzien-Nogalska et al., 2017). The cofactor nicotinamide adenine dinucleotide (NAD+) was
recently discovered as a transcriptional modification of prokaryotic mRNA (Chen et al., 2009) and
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eukaryotic mRNA (Julius et al., 2018). It has since then been suggested that NudC is involved in
prokaryotic RNA decapping, eventually triggering its decay (Cahová et al., 2014). Its functional
homolog in mouse, Nudt12 has also been shown to decap both canonical capped mRNA, between
the β- and γ- phosphate moieties and NAD+-capped RNA in vitro (Grudzien-Nogalska et al., 2019).
It could be reasoned that for the human Nudt3, Nudt12, Nudt16 and Nudt20 (Dcp2) and the
bacterial NudC Nudix hydrolases to be active RNA decapping enzymes, there has to be direct
interaction between these RNA decapping Nudix proteins and their oligonucleotide substrates.
This hypothesis is tested in Chapter 7.
To further support the results observed in Chapter 7, it has been reported that Nudt20
(Dcp2) in budding yeast has an additional well conserved RNA binding channel that promotes
decapping by the Dcp1/Dcp2 complex. The interactions between the protein and its 7mG-capped
RNA substrate have been shown using gel shift assays (Deshmukh et al., 2008). Although human
Nudt3 and Nudt16 are functional RNA decapping enzymes, they do not have any domain
additional to the Nudix catalytic site. E. coli RNA decapping enzyme, NudC has been shown to
have a positively charged area adjacent to the NAD+ binding domain, suggesting its role in nucleic
acid interaction (Höfer et al., 2016). Its functional homolog in humans, Nudt12 also has an
additional Ankyrin repeat domain, essential for NAD+-capped RNA decapping activity (GrudzienNogalska et al., 2019). Additionally, both NudC and Nudt12 have Zinc-finger domains, suggesting
yet another possible binding site for nucleic acids.
Another technique to look at interactions between fluorescent molecules is single molecule
protein induced fluorescence enhancement (smPIFE/PIFE), which only needs a single fluorescent
tag attached to nucleic acids to which an unlabeled protein is bound (Hwang et al., 2014). The
local assay environment such as the interacting protein reduces the rate at which the fluorophore
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isomerizes from the photo-active trans state to the photo-inactive cis state, resulting in an increase
of quantum yield. This technique is well used to study the energetics of interactions between
fluorescent tags and interacting protein molecules in Chapter 8.
Liquid chromatography–mass spectrometry (LC/MS) is an analytical technique,
combining the physical separation of liquid chromatography with the mass analysis of mass
spectrometry. Non-canonical caps on the terminal end of RNA molecules from E. coli and S.
venezuelae were identified using LC/MS (Liu et al., 2009). The catalytic activity of proteins on
their substrates may be studied using this technique as well. The decapping activity of NudC
(Cahová H et al., 2014) and Nudt12 (Grudzien-Nogalska et al., 2017) on ncinRNA has been
demonstrated using radiolabeling. It may be argued that more quantitative results may be achieved
using a more analytical approach such as LC/MS, as discussed in Chapter 7.
The role of the cofactor NAD+ on the terminal end of both prokaryotic and eukaryotic
mRNA is yet to be explained. It has been suggested that this transcriptional modification might
stabilize mRNA similar to the 7mG cap on the 5’-end of eukaryotic mRNA molecules. NAD
existing in both the oxidized form, NAD+ and its reduced form, NADH are cofactors that are
essential to metabolism. Chapter 7 is the first study ever to demonstrate that the NAD+/NADH on
the terminal end of RNA may play an important role in cellular redox reactions. We tested this
hypothesis using mammalian heart and muscle L-lactate dehydrogenase, a vital enzyme in
anaerobic respiration. The results from this experiment can be further supported by the fact that
several NAD+/NADH using metabolic enzymes have been previously reported to be mRNA
binding proteins as discussed. Chapter 9 is the first ever study to show a clear biochemical role of
ncinRNAs participating in redox reactions. It may therefore be suggested that NAD+-capped RNAs
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might form a new class of key ribonucleoproteins or even ribozymes capable of catalyzing redox
reactions, in vivo.
This thesis addresses the role that NADH-cleaving nudix protein may play in the cellular
environment. For the first time, the housecleaning activity of this subclass of nudix enzymes are
studied. With the discovery of ncinRNAs, its physiological role has never quite been understood.
For the first time, this thesis shows a clear biochemical activity of this non-canonical
transcriptional modification.
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Chapter 2 Literature review

2.1

Bacterial Nudix hydrolases

Members of this super family of proteins hydrolyze a wide variety of unrelated substrates
all having a common nucleoside diphosphate linked to some other moiety X, hence their name
Nudix. The Escherichia coli genome encodes for 13 such Nudix hydrolase genes. Several of these
enzymes initially discovered in E. coli have since then been identified in other prokaryotes, archaea
and eukaryotes. Of the 13 E. coli Nudix hydrolases, most of them have the well conserved Nudix
motif with the exception of NudK which has a conservative replacement of lysine for arginine and
NudD (orf1.9) which has a slight reshuffle of amino acids as well.
2.1.1 NudA (MutT)
The E. coli genome encodes for a mutT mutator gene, expressing the MutT
pyrophosphohydrolase (or NudA) protein. Initially, MutT was thought to be responsible for only
a single, unidirectional AT → CG transversion unlike other defective mutator genes causing a
variety of mutations in DNA such as transitions, frameshifts or transversions. However, with
further studies, this enzyme was found to also catalyze the hydrolysis of canonical and mutagenic
nucleoside triphosphates, most commonly the toxic form of dGTP: 8-oxo-dGTP. It does so by
substituting at the seldom attacked β- phosphate, to yield nucleoside monophosphate and inorganic
pyrophosphate. 8-oxo-dGTP is the product of oxidative damage to guanine containing nucleotides,
which often mispairs with template adenine during DNA replication. NudA (MutT) was hence
believed to be “sanitizing” (Bessman et al., 1998) the nucleotide pool at the site of DNA synthesis.
Typical to members of this family, two divalent metal ions are essential for its catalytic activity,
one coordinated to the β- and γ- phosphoryl groups of the substrate and the second coordinated to
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the protein. The tertiary structure of NudA (MutT) is globular and the specific binding sites for
divalent metal ions and nucleotides have since then been identified via NMR relaxation method
(Abeygunawardana et al., 1995).
2.1.2 NudB (Orf17)
The E. coli genome encodes for orf17 encoding the highly conserved Nudix motif
characteristic of members of the MutT family of proteins. The gene expresses the NudB protein, a
nucleoside triphosphate pyrophosphohydrolase, with a marked preference for deoxyadenosine
triphosphate (dATP) over other deoxynucleoside triphosphates. NudB catalyzes the hydrolysis of
dATP via a nucleophilic attack at the β- phosphate to produce deoxyadenosine monophosphate
(dAMP) and inorganic pyrophosphate (O'Handley et al., 1995). Similar to the other proteins in this
family, NudB also has an alkaline pH optimum and a requirement for divalent cations (Bessman
et al., 1996). Despite the sequence similarity, NudB does not share the same antimutator properties
as NudA (MutT). Almost a decade after the enzyme’s discovery, it was detected that the deletion
of the nudB gene led to a lag in bacterial growth and increased sensitivity to drugs commonly used
for bacterial infection, namely sulfamethoxazole (SMX) and trimethoprim (TMP) in both E. coli
and Salmonella enterica (Deng et al., 2017). This is because the deletion of nudB causes
dihydroneopterin triphosphate to flux more into the tetrahydromonapterin biosynthesis pathway,
leading to an excess production of tetrahydromonapterin, which then leads to an increased
sensitivity to the drugs, both SMX and TMP.
2.1.3 NudC (Orf257)
Several proteins cleaving NAD into NMN and AMP have been reported in a large variety
of prokaryotes and eukaryotes, following the purification of NAD pyrophosphatases from potato
extracts (Kornberg et al., 1950). One such protein is expressed from the E. coli open reading frame
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orf257, homologous to the active site of the MutT enzyme (Frick & Bessman, 1995). Unlike the
other members of the MutT family of proteins, NudC does not hydrolyze nucleoside triphosphates.
Interestingly, this enzyme is selectively active only on ß-isomers of dinucleotides and not the αisomers of NAD. NudC is can hydrolyze a wide array of substrates ranging from NAD+, NADH,
NADP+, NADPH, FAD, ADP-ribose, to a family of bis(5’-nucleosidyl) polyphosphates such as
diadenosine tetraphosphate (AppppA). Typical to this family of proteins, NudC enzymatic
catalysis was observed to be the most active at alkaline pH conditions, peaking at pH 8.5, at 37 °C
in the presence of divalent metal ions, with most activity in the presence of Mn2+ or Mg2+, lower
activity in the presence of Zn2+, Co2+ or Fe2+ to no activity detected in the presence of Cu2+ or Ca2+.
Initially, it was thought that the remarkable preference for the reduced form of NAD+, NADH may
be related to its physiological function. It has been hypothesized that NudC acts as a
‘housecleaning enzyme’, which may regulate intracellular NADH/NAD+ ratio (Bessman et al.,
1996). Why the genome would express a protein that hydrolyzes and eventually inactivates an
important redox cofactor in cellular metabolism is still a concern.
In recent years, the metabolic cofactor NAD was found to be covalently attached to the
terminal end of small regulatory bacterial RNAs. Bacterial nudix hydrolase NudC has been
detected to be an active NAD decapping enzyme both in vitro and in vivo (Höfer et al., 2016). The
enzyme efficiently removes the NAD moiety from the terminal end by hydrolyzing the
pyrophosphate bond to produce free nicotinamide mononucleotide (NMN) and 5’monophosphorylated RNA. E. coli NudC protein prefers NAD-capped RNA over free NAD by 5folds and NADH by 170-fold, indicating that the primary cellular substrate of NudC might be
NAD-capped RNA and not NAD+ or NADH, as previously thought. Although the NAD cap has
been reasoned to stabilize the sRNAs against in vitro endonucleolytic decay, similar to the role of
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m7G caps on the terminal end of eukaryotic mRNA transcripts, it was essential to investigate for
an RNA decapping enzyme.
The high-resolution crystal structures of E. coli NudC in complex with NAD and NMN
uncovered the structural basis of decapping of NAD-capped RNA by the NudC protein (Hofer K
et al., 2016). NudC binds a diverse set of cellular RNAs in an unspecific fashion with a surprisingly
strong preference for a purine as first nucleotide (Höfer et al., 2016). The structure of each of the
NudC monomeric units is constituted of two tandem Nudix-fold domains, namely the N-terminal
domain (NTD) and the C-terminal domain (CTD). The Nudix fold comprises of a beta sheet with
alpha helices on each side, while the Nudix motif comprises of the catalytic site. Between the two
domains, four cysteine residues coordinate one Zn2+ ion to form an extended zinc-binding motif,
which protrudes out from the NTD. The catalytic activity resides in the highly conserved 23-amino
acid Nudix motif and has been found to be dependent on the conserved glutamate residues. In
addition to the Nudix motif, residues engaged in substrate binding are also essential for its
enzymatic function. Since the first report of the purification of the NudC protein, it has been found
to co-purify with a highly diverse population of tightly interacting nucleic acids (Frick & Bessman,
1995), with very little enrichment or depletion of any specific sequences. It has been suggested
that the positively charged surface neighboring the entrance to the catalytic center could be
involved in electrostatic interactions for RNA binding, however never confirmed. NGS analysis
revealed that adenosine was the first base in all RNA transcripts covalently modified with NAD
(Cahova et al., 2015). When the adenosine of NAD is substituted by guanosine, cytidine or uridine,
the rate of decapping by NudC was considerably reduced for the pyridine replacements, further
suggesting a preference for a 5’- purine nucleotide (Höfer et al., 2016).
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Although growing crystals of NudC in complex with NAD-capped RNA was unsuccessful,
NudC in complex with free NAD was successfully solved by molecular replacement method at 2.6
Å resolution (Höfer et al., 2016, PDB: 5IW4). Each of these monomeric unites binds a NAD
ligand, where the nicotinamide moiety of NAD is buried in a hydrophobic binding pocket through
stacking and hydrogen-bonding interactions, while the adenine ring extends into another
hydrophobic pocket at the dimer interface. The adenine moiety of NAD is stacked between the
side chains from one NudC monomer to another, confirming that dimerization is crucial for
substrate recognition and binding (Höfer et al., 2016). Interestingly, there are several positively
charged residues huddled outside the entrance of the NAD binding pocket, suggesting that they
may be involved in the recognition of the sugar-phosphate backbones of NAD modified RNA
transcripts. Owing to the narrow dimensions of the cleft above the adenosine ribose in the NAD
ligand bound form of NudC, it was confirmed that NudC is single-strand specific.
Additionally, the crystal structure of NudC in complex with its cleavage product, NMN
was solved at 2.7 Å resolution (Höfer et al., 2016, PDB: 5IW4, 5IW5). Similar to the NudC-NAD
complex, the NMN molecule too, is deeply buried in a hydrophobic binding pocket between the
NTD and the CTD, with the pyridine ring facing towards the bottom of this pocket. Surprisingly,
when the NTDs of one monomer of ligand-free, substrate NAD-bound and product NMN-bound
NudC were superimposed, a significant change in the orientation of CTD was observed, suggesting
a conformational change in free, substrate bound and product bound NudC protein. Also, the
relative orientation between the two monomers gradually move a little closer upon binding the
substrate, revealing that the catalytic activity is dependent not only on the conformation of each
monomer, but also on the dimeric arrangement.
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Figure 2-1| Crystal structure of E. coli NudC dimer
Crystal structure of the bacterial NudC (PDB: 5IW4) in
complex with its substrate, NAD+. Its two monomeric units,
highlighted in grey and cyan, are in complex, each have a
binding site for the substrate. This was solved at 2.7 Å
resolution. (Höfer et al., 2016)
Thus, a study by the Jaschke Lab (Höfer et al., 2016)
revealed a possible biological role for NudC in the cleavage
of NAD-capped RNA over known small-molecule substrates
such as NAD+ and NADH. The E. coli genome encodes for 13 Nudix enzymes, most of which
have no clear physiological function. It may be hypothesized that these hydrolases might process
RNAs capped with other non-canonical caps such as nucleotide sugars, dinucleoside
polyphosphates, or other dinucleotide coenzymes. Interestingly enough, NudC was not linked with
McaS (IsrA) sRNA, one of the most highly NAD modified sRNAs in bacteria (van Nues et al.,
2016). This indicates that the differential decapping activity by NudC might be much more precise.
Over the years, Nudix proteins from the plant pathogen Pseudomonas syringae and from
the human pathogen Pseudomonas aeruginosa have also been well studied (Modzelan M et al.,
2014). P. syringae pv. tomato str. DC3000 and P. aeruginosa encodes for 10 and 12 Nudix
hydrolases respectively. Additionally, PsNudC and PaNudC contain SQPWPXPXS motif specific
for NADH Nudix hydrolases (Dunn et al., 1999), and very similar to that of E. coli NudC. They
have similar and preferential in vitro activity on the reduced NADH over oxidized NAD+ under
alkaline pH conditions, and in the presence of divalent metal ions. Similar to other NADH Nudix
phosphohydrolases, the homologous proteins, PsNudC and PaNudC exists as dimers in solution.
The conserved glutamic acid residue (E190) in the Nudix motif is responsible for cofactor binding.
Site directed mutagenesis of this glutamate residue removes its catalytic activity, without affecting
the protein’s ability to form homodimers. It has been hypothesized that intracellular levels of
11

NADH/NAD+ in bacteria are regulated by an alternative pathway, with NADH being accumulated
when terminal oxygen acceptors become limited. This was confirmed when increased levels of
NADH/NAD+ was observed in the late exponential and stationary phases of growth of the PsNudC
mutant, indicating that the Nudix NADH hydrolase is involved in regulating the intercellular redox
status under limiting oxygen stress. However, the same was not observed for its homologous
counterpart in P. aeruginosa. Of course, further scrutiny is required to solve these discrepancies.
2.1.4 NudD (Orf1.9)
The E. coli genome encodes for yet another gene, the nudD (aka orf1.9 or yefc) gene that
expresses NudD, a protein of the same Nudix hydrolase superfamily of enzymes (Frick et al.,
1995). NudD forms a novel subclass of this family, by catalyzing the hydrolysis of GDP-mannose
or GDP-glucose by nucleophilic substitution at carbon to yield GDP and mannose or glucose
respectively (Bessman et al., 2000). Because of this difference in its nucleophilic mechanism, it
has been questioned whether NudD is a member of the Nudix protein family or simply an example
of convergent evolution (Bessman et al., 2006). Perhaps the hydrolysis of GDP-mannose is not the
sole biological role of the enzyme.
Surprisingly, the enzyme has little to no activity on other common Nudix hydrolase
substrates, such as nucleotides, dinucleotides, nucleotide sugars, or sugar phosphates. Because of
its substrate specificity, NudD is often referred to as the E. coli GDP-mannose mannosyl hydrolase
(GDPMH). This enzyme, comprising of 160 amino acids contains the well conserved 23-amino
acid Nudix sequence responsible for novel nucleoside diphosphate binding site and catalytic
activity. Similar to the members of this family, NudD too has an alkaline pH optimum between
9.0 and 9.5. However, unlike the other proteins in the Nudix family, NudD only requires one
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divalent cation per active site for its catalytic activity by facilitating the removal of the GDP
leaving group (Mildvan et al., 2002).
2.1.5 NudE (Orf186)
Another gene encoded by the E. coli genome, nudE (aka orf186) is also a member of the
Nudix hydrolase family of genes. The gene expresses NudE, a protein that has been identified as
an enzyme highly specific for compounds containing adenosine diphosphate (ADP). Typical to
members of this family, NudE too has the well conserved 23-amino acid Nudix motif. The three
major substrates for NudE are adenosine 5'-triphospho-5'-adenosine (AP3A), ADP-ribose, and
NADH, all of which are involved in a variety of essential regulatory processes in vivo. This
substrate specificity supports the hypothesis that Nudix hydrolases may play an important role to
monitor the concentrations of reactive nucleoside diphosphate derivatives and in the regulation of
their accumulation during metabolism (Bessman MJ et al., 1998). NudE is not only specific for E.
coli and has since then been identified in the bacterial virus, T4 bacteriophage. The T4 gene e.1
expresses for a protein of the Nudix hydrolases superfamily and most closely resembles the E. coli
NudE, hence its name NudE.1. Expectedly, NudE.1 is also active on a similar range of substrates
including FAD, AP3A and ADP-ribose at an alkaline pH optimum requiring divalent metal ions
(Bessman et al., 2002).
2.1.6 NudF (Orf135)
The E. coli genome encodes for yet another gene, nudF (aka orf135), expressing a protein
NudF, which is a member of the Nudix hydrolase family of enzymes with substrate specificity for
cytidine triphosphate (CTP), deoxycytidine triphosphate (dCTP), but mostly active on 5’-methyldCTP. Unlike other members of the Nudix hydrolase superfamily of proteins with similar catalytic
activity, NudF is very specific for pyrimidine deoxy-nucleoside triphosphates. The protein cleaves

13

its substrates to produce a nucleoside monophosphate and inorganic pyrophosphate at alkaline pH
conditions, requiring divalent metal cations for optimal catalysis. It has been hypothesized that
NudF may be involved in pyrimidine biosynthesis, lipid biosynthesis, and in controlling levels of
5-methyl-dCTP in vivo (Bessman et al., 2001).
2.1.7 NudH (RppH, Orf176)
The E. coli genome encodes for the nudH (aka orf176 or ygdP) gene, connected to the
invasion of brain microvascular endothelial cells. This gene expresses NudH (aka Orf176 or YgdP)
or more recently termed as the RppH protein which has been identified as another member of the
dinucleoside oligophosphate pyrophosphatase subfamily of the Nudix hydrolase super family of
proteins. NudH catalyzes the hydrolysis of diadenosine tetra-, penta- and hexa- phosphate with a
striking preference for diadenosine pentaphosphate, a precursor of ADP and ATP. Common to
Nudix hydrolases, this protein too has a requirement for divalent metal cations and a pH optimum
between 8.5 and 9. It should be noted that this is the second identification of a member of the
Nudix hydrolase subfamily of dinucleoside oligophosphate pyrophosphatases associated with the
invasiveness of a human pathogen (Bessman et al., 2001), after IalA. The first identified gene
associated with the invasion of human red blood cells by Bartonella bacilliformis, ialA was
identified by Bessman et al. (1999). The protein product of the gene, IalA contains the 23-amino
acid sequence representative of Nudix hydrolases. The enzyme cleaves the pyrophosphate linkage
of dinucleoside polyphosphates to yield nucleoside triphosphate and the remaining nucleotide
moiety. It is most active on adenosine 5'-tetraphospho-5'-adenosine (Ap4A), but also poorly
hydrolyses Ap5A, Ap6A, Gp4G and Gp5G.
The hypothesis that degradation of messenger RNA (mRNA) in bacteria is initiated by
endonucleolytic cleavage had been challenged by the discovery of a non-nucleolytic event that
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triggers mRNA decay and its rapid turnover. This was better supported by endonuclease RNase Emediated catalysis on the 5’- monophosphate of mRNA transcripts. However, an enzyme to
remove the terminal pyrophosphate was yet to be identified in any bacterial species. Since then,
Belasco JG et al. identified the E. coli protein RppH (EcRppH, formerly NudH or YgdP) as the
RNA pyrophosphohydrolase that initiates mRNA decay by this 5′- end dependent pathway.
EcRppH has been demonstrated to efficiently remove pyrophosphate from the terminal end of
triphosphorylated RNA transcripts, irrespective of the terminal nucleotide, in vitro. In vivo,
EcRppH accelerates the degradation of mRNA transcripts by the conversion of triphosphorylated
5′ ends to their monophosphorylated forms which can undergo further ribonuclease cleavage
(Belasco et al., 2008). This activity of EcRppH to trigger bacterial mRNA decay by removing a
protective structure at the 5′- terminal is in accordance to the removal of cap structures from the
5′-end of eukaryotic mRNA substrates by Dcp2 (Nudt20), also a member of the Nudix hydrolase
superfamily. Despite the significant structural differences between bacterial and human mRNAs,
the proteins involved in its decapping seem to have evolved from a shared ancestor.
Soon after, the crystal structure of Nudix hydrolase from Bdellovibrio bacteriovorus
(BdRppH) was solved at 1.9Å resolution (Amzel et al., 2009). BdRppH showed significant
similarities to eukaryotic proteins involved in decapping, by the presence of positively charged
residues that may be the binding site for nucleic acids. The hypothesis was further supported by
the structure of the complex of BdRppH with GTP, where GTP was bound in a position
comparable to that observed in the m7GpppA-X29 complex, a decapping enzyme from Xenopus
laevis in complex with the eukaryotic mRNA cap structure (Scarsdale et al., 2006). In 2013, Piton
J et al. solved the crystal structure of the RppH protein from Bacillus subtilis (BsRppH). This study
elucidated the structural and functional differences between several RNA decapping enzymes in
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distantly related bacteria. BsRppH has a binding pocket that specifically prefers guanosine residues
in the second position of its RNA targets, unlike BdRppH which has a binding pocket only for the
first residue of its RNA substrates. EcRppH requires at least two or more single stranded
nucleotides at the terminal mRNA end and although it seems to tolerate variation in sequence on
the terminal end, the protein has some preference for adenine over guanine at the first position and
for a purine at the second position (Foley et al., 2015). Also, BdRppH releases inorganic
pyrophosphate from the terminal ends of their primary transcripts, whereas BsRppH catalyzes the
same reaction in two different steps, involving exonucleolytic degradation by a second enzyme,
RNase J, releasing two phosphates (Richards et al., 2011). EcRppH too catalyzes a two-step 5’end-dependent mRNA decay starting with the removal of γ-phosphate, by a yet to be identified
bacterial enzyme, leading to a subsequent β-phosphate removal by EcRppH (Luciano et al., 2017).
It was soon confirmed that this diphosphorylated intermediate form is the preferred biological
substrates for the bacterial enzyme (Luciano et al., 2018).
ADP-ribosylation is a post-translational modification found extensively in diseased
cellular environments. Surprisingly, the E. coli RppH protein was found to be catalytically active
on another substrate, protein-conjugated ADP-ribose (protein-conjugated ADPr), hydrolyzing it to
its phosphoribose attachment site, in vitro. It was confirmed that a short, novel 310-helix
downstream from the well conserved Nudix signature motif was responsible for the degradation
of protein-conjugated ADPr (Daniels et al., 2015).
2.1.8 NudI (Orf141)
The E. coli genome encodes for nudI (aka orf141 or yfaO) expressing the NudI (Orf141)
protein, a member of the Nudix hydrolase superfamily of proteins. NudI is a nucleoside
triphosphatase with preference for pyrimidine deoxynucleoside triphosphates, such as
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deoxyuridine triphosphate (dUTP), deoxythymidine triphosphate (dTTP) and dCTP, with much
less activity on their respective diphosphate substrates. Typical to this class of hydrolases, NudI
has a divalent metal ion requirement for activity and an alkaline pH optimum (Bessman et al.,
2006) as well.
2.1.9 NudJ (Orf153)
The E. coli genome encodes for nudJ (orf153 or ymfB) expressing the NudJ protein, also
a member of the Nudix hydrolase superfamily of enzymes. Unlike the other E. coli other Nudix
nucleoside triphosphatases, NudJ is a nonspecific nucleoside tri- and diphosphatase and
surprisingly, releases inorganic orthophosphate from triphosphates instead of the usual inorganic
pyrophosphate. None of the other typical Nudix hydrolase substrates tested, including NADH,
GDP-mannose and ADP-ribose, are hydrolyzed by NudJ. NudI seems to have similar if not better
catalytic activity on their mutual substrates except GDP, thus questioning the physiological role of
NudJ in vivo. The enzyme also has no difference preference between deoxyribose over ribose
substrates. Typical to this class of hydrolases, NudJ also has a divalent cation requirement for its
activity and a pH optimum between 8.5 to 9 (Bessman et al., 2006).
2.1.10 NudK (Orf191)
The E. coli genome encodes for nudK (aka orf191 or yffH) responsible for the expression
of the NudK protein, another member of the Nudix hydrolase superfamily. Although NudK
hydrolyzes ADP-ribose, it has a much higher catalytic activity on GDP-mannose (Bessman MJ et
al., 2006) in addition to NudD. Further studies revealed that NudK has a marked preference for
purine over pyrimidine nucleotide sugars and for the 6-keto over the 6-amino group amongst the
tested purine substrates. The nudk gene contains the consensus Nudix motif, with a conservative
replacement of the lysine residue for arginine (Bradford et al., 1976).
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2.1.11 NudL (Orf192)
The E. coli genome encodes for nudL (aka orf192) gene expressing NudL, a CoA
pyrophosphatase. It has also been designated as member of the Nudix hydrolase superfamily of
proteins because nudL has the very well conserved Nudix box and an amino acid motif upstream
of the Nudix sequence characteristic of coA pyrophosphatases (Bessman et al., 2006).
2.2

Human nudix hydrolases

The human genome encodes for a total of 22 Nudix hydrolases, six of which have been
reported to possess mRNA decapping activity. Owing to their name, these enzymes have catalytic
activity on a wide range of substrates including canonical (d)NTPs, oxidized (d)NTPs, nonnucleoside polyphosphates and capped mRNA transcripts.

Table 2-1| Substrate specificity of Nudix proteins
Nudix protein
SUBSTRATE
Nudt1 (MTH1)
8-oxo dGTP
Nudt3
Diphosphoinositol‐polyphosphate
NudC
NAD
Nudt12
or
NADP
Nudt16
m7G-5′-pppN
or
m7G-5′-ppp‐mRNA
Nudt20 (Dcp2)
m7G-5′-pppN
or
m7G-5′-ppp‐mRNA
The substrate specificity of the Nudix proteins of our interest amongst the 347 proteins of this
superfamily that have been functionally characterized, structurally determined or have
phylogenetically important Nudix homology proteins domains. From (Brenner et al., 2017).
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Figure 2-2| Sequences of
Nudix proteins
The sequences of the Nudix
proteins of our interest has been
shown here, with each protein
having the characteristic Nudix
motif (blue), while NADcleaving NudC and Nudt12
proteins both have a Zinc-finger
domain (red), known to interact
with nucleic acids. Nudt12 also
has an additional ankyrin repeat
(orange), unlike the other Nudix
proteins.
2.2.1 Nudt1 (MutH1)
8-oxo-7,8-dihydrodeoxyguanosine triphosphate (also known as 8-oxo-dGTP) is produced
by active oxygen species in the nucleotide pool in vivo and can be misincorporated into DNA
during replication. The human genome encodes for the MTH1 (aka NUDT1) gene, the mutT
human homolog, expressing Nudt1 protein, an 8-OH-dGTPase. Nudt1 hydrolyzes 8-oxo-dGTP to
yield 8-oxo-dGMP, thereby preventing DNA mutations (Furuichi M et al., 1994), localized in vivo
both in the cytoplasm and the mitochondria (Kang D et al., 1995).
A subset of mammalian Nudix enzymes have been shown to lack decapping activity,
including Nudt1 (Song et al. 2010), thus suggesting that decapping is not a characteristic feature
of all 8-OH-dGTPases. However, the Nudt1 protein has been found to be required for the efficient
survival of cancer cells (Carreras-Puigvert et al., 2017). The protein is overexpressed in most
analyzed cancer cells with an increased activity in lung cancer tissues (Speina E. et al, 2005).
Nudt1 prevents the misincorporation and damage after DNA replication caused either by increased
levels of reactive oxygen species (ROS) or dysfunctional redox regulation, leading to oxidative
damage to DNA, or to the free nucleotide bases in the cellular and mitochondrial deoxynucleoside
triphosphate (dNTP) pool (Helleday et al., 2014). Thus initially, selectively inhibiting NUDT1 was
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thought to be a novel anticancer therapeutic approach, however later disproved, considering
selective small molecule inhibitors, siRNA knock-down and CRISPR-mediated knockout of
NUDT1 did not support this previous hypothesis of the Nudt1 protein being essential for the
survival of cancer cells (Kettle et al, 2016).
2.2.2 Nudt3
The human genome encodes for the NUDT3 gene expressing Nudt3, a protein
characterized as a diphosphorylated inositol phosphate phosphohydrolase. This was the first
identified mammalian Nudix hydrolase to share the common highly conserved Nudix motif with
Bartonella bacilliformis Ap6A/Ap5A hydrolase, responsible for a preferential activity on Ap6A
and Ap5A over other diadenosine polyphosphates (Safrany et al., 1999). Nudt3 has been identified
as a cytoplasmic protein, suggesting its role in the decay of mRNAs in the cytoplasm (McLennan
et al., 2006). Since then, Nudt3 has also been shown to be have in vivo mRNA decapping activity
(Kiledjian et al., 2016). The protein can cleave its nucleic acid substrate either between the α- and
β- phosphate, or between the β- and γ- phosphate with similar activity to yield either m7GMP or
m7GDP from a monomethylated capped RNA substrate (Song et al., 2013). Surprisingly, Nudt3
can also decap unmethylated capped RNA to yield the expected GDP or GMP products. Similar
to other members of the protein family, Nudt3 has decapping activity only on a small subset of
mRNAs, preferentially mRNAs encoding proteins that are integral for cell motility (Nogalska et
al., 2016). Nudt3 is the third mammalian Nudix hydrolase to be identified as an mRNA decapping
enzyme, suggesting the existence of several other decapping enzymes targeting specific mRNA
subsets instead of a single mammalian decapping enzyme that nonspecifically targets all cellular
mRNAs. The S. cerevisiae orthologue of Nudt3, Ddp1 also shares similar robust decapping activity
in vitro at least (Song et al., 2013), confirming that the presence of multiple RNA decapping
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enzymes is not restricted to multicellular organisms alone. Whether Ddp1p functions as a
decapping enzyme in yeast cells in vivo is yet to be seen.
2.2.3 Nudt4
The human genome encodes for NUDT4 gene expressing the Nudt4 protein, a
diphosphoinositol polyphosphate phosphohydrolase (DIPP). A member of the Nudix hydrolase
superfamily of proteins, Nudt4 does not seem to have mRNA decapping activity either.
Interestingly, high expression of the NUDT4 gene has been detected throughout normal tissues,
with a significant downregulation in all analyzed cancer cells (Carreras-Puigvert et al., 2017).
2.2.4 Nudt7
The human genome encodes for the NUDT7 gene expressing the Nudt7 protein, a member
of the Nudix hydrolase superfamily of proteins. Nudt7 hydrolyses coenzyme A (CoA), CoA esters
and oxidized CoA to yield 3’,5’-ADP and the corresponding acyl-phosphopantetheine derivatives
as products. The mouse ortholog of the human NUDT7 gene, NUDT7α expresses a similar CoA
diphosphatase. In vivo studies revealed that Nudt7α is confined to the peroxisome and has a Cterminal peroxisomal targeting signal type 1 (PST1) that directs the enzyme to the organelle. In
cells, CoA is found in three distinct pools in the cytosol, mitochondria and peroxisome. CoA
synthesis is finished in the cytosol and only a minor portion of the cytosolic CoA is transported
into mitochondria and peroxisomes in liver cells. It is hypothesized that the Nudt7α may either be
involved in the removal of oxidized CoA from peroxisomes, although preliminary in vitro studies
to confirm this idea have not been successful. Alternatively, Nudt7α may also regulate CoA and
acyl-CoA levels in the peroxisome in response to metabolic demand (Gasmi et al., 2001).
Expectedly, the removal of the C-terminal PTS1 alters Nudt7α cellular localization. It did not
however affect the catalytic activity of Nudt7α. Neuron-specific expression of PTS1 deficient
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Nudt7α confined it to the cytoplasm and resulted in reduced brain CoA levels which interestingly
led to a significant decline in motor function (Shumar et al., 2015). It should also be noted that
Nudt7 lacks mRNA decapping activity (Song et al., 2010).
Cellular localization experiments of the human NUDT7 protein showed cytoplasmic
staining of hepatocytes and testicular Leydig cells, thus failing to corroborate with the above
murine results (Carreras-Puigvert et al., 2017).
Upregulation of its orthologue in pigs, the expression of NUDT7 in muscle cells is thought
to reduce succinyl-CoA content and hence reduce the level of heme biosynthesis (Taniguchi et al.,
2010).
2.2.5 Nudt9
The human gene NUDT9 was first identified in bacteria and yeast encoding for a protein
belonging to a subfamily of Nudix hydrolases active on ADP-ribose (Dunn et al., 1999), a product
of NAD hydrolysis. Later discovered in humans as well, the Nudt9 protein hydrolyzes ADP-ribose
and IDP-ribose to their corresponding nucleoside 5'-monophosphates and ribose 5-phosphate, with
minimal to no activity on other nucleotide substrates (Lin et al., 2002). The NUDT9 gene has a
proline residue downstream of the characteristic Nudix box, common to the ADP-ribose
pyrophosphatase subfamily. Also characteristic to the Nudix family of proteins, Nudt9 hydrolyzes
its substrates in a divalent metal ion dependent manner at near neutral pH optimum with a
nucleophilic attack on the adenosyl phosphate moiety (Gabelli et al., 2002). The analysis of the
human NUDT9 gene indicated two isoforms named, NUDT9α, the dominant form and NUDT9β,
a product of unusual mRNA splicing. The protein expressed by NUDT9α has been identified as
an N-terminal signal peptide, localized specifically to the mitochondria. Similar specific cellular
localization has not been identified for the protein of the NUDTβ transcript (Perraud et al., 2003).
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Interestingly enough in humans, the protein was differentially expressed in endometrial glandular
cells at different phases of the menstrual cycle and more prominently in the epithelial glandular
component than in the stromal component of endometrial carcinomas (Chen et al., 2009). Human
Nudt9 showed cytoplasmic staining of glandular cells in the fallopian tube and of neurons and
neuropil in the cortex (Carreras-Puigvert et al., 2017).
Two enzymatically indistinguishable human proteins, the highly specific ADP-ribose
purified from placenta and a considerably less active recombinant Nudt9, both having
submicromolar Km for their respective substrates confirms that ADP-ribose pyrophosphatase
present in human tissues is indeed a product of the NUDT9 gene (Ribeiro et al., 2001; Carloto et
al., 2006). Thus, making Nudt9 a major candidate to control the accumulation of free ADP-ribose
in humans, a potentially toxic compound due to its non-enzymic reactivity towards protein side
chains. ADP-ribose can regulate calcium entry in vertebrate (Perraud et al., 2001), where the
proteolytically resistant C-terminal domain of the Nudt9 protein serves as a binding site for ADPribose (Yu et al., 2017), enhanced by the proteolytically labile N-terminal portion. This eventually
led to the detection of Nudt9 as a modulator of the hypoxia inducible factor-1α (HIF-1α)
accumulation in cancer cells preceded by the activation of Ca2+/calmodulin-dependent protein
kinase kinase β (CaMKKβ) (Yoon et al., 2018). Similar to only a few members of the Nudix
hydrolase superfamily, Nudt9 is deficient of mRNA decapping activity as well (Song et al. 2010).
2.2.6 Nudt10
Although phylogenetic analysis of the Nudix hydrolase Nudt10 identified the protein as a
diphosphoinositol polyphosphate phosphohydrolase, no activity on its major substrate, 5diphosphoinositol pentakisphosphate (5-PP-InsP5) could be detected (Carreras-Puigvert et al.,
2017). Interestingly, given the very similar sequences, the human Nudt10 and Nudt11 mRNAs
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encode identical proteins (Song et al., 2013) and the expression of both proteins was found to be
essential for cancer cell survival. Nudt10 lacks efficient mRNA decapping activity (Song et al.
2010).
2.2.7 Nudt12
The human genome contains 24 genes encoding proteins belonging to the Nudix
superfamily. NUDT12 is a member of a subset of this superfamily encoding for NADH
diphosphatases and the closest homolog of the bacterial NudC protein. The successful
recombination of NUDT12 from pET vectors in E. coli BL21 (DE3) cells has not been reported
yet. Characterization of the human Nudt12 protein was thus done using a baculovirus expression
system (Abdelraheim et al., 2003). Not only does the human NUDT12 gene have a very well
conserved Nudix motif close to the C terminus, it also has a downstream sequence CQPWPMPSS
characteristic of other known NADH diphosphatases. The large N-terminal domain also contains
the Nudix fold and a single ankyrin repeat sequence which is required for RNA deNADding
activity but unnecessary for the hydrolysis of NAD alone (Grudzien-Nogalska et al., 2019). This
class of enzymes have a clear preference for reduced nicotinamide nucleotides.

Table 2-2| Substrate specificity of Nudt12
SUBSTRATE
RELATIVE ACTIVITY (%)
ADP
2
ADP-ribose
57
AMP
0.2
dATP
4.9
FAD
63
NAD+
59
NADH
100
NADP+
63
NADPH
136
Each activity has been calculated at substrate concentration= 250 µM and normalized, where 100%
activity is assumed to be 11.5 µmol NADH hydrolyzed• min-1• (mg protein)-1 under similar
conditions. Values are averages of duplicate experiments. Data from (Abdelraheim et al., 2003).
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As expected, Nudt12 has also been found to be enzymatically active on a wide range of
substrates, most active on NADH and NADPH and least active on deoxynucleoside 5’triphosphates, nucleoside 5’-diphosphates and 5’monophosphates. Assays to determine substrate
specificity and kinetic parameters were measured colorimetrically under physiological conditions
at alkaline pH and 0.4 mM Mg2+ ion concentration.
In 2003, Nudt12 was expressed as a C-terminal fusion to enhanced green fluorescent
protein and found to be localized to the peroxisomes and larger, unidentified structures in the
cytoplasm by the C-terminal tripeptide PNL acting as a novel peroxisomal targeting signal type 1
(PTS1). They were later confirmed in the cytoplasm in kidney cells (Carreras-Puigvert et al.,
2017). Deletion of this PTS1 obliterated the peroxisomal localization. HeLa cells were also cotransfected with the recombinant C-terminal fluorescent construct of Nudt12 and another Cterminal fusion to red fluorescent protein of a known peroxisomal protein- mouse Nudt7 CoA
diphosphatase. The two signals were found to co-localize, leading to the belief that the role of
Nudt12 may be to regulate peroxisomal nucleotide cofactor coenzyme concentrations or to remove
unknown and probably toxic oxidized nucleotide metabolites generated within the cell organelle.
Mammalian cells contain more than 20 genes encoding proteins belonging to the Nudix
superfamily. Mouse Nudt12 and Nudt13 are members of this superfamily encoding for NADH
diphosphatases. His-tagged recombinant proteins were expressed from cDNAs encoding the for
these diphosphatases and their activity on mRNA decapping has been studied extensively. The
tested recombinant proteins have a well conserved Nudix motif.
Nudt12 among other Nudix hydrolases also effective decapping activity on unmethylated
capped RNA (Song et al., 2013). Nudt12 can cleave either between the α- or β- phosphate to yield
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GMP. For monomethylated capped RNA substrates, Nudt12 can hydrolyze between the α-β- and
β-γ- phosphates.

Figure 2-3| Possible cleavage site(s) within the cap structure

Nudt3, Nudt12 and Nudt16 have effective decapping activity on both (A) unmethylated and (B)
monomethylated capped RNA, cleaving either between the α- or β- phosphate to yield GMP, or
between the α-β- and β-γ- phosphates, respectively. Based on information from (Song MG et al.,
2013)
When compared to DcpS, a scavenger mRNA decapping pyrophosphatase, the scavenger
decapping of Nudt12 on m7GpppG cap structure, although existent is not comparable in vitro.
Similar to the bacterial and human Nudix NADH diphosphatase, mouse Nudt12 can also hydrolyze
free NAD into nicotinamide riboside monophosphate (NMN) and adenosine monophosphate
(AMP). As predicted, Nudt12 cleaves the NAD-capped RNA substrate between the diphosphate
linkage, mimicking the activity of NudC releasing NMN from NAD-capped RNA yet different
from that of the Decapping and eXOribonuclease (DXO) protein, which removes the entire NAD
moiety from the RNA substrate (Grudzien-Nogalska et al., 2019). Nudt12 uses the same active site
to both deNAD and decap m7G-capped RNA and has an impressive preference for deNADding
over decapping. DeNADding enzymes have thus been classified into three broad categories. The
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first class is the DXO family proteins that remove the entire NAD moiety from the 5’ end of the
RNA substrate. The second one comprises of NudC and Nudt12 which cleaves the pyrophosphate
linkage within the NAD alone or on the 5’end of the RNA substrate. The third class comprises of
RppH which is minimally active on free NAD but does cleave NAD off the 5’end of RNA. These
classes of deNADding enzymes also function differently under environmental stress.

Table 2-3| Classes of deNADding enzymes
CLASS ENZYME SUBSTRATE
PRODUCT
1
DXO
NRppA--- RNA
NRppA + p--- RNA
2
NudC
NRppA
NRp + pA or
Nudt12
or
NRp + pA--- RNA
NRppA --- RNA
3
RppH
NRppA --- RNA NRp + pA--- RNA
The first class of DXO family of proteins remove the entire NAD modification from the terminal
end of RNA, while the second class of NAD-cleaving Nudix hydrolases cleaves the phosphodiester
linkage within the NAD alone, or when attached to RNA. The third class, the bacterial RppH
cleaves NAD off the terminal end of RNA transcripts. Table based on information from (Kiledjian,
2019).
Not only does Nudt12 function as a deNADding enzyme in vivo as it does in vitro, it also
modulates the stability of NAD-capped RNAs. Cells lacking either Nudt12 or DXO or both
contained an increase in total NAD-capped RNA levels, indicating that Nudt12 and DXO target
specific and distinct groups of cellular mRNAs. mRNAs involved in oxidative phosphorylation
are specifically targets for Nudt12, unlike the snoRNAs and the related small Cajal body RNAs
that are deNADded by DXO. Cellular stress, either heat shock or glucose deprivation led to an
impressive increase in NAD-capped RNA transcripts. The specific Nudt12 targeted NAD-capped
mRNAs favorably increased after glucose deprivation, but not heat shock confirming that Nudt12
indeed modulates mRNAs involved in cellular metabolism. This suggests that there may be a
physiological connection between the metabolic cellular environment and its mRNA composition.
However, how these deNADding enzymes target specific RNA substrates is still a mystery.
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Certain Nudix hydrolases, including Nudt12 is overexpressed in a variety of cancer cells.
The human protein is involved in the regulation of endogenous HIF-1α protein under hypoxic
conditions in HeLa cells. Highly oxidative environment in these cells lead to the accumulation of
ADP-ribose, which initiates homeostasis by overexpression of ADP-ribose cleaving Nudix
hydrolases. Even though Nudt12 does not completely remove the substrate, the cells survive by
enhancing HIF-1α protein expression (Yoon et al., 2018).
The catalytic domain of mouse Nudt12 consists of a N-terminal subdomain, a zinc-binding
motif and a C-terminal subdomain. It forms a dimer of similar conformational monomers. This has
been solved in complex with AMP and three Mg2+ ions. Although the structure of mouse Nudt12
and E. coli NudC are very similar, there are noticeable structural differences in the N-terminal
domain. The interactions between the phosphate group of AMP and Nudt12 are mediated by the
three Mg2+ ions, unlike the AMP portion of NAD in complex with NudC.

Figure 2-4| Crystal structure of the mouse Nudt12
dimer
Crystal structure of the mouse Nudt12 (PDB: 6O3P)
protein (Kiledjian, 2019). Its two monomers,
highlighted in grey and cyan, are in complex with AMP
and three Mg2+ ions (yellow). This was solved by at
1.6Å resolution.
2.2.8 Nudt13
The human genome encodes for NUDT13, containing a sequence typical of the NADH
pyrophosphohydrolase subfamily of the Nudix hydrolases. The gene expresses the Nudt13 protein,
with in vitro hydrolytic activity on NADH/NADPH to yield NMNH and AMP/2',5'-ADP.
Characteristic to this class of Nudix hydrolases, Nudt13 too had a striking preference for the
reduced pyridine nucleotides over nucleotide substrates. Expression of Nudt13 as an N-terminal
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fusion to green fluorescent protein confirmed that it is explicitly a mitochondrial protein, directed
to the organelle by the N-terminal targeting peptide. Its subcellular localization suggests that the
physiological role of Nudt13 may be to regulate the concentration of reduced pyridine nucleotide
cofactors and in the maintenance of NAD(P)+/NAD(P)H ratio in the mitochondria (Abdelraheim
SR, et al., 2017). Interestingly enough, compared with all other analyzed Nudix enzymes, Nudt13
was essential for the survival of human epithelial CCD841 cells (Carreras-Puigvert J et al., 2017).
2.2.9 Nudt16
The mammalian genome encodes for NUDT16 gene expressing Nudt16, a Nudix inosine
triphosphate (ITP)/xanthosine triphosphate (XTP)/GTP-binding protein (Iyama et al., 2010).
Initially, the protein was identified in Xenopus as X29, a nucleolar decapping enzyme that
specifically binds the U8 snoRNA (Tomasevic et al., 1999). Typical to this class of enzymes, the
Nudt16 protein utilizes divalent metal ions, with a very efficient yet unspecific hydrolysis and
decapping activity in the presence of Mn2+ or Co2+ for all RNA transcripts, and with very specific
activity for only U8 snoRNAs in the presence of Mg2+ (Peculis et al., 2007).
In vivo, Nudt16 was found to be predominantly localized in the nucleus, especially in the
nucleolus and to be involved in mRNA decapping (Song et al. 2010; Iyama et al., 2010).
Interestingly, Nudt16 also has in vitro hydrolytic activity on protein-conjugated ADP ribose. As
discussed previously, this activity is owed to the 310 helix sequence found downstream from the
Nudix box (Daniels et al., 2015). Initially, Iyama et al. (2010), proposed that Nudt16 is a
(deoxy)inosine diphosphatase, protecting the cells from deleterious effects of (d)ITP,
accumulation of single-strand breaks in nuclear DNA and/or increased levels of inosine in RNA.
However, subsequently the protein was found to have mRNA decapping activity in vitro.
Nudt16 predominantly cleaves capped mRNA transcripts between the α- and β- phosphate, while
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substrates with an unmethylated cap is cleaved both between the α- and β-, and β- and γphosphates with comparable activity (Song et al., 2013). Other cap analog structures containing
additional modifications such as m7Gpppm2’-OG, m2,2,7GpppG, GpppG and ApppG were also
hydrolyzed by Nudt16, with an efficiency comparable or higher to that for canonical cap hydrolysis
(Grzela et al., 2018). Under similar conditions, the protein also has minimal activity on isolated
cap structures and short capped oligonucleotides. Together, confirming that the enzyme recognizes
the first transcribed nucleotide alone.
2.2.10 Nudt20 (Dcp2)
The Nudt20 (Dcp2) protein was first identified in yeast by Parker et al. (1999) to be
associated with the major pathway of mRNA degradation and for long believed to be the only
mRNA decapping enzyme. The protein, containing a MutT/Nudix motif in its N-terminal domain,
both necessary and sufficient for mRNA decapping, was recruited for the decapping of both
nascent and aberrant mRNA transcripts. Later, the protein was confirmed as pyrophosphatase and
renamed Nudt20 as a member of the Nudix hydrolase superfamily of proteins. The core decapping
enzyme, encoded by the DCP1 gene comprises of the regulatory Dcp1 and the catalytic Dcp2
subunit, which interacts with further accessory enhancer proteins such as the Lsm1-7 complex,
Pat1, Edc1-Edc2 and/or Edc3 to reach its catalytic optimum (Charenton et al., 2016). Human Dcp2
protein cleaves the canonical capped RNA transcripts to yield m7GDP and 5'-phosphorylated
mRNAs, that are subsequent substrates for 5'-3' exonuclease decay. Consistent to members of the
Nudix family, Dcp2 has an alkaline pH optimum. However, unlike typical members of the family,
human Dcp2 requires the presence of a long RNA substrate, preferably longer than ~25
nucleotides, attached to the cap structure. This substrate specificity alone confirms that capped
mRNA transcripts are natural substrates for the enzyme. In vivo, human Dcp2 co-localizes mostly
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in specific sub-structures in the cytoplasm with very minimal traces in the nucleus suggesting that
mRNA decay may occur in a dedicated cellular compartment (van Dijk et al., 2002; Wang et al.,
2002), subsequently better confirmed by the identification of P-bodies (Sheth et al., 2003).
Substrate specificity for Dcp2 is achieved in multiple possible ways. RNA cap recognition
occurs during the catalytic step of the enzyme, with an ATP molecule bound in the catalytic pocket
in the closed complex formation. The transcript, within 10 nucleotides of the cap structure, itself
may promote decapping by binding to the dorsal surface of the Nudix motif or the secondary
structure of the stem-loop commonly termed as the “Dcp2 binding and decapping element”,
thereby increasing the local concentration of the cap for formation of weak, but specific
interactions (Deshmukh et al., 2008; She et al., 2008). Alternatively, decapping can also be
stimulated by a cis-element in the mRNA target (such as an AU-rich element in the 3’- UTR or
oligouridylation at the 3’- end of an already deadenylated RNA), which is recognized by Dcp2,
which in turn employs the Dcp1:Dcp2 complex (Li et al., 2010).
2.3

Pyridine Dinucleotides in Biology

Initially, the pyridine dinucleotides, NADP+ and NADPH, were believed to be functional
as essential coenzymes in reductive-oxidative glycolysis alone. Soon, its role in human nutrition
and cofactor biosynthesis was confirmed. More recently, the role of NAD+ in protein deacetylation
shed new light. In 2006, Belenky et al. classified NAD+ consumers into three broad classes; first,
ADP-ribose transferases or poly (ADP-ribose) polymerases, second are the cADP-ribose synthases
and third are type III protein lysine/histone deacetylases.
2.3.1 Metabolism
Nicotinamide adenine dinucleotide (NAD), its oxidized form, NAD+, its reduced form,
NADH, and their phosphorylated forms, NADP+ and NADPH, are electron carriers and cofactors
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of various metabolic redox reactions thereby essential for the maintenance of in vivo cellular redox
homeostasis. In mammalian cells, NAD+ is synthesized by three different pathways: the de novo
pathway, the Preiss–Handler pathway and the salvage pathway using tryptophan, nicotinic acid,
nicotinamide and nicotinamide riboside as precursors. Upon metabolic pathway analysis, the
concentration of the NAD moiety is usually assumed to be constant, even though its redox state
may change. Although recently, several NAD-consuming reactions have been identified,
challenging this exact assumption. NAD-consuming reactions are typical of NAD+-dependent
signaling and gene regulation pathways such as DNA-repair or regulation of enzymes fundamental
to metabolism, including poly-ADP-ribosylation of proteins, NAD+-dependent deacetylation by
sirtuins and the formation of messenger molecules such as cyclic ADP-ribose (cADPR). Imbalance
in NAD homoeostasis has been associated with various diseases, thus the complete understanding
of the dynamics of NAD metabolism is essential for efficient pharmacological development in this
area (Opitz et al., 2015; Xiao et al., 2018).
Intracellular concentrations of these cofactors usually range in the micromolar range, in
human cells. The inner mitochondrial membrane is impermeable to NADH and NADPH, hence
have to be regulated by multiple shuttle systems, thus maintaining in vivo subcellular localization
(Houtkooper et al., 2010). These shuttle mechanisms aid the cells to maintain redox homeostasis
in both normal and stressed conditions, arising from excess levels of cellular NADH and/or
NADPH.
2.3.2 Sirtuins (Histone Deacetylases)
Histone deacetylases (HDACs) are enzymes that deacetylate lysine side chains in histones
and some non-histone proteins, leading to altered states of conformation and activity of these
proteins. The catalytic activity of one subclass of these enzymes depends on NAD+. Nicotinamide
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(Nam) and O-acetyl ADP ribose are formed as a result of this acetyl transfer. These NAD+dependent deacetylases are more commonly termed sirtuins because of the homologous yeast
histone deacetylase silent information regulator 2 (Sir2). Sirtuins contain a Nam binding that site
that may be occupied in the presence of substrate or enzyme intermediate, leading to product
inhibition. Thus, the salvage of Nam is essential for NAD+ metabolism (Sauve et al., 2005).
Sirtuins are very well conserved from prokaryotes to eukaryotes and have since then been
implicated in the regulation of molecular mechanisms of aging. Sirtuins also function as sensors
for glucose uptake in response to NAD+ levels (Trapp et al., 2006).
2.3.3 Poly (ADP-ribose) Polymerase
Poly (ADP-ribose) polymerases (PARPs) catabolizes NAD+ to yield an ADP-ribosyl
protein modification and/or form an ADP-ribose polymer (PAR). In response to DNA damages,
PARP-1 utilizes NAD+ as a substrate to catalyze the covalent attachment of negatively charged
PAR moieties on PARP-1 itself (automodification) or on acceptor proteins which are usually
involved in DNA transactions (heteromodification), as a unique post-translational modification. It
has been hypothesized that the inhibition of PARP may be linked with the protection of in vivo
levels of NAD+, which leads to the regulation of cell survival, transcriptional regulation and
telomere cohesion during cell division and energy metabolism (Belenky et al., 2006; de Murcia et
al., 2006).
2.3.4 DNA Ligase
DNA ligases catalyzes the closure of nicks in the phosphodiester backbone of doublestranded DNA, hence is crucial for DNA replication and repair. They are classified as NAD+ or
ATP-dependent enzymes based on their preference for the respective co-factors. The NAD+dependent ligases (LigA) are found exclusively in eubacteria and some viruses (Sriskanda et al.,
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2001). The ATP-dependent ligases are found in all other kingdoms, including both prokaryotes to
eukaryotes. Either cofactor is recognized as an AMP-donor triggering the transfer of bound AMP
to a free 5′- phosphate on DNA, which in turn catalyzes the joining of the nick and finally releases
free AMP (Khorana et al., 1970; Sgaramella et al., 1970).
2.3.5 NAD Binding Pocket composed of RNA
A complex secondary structure of the RNA aptamer, containing two interacting stem-loops
was identified as nicotinamide-binding site. Site-directed mutation within the binding site
confirmed the comparative specificity between the two redox states of the nicotinamide-containing
cofactor (Lauhon et al., 1995).
2.3.6 NAD Ribozymes
Ribozymes are RNA molecules, capable of catalyzing chemical reactions. Compared to a
protein enzyme, the catalytic unit of an RNA molecule is only a small portion, yet its activity is
considerably higher. Two essential cellular processes are known to be catalyzed by ribozymes: the
peptidyl transferase by the large subunit of the ribosome and eukaryotic mRNA splicing by the
U2-U6 snRNA.
RNA can specifically bind cofactors, namely riboflavin and beta-nicotinamide
mononucleotide (NMN) with low micromolar affinity (Lauhon et al., 1995).

These RNA

molecules are able to discriminate between the two redox states of the nicotinamide-containing
cofactors, as well. This discovery led to a framework for generating novel ribozymes that might
catalyze metabolic redox reactions.
An RNA molecule (ribox02), coupled with a Zn2+-dependent redox relay between NADH
and FAD to give a NAD+-regeneration system, was identified to have catalytic activity similar to
protein alcohol dehydrogenase (Tsukiji et al., 2003). Ribox02 oxidizes benzyl alcohol derivatives
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to its corresponding aldehyde, covalently attached to the 5′-end of RNA in the presence of NAD+
and Zn2+. Interestingly enough, the conjugate of the same ribozyme is able to catalyze the reverse
reduction reaction in a NADH and Zn2+ dependent mechanism (Tsukiji et al., 2004).
2.3.7 RNA binding metabolic enzymes
Initially, proteins that bind RNA were considered functionally distinct from proteins that
bind DNA which was eventually debunked with the discovery of long non-coding RNAs
(lncRNAs). Nucleic acid binding proteins regulates several cellular processes like transcription,
translation, gene silencing, microRNA biogenesis and telomere maintenance (Hudson et al., 2014).
Several NAD+-dependent glycolytic enzymes, such as lactate dehydrogenase (LDH),
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Pekala et al., 1996) and phosphoglycerate
kinase (PGK) (Shetty et al., 2004), have been demonstrated to bind RNA. LDH catalyzes the
reversible hydride transfer from lactate to pyruvate and back, in a NAD+/NADH dependent
manner. The direct interaction of LDH with an AU-rich element RNA-binding protein 1 (AUF1)
has been confirmed to exist as a complex in vivo (Pioli et al., 2002). These glycolytic enzymes
also possess a coenzyme binding domain and it has been revealed that NAD+ or NADH binding
can compete with RNA binding.
GAPDH is a noncanonical RNA-binding protein (RBP) that binds to a variety of RNA
transcripts, including tRNA, ribozymes and viral RNAs, to regulate the stability and translation of
cellular mRNAs (Garcin et al., 2015; Garcin, 2018). GAPDH was classified as an AU-rich
sequence binding protein (AUBP) because the enzyme showed a strong preference for RNAs
containing AU-rich sequences in the NAD+-binding site (Nagy et al., 1995; White et al., 2016).
2.4

Damaged NADH
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Human renalase (HsRen) was first discovered as a flavoprotein secreted into the blood by
the kidney as a hormone to decrease concentrations of catecholamine neurotransmitters, hence
lowering blood pressure and cardiac rate (Xu et al., 2005). Initially, it was suggested that the
catalytic role of the enzyme is to oxidize epinephrine to adrenochrome (Desor et al., 2012).
However, this conversion is effortless under a variety of other conditions and has led to question
the direct role of renalase with the breakdown of catecholamines. More recently, it has been
established that renalase is not the third monoamine oxidase (Beaupre et al., 2015) and is in fact
responsible for the catalytic oxidation of isomeric forms of NAD(P)H molecules that are reduced
at the 2 or 6 position of the nicotinamide ring instead of the metabolically active 4-position. This
is the first instance that a flavoprotein has been shown to catalyze an anomerization reaction and
redefines the metabolic function of renalase as a house-keeping enzyme than a regulator of blood
pressure (Beaupre et al., 2013).
Although the renalase sequence is not very well conserved among species and makes it
difficult to recognize the protein across various species, three renalases from Human,
Pseudomonas phaseolicola and Pseudomonas aeruginosa have common catalytic activity (Moran
et al., 2017). Regardless of the poor sequence conservation, these proteins have similar tertiary
structure. Like most other redox active flavoproteins, renalase has a flavin adenine dinucleotide
(FAD) cofactor hidden deep within the protein.
The discovery of isomeric forms of NAD(P)H as a substrate for renalase was almost
serendipitous. The 2-dihyhdroNAD (2DHNAD(P)) and 6-dihydroNAD (6DHNAD(P)) differs
from NAD(P)H in the position of the hydride which resides on either the 2 or the 6 position of the
nicotinamide instead of the native 4 position. In-vitro, these molecules can be synthesized from
nonspecific borohydride reduction of NAD(P)+ or tautomerization of NAD(P)H.
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Figure 2-5| Reduction of β-NAD(P)+

In vitro borohydride reduction places the hydride on either the 2 or 6 position of the nicotinamide
instead of the canonical 4 position, highlighted in red to yield wither 2-dihyhdroNAD
(2DHNAD(P)) or 6- dihydroNAD (6DHNAD(P)) respectively. Figure based on information from
(Moran, 2016).
The quick and complete reduction of the renalase Flavin cofactor was initiated with
saturating amounts of an aged NAD(P)H solution stored at -20°C. When the 6- and 2-DHNAD
species formed by nonenzymatic reduction of NAD+ was reacted with renalase, two out of the
three products formed were oxidized to NAD+ by the enzyme, indicating that the enzyme can
oxidize two separate isomeric forms of the substrate. The bacterial renalase (PpRen) reduces 2DHNAD(P) more rapidly than 6-DHNAD(P). However, the human form (HsRen) reduces 6DHNAD relatively slower than 2-DHNAD. For both renalases, NADH seems to bind tighter than
NAD(P)H which is probably because of the solvent exposed 2’-phospho group having no favorable
interactions with the enzyme. Although HsRen seems to bind 2-DHNAD and 6-DHNAD slightly
better than 4-DHNAD (NADH), PpRen does not share the same isomeric selectivity. This
incompetence of renalase to distinguish between NAD(P)H isomers suggested that other cofactor
dependent enzymes may experience similar inhibition by 2- and 6-DHNAD(P). This proves that
the isomeric forms of β-NAD(P)H are possibly toxic to the cell, hindering the activity of several
primary metabolic enzymes (Beaupre et al., 2015).
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Table 2-4| Inhibitory effect of 6DHNAD
ENZYME
6DHNAD Ki (µM)
P. phaseolicola GAPDH 1.63 ± 0.195
P. phaseolicola IDH
1.39 ± 0.130
P. phaseolicola ME
4.51 ± 0.185
P. phaseolicola DLD
ND
E. coli MDH
0.585 ± 0.037
Pig DLD
3.1 ± 0.3
Rabbit LDH
ND
Inhibition constants, Ki were calculated by IC50 analysis at a ß-NADH substrate concentration
equivalent to the Km value. No inhibition was observed for either P. phaseolicola DLD or rabbit
LDH. Table based on information from (Moran et al., 2017).
It may be hypothesized that in the cellular environment, the metabolic role of renalase is
to oxidize the inhibitory isomers of NADH to form NAD+ and deliver the electrons gathered to
dioxygen using the flavin cofactor forming H2O2 and NAD(P)+. Although the isomers are
inhibitory towards an array of enzymes, the obvious concern is whether these toxic isomers of βNAD(P)H exist in-vivo. Renalase oxidizes these toxic isomers more rapidly than catecholamines
with or without NAD(P)H. To support this concern, it may be argued that renalase has been
identified in species, where they do not require catecholamines or experience hypertension such
as Pseudomonas.
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2.5

Canonical caps

Initially, the presence and absence of a molecular cap structure on the 5’- end of messenger
RNAs was considered to be the distinction between eukaryotes and prokaryotes. In eukaryotic
cells, the m7G 5’- cap structure is added co-transcriptionally to the 5’- end of nascent pre-mRNA
transcripts. The cap is attached in parallel with RNA transcription, due to the combined effect of
three enzymatic steps. The function of this cap feature and cellular cap binding proteins in gene
expression regulation has been studied extensively. This modification stabilizes mRNAs by
protecting them against exonucleases and leads to polyadenylation, splicing and nuclear export of
mRNAs. Thus, the cap structure plays a significant role in the life cycle of mRNA and is crucial
for efficient gene expression and cell viability. The cap structure is needed for optimal translation
of a vast majority of cellular mRNAs (Topisirovic et al., 2011). It is extensively found on
eukaryotic viral and parasitic mRNA transcripts. In the eukaryotic cellular environment, two capbinding proteins have been studied extensively: eukaryotic translation initiation factor 4E (eIF4E)
in the cytoplasm and the nuclear cap binding complex (nCBC), a nuclear complex consisting of
cap binding protein 20 (CBP 20) and cap binding protein 80 (CBP 80).
2.6

Non-canonical caps

More recently, chemical modifications have been discovered in bacterial RNAs that
structurally resembles the eukaryotic mRNA cap, although the capping mechanism is
fundamentally different than that of eukaryotes (Bird et al., 2016). Using MS-based technique, two
essential coenzymes in bacterial physiology, nicotinamide adenine dinucletide (NAD+) and 3’dephospho-coenzyme A (dpCoA) have been identified on the 5’- end of RNA transcripts from E.
coli and Streptomyces venezuelae. This explains how coenzyme-modified RNA is synthesized in
bacteria. It has been confirmed that the coenzymes and metabolites, such as NAD+, its reduced
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equivalent NADH, Flavin adenine dinucleotide (FAD), uridine containing precursors of
oligosaccharide and cell wall biosynthesis and dpCoA compete with the regular NTP, adenosine
triphosphate, in the initiation step of transcription, and is incorporated by bacterial RNA
polymerase (RNAP) into a full-length RNA at the +1 position. Although whether NADH, FAD,
UDP-glucose and UDP-N-acetylglucosamine modified RNA exist in cellular environments is yet
to be proven. The km for NAD+ in transcription initiation is considerably lower than the in vivo
concentration of NAD+. RNAP successfully incorporates an array of known nucleotide-containing
molecules and identified yet uncharacterized moieties at the terminal end of RNA substrate,
suggesting a wide range of RNA caps in vivo. Upon crystallization of RNAP in complex with a
short NAD capped RNA, the NMN part of the molecule does not contact DNA but faces the protein
instead. Also, two domains of the RNAP enzyme, the rifampicin-binding pocket and the RNAP
active center determine NAD+ capping efficiency. It is interesting to note that rifampicin resistant
RNAPs are deficient in capping (Julius et al., 2017).
Human mitochondrial RNAP, too, can cap RNA with NAD+ and other ADP-containing
cofactors, on one of the two human mitochondrial promoters, light strand promoter (LSP) in vitro
(Julius et al., 2018). Although the efficiency of NAD+ initiation is markedly lower than that of
ATP, the mitochondrial RNAP is probably responsible for mitochondrial NAD+ modified RNA
transcripts.
Unfortunately, the technique to identify these chemical modifications required the
complete hydrolysis of the RNA substrates and failed to identify the sequences. A novel capture
protocol, the NAD captureSeq was designed, combining enzymatic transglycolation with “click”
chemistry (Cahová et al., 2015). The technique involved the isolation of NAD-modified RNA by
reacting with ADP-ribosyl cyclase (ADPRC) followed by a “click” reaction by copper-catalyzed
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azide alkyne cycloaddition (CuAAC) and specific enrichment, cDNA preparation and the
validation of NGS results. In E. coli, sRNAs regulating plasmid replication (RNAI and CopA),
mRNAs encoding for proteins involved in cellular metabolism (gatY, pgk, hdeD) or leader
peptides with known regulatory functions (ilvL, hisL) were identified with this approach. It is
worth mentioning that tRNAs and rRNAs were not enriched with this protocol. In yeast and human
cells, a subset of eukaryotic RNAs (mRNA, snoRNA and small Cajal body RNAs [scaRNAs])
were enriched with the NAD captureSeq technique.
The main concern that remains is the biological role of these NAD modifications on RNA
transcripts. The role of bacterial NAD+ cap on translation is not known yet, although it is believed
that the NAD+ cap structure enhances RNA stability. However, whether selective stabilization and
degradation are the only functions of these unconventional RNA headgears still remains to be seen.
It may be argued that the deletion of the decapping enzyme, NudC did not affect the overall in vivo
stability of the RNA transcripts most abundantly modified by heavily NAD+ namely RNAI and
GcvB. In E. coli, proportion of NAD-capped RNA found in the stationary phase was much higher
than the exponential phase, suggesting that non-canonical capping may be responsive to alterations
in cellular metabolism. The coenzymes and metabolites attached to RNA may provide a layer of
‘epitranscriptomic’ information that modifies the activity of RNA without altering its sequence,
has recently been proposed as a possible role as well. However, in eukaryotic cells, NAD-capped
mRNA failed to translate.
Terminal modifications of RNAs are reversible to allow RNA turnover. Thus, removal of
the 5’-cap is essential to controlling mRNA stability and efficient gene expression. Its regulation
is dependent on the availability of the decapping enzyme and the recognition of the mRNA
transcript containing the 5’-end modification. Eukaryotic mRNA decay is initiated with the
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removal of the 3’-poly(A) tail. It is followed by either 3’→5’ decay where the RNA transcript is
exonucleolytically degraded by the cytoplasmic exosome and the potentially toxic cap structure is
hydrolyzed by scavenger decapping enzymes or 5’→3’ degradation where the cap pyrophosphate
bond is first cleaved by decapping enzymes proceeded by exoribonucleolytic degradation of the
monophosphorylated RNA. Mammalian cells express multiple mRNA decapping enzymes, all
Nudix proteins such as Dcp2 (Nudt20), Nudt2, Nudt3, Nudt12, Nudt15, Nudt16, Nudt17, and
Nudt19 (Grudzien-Nogalska E et al., 2017). Decapping is not only restricted to eukaryotic proteins,
the bacterial Nudix protein RppH is involved in the hydrolysis of the 5’ triphosphorylated ends to
their monophosphorylated forms in a ‘5’- dependent pathway’. Similar to the eukaryotic Nudix
hydrolases, bacterial Nudix NADH diphosphatase NudC efficiently removes the NAD+ caps from
RNA to produce 5’- monophosphorylated RNA. Additional bacterial Nudix hydrolases have been
characterized with potential but poor decapping activity, suggesting redundancy. In yeast,
decapping is carried out by the Nudix hydrolase NPY1 and by Nudt19 in Oryza sativa (Zhang et
al., 2016).
Eukaryotic and prokaryotic RNA decapping enzymes have been classified into four
categories based on their different catalytic mechanisms and structures. First are the nudix
hydrolases, which account for most eukaryotic decapping enzymes hydrolyzing the cap phosphate
bond. Second are the DXO family of proteins, which are involved in mRNA cap quality control,
selectively degrade mRNAs with a mutated cap or non-canonical caps. Third are the Histidine
triad (HIT) family of proteins, which are involved in the cleavage of a pyrophosphate bond of
capped di- or oligonucleotides. Fourth are the ApaH-like phosphatases, which are involved in the
5’→ 3’ decay of capped mRNA transcripts.
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2.7

Assays

2.7.1 Colorimetric assay
As early as in 1966, a simple and quantitative protocol was demonstrated for the easy
colorimetric determination of inorganic phosphate. This assay was based on the principle that a
alkaline triphenylmethane dye, such as malachite green (MG) at lower pH forms a complex with
phosphomolybdate, causing a shift in its absorption maximum (Itaya & Ui, 1966). Release of
inorganic phosphate as low as 50 ng can be detected by this method. Since the initial discovery of
the quantitation assay, it has been modified by Penney (1976) by eliminating the use of detergents
altogether while Rosenfeld et al. (1978) replicated the same principle to quantify organic
phosphorus in phospholipids, and Karl et al. (1982) investigated the effects of interfering proteins
and detergents in this assay.
Catalytic activity may also be monitored upon the incubation of Nudix hydrolase, coupling
enzyme (phosphatase) and an inorganic phosphate (Pi) sensor (Brune M et al., 1998) with an
already identified Nudix substrate. The Nudix hydrolase cleaves between the diphosphate bond,
yielding a molecule with a terminal phosphate group. A coupling phosphatase then releases an
inorganic pyrophosphate, which is captured by the Pi sensor, generating an increase in
fluorescence (Xu A et al., 2013).
2.7.2 High Performance Liquid Chromatography (HPLC)
The identity of substrates and enzyme-treated products can be confirmed from highpressure liquid chromatography (HPLC) analysis. After incubation, the sample is filtered to
remove the protein and subjected to identical HPLC analysis. The samples injected onto a Waters
Xterra C18 cartridge column (4.6 × 150 mm2) are run isocratically at 0.5 mL/min with 10 mM
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NaPi, pH 7.5, coupled to a Waters 600E pump and a Waters 2487 detector. The elution of the
components can then be observed at their absorption maxima (Beaupre et al., 2013).
2.7.3 In vitro transcription of ncinRNA
Adenosine-containing coenzymes CoA, NAD, NADH and FAD can initiate in vitro
transcription under the T7 class II promoter by T7 RNA polymerase to yield these coenzymes
covalently attached to the terminal end of the RNA transcripts. In vitro transcription of noncanonical capped RNA was confirmed, either by polyacrylamide gel electrophoresis, excision and
recovery by ethanol precipitation and recorded to have a fluorescence (FAD emission wavelength
at 530 nm when excited at 370 nm) spectrum (Huang, 2003) or identified by mass spectrometry
after exonucleolytic treatment (Höfer et al., 2016) or by acryloylaminophenyl boronic acid (APB)
affinity gel electrophoresis (Nübel et al., 2017).
2.7.4 Fluorescence Enhancement Assay
Unlike fluorescence resonance energy transfer (FRET) which requires two fluorescent
dyes, protein induced fluorescence enhancement (PIFE/PIFE) only needs a single dye attached to
nucleic acids to which an unlabeled protein is bound (Hwang et al., 2014). A method similar to the
PIFE protocol to study T7 DNA polymerase binding to DNA was the first every report of protein
binding to fluorescently labeled DNA, by monitoring a change in the intensity with single molecule
resolution (Luo et al., 2007).
Hwang et al., explained that PIFE is a photophysical phenomenon, where the intensity of
a fluorophore increases upon proximal binding to a protein (Hwang et al., 2011). This is commonly
demonstrated by fluorophores such as Cy3 attached to nucleic acid substrates, undergoing a cistrans photoisomerization reaction. The local molecular environment with the addition of proteins
reduces the rate at which the fluorophore can isomerize from the photo-active trans state to the
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photo-inactive cis state, resulting in an increase of quantum yield. The lifetime of the fluorescent
dye and an increase in viscosity of the in vitro experimental environment are factors affecting
fluorescence enhancement.
2.7.5 Lactate dehydrogenase assay
Vanderlinde (1985) studied the bidirectional redox reaction catalyzed by lactate
dehydrogenase between pyruvate and lactate. The production of NADH at 340 nm in the lactate
to pyruvate oxidation and the decay of NADH at 340 nm produced in the pyruvate to lactate
reduction reaction has been monitored spectrophotometrically (Vanderlinde, 1985).
2.7.6 Liquid chromatography–mass spectrometry (LC/MS)
David Liu’s lab (Chen et al., 2009) demonstrated a general protocol for the easy
identification of small molecule-RNA conjugates in both E. coli and S. venezuelae. NAD-modified
RNAs were identified amongst whole cellular RNAs isolated form whole cellular extracts.
Nuclease P1 treated samples were injected into high-resolution LC/MS. The stationary phase used
was a C18 column (1.7 µm, 2.1 mm x 100 mm), while the mobile phase was a combination of
0.1% aqueous ammonium formate, and 100% methanol. Electrospray ionization (ESI) was used,
keeping the flow rate at 0.300 mLmin-1 (Chen et al., 2009). These conditions will be mimicked in
our LC/MS experiments as well.

45

Chapter 3 Materials & Methods

3.1

Materials

3.1.1 Plasmid Vectors
pET24d-NudC and pET33-Nudt12 were constructed, as described in sections 3.1.2.1 and
3.1.2.2. Plasmids expressing NUDT1 (MutH1), NUDT3A, NUDT16A and NUDT20 (Dcp2) were
purchased from Addgene. The purchased construct was transformed into BL21(DE3) cells for
protein expression.
3.1.1.1 pET24d-NudC
E. coli nudC gene was amplified using PCR from DH5α colonies, with primers (Integrated
DNA Technologies, Coralville, IA) containing NcoI and BamHI restriction sites. The PCR product
was then cut with NcoI and BamHI and ligated into a similarly digested pET24d plasmid
(Novagen).
3.1.1.2 pET33-Nudt12
NUDT12 gene was amplified using PCR from pCMV-Nudt12, with primers (OriGene
Technologies Inc, Rockville, MD) containing BamHI and NdeI restriction sites. The PCR product
was then cut with NotI and ligated into a similarly digested pET33 plasmid (Novagen).
3.1.1.3 Nudt1
The vector expressing NUDT1 was designed and purchased through Addgene (Addgene
plasmid # 74660). The purchased construct was transformed into BL21(DE3) cells for protein
expression.
3.1.1.4 Nudt3A
The vector expressing NUDT3A was designed and purchased through Addgene (Addgene
plasmid # 42348). The purchased construct was transformed into BL21(DE3) cells for protein
expression.
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3.1.1.5 Nudt16A
The vector expressing NUDT16A was designed and purchased through Addgene (Addgene
plasmid # 42404). The purchased construct was transformed into BL21(DE3) cells for protein
expression.
3.1.1.6 pET28a-hDcp2
The vector expressing pET28a-hDcp2 was designed and purchased through Addgene
(Addgene plasmid # 72214) (Wang et al., 2002). The purchased construct was transformed into
BL21(DE3) cells for protein expression.
3.1.2 Proteins
The Nudix proteins of interest in this thesis have been listed below (Table 3-1). Subsequent
experiments discussing purification, concentration calculations and SDS-PAGE analysis of these
proteins are based on this table.

Table 3-1| Nudix hydrolases (properties)
Protein
NudC
Nudt1
Nudt3A
Nudt12
Nudt16A
Nudt20 (hDcp2)

Amino Acids
257
158
194
339
200
167

Fusion Tag
None
N-His
N-His
N-His
N- His
N-His

Mass (kDa)
27
22.5
19.7
52
22
49

Extinction Coefficient
61880 M-1cm-1
33,460 M-1cm-1
28,420 M-1cm-1
66,640 M-1cm-1
12,950 M-1cm-1
49,390 M-1cm-1

3.1.2.1 NudC purification
NudC was purified from BL21(DE3) Escherichia coli cells. The protein was purified from
soluble cell extracts by first precipitating the protein with nucleic acids using streptomycin sulfate.
The pellet was then dissolved and fractionated using a DEAE Sepharose column eluted over a 0500 mM NaCl gradient.
3.1.2.2 Nudt12 purification
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Nudt12 was purified from BL21(DE3) Escherichia coli cells. One-liter cultures were
harvested, lysed by sonication, and purified by using Ni-NTA column chromatography, gel
filtration column chromatography, and ultrafiltration. Final protein concentrations were
determined from absorbance at 280 nm using the extinction coefficients (Table 3-1).
3.1.2.3 Nudt1, Nudt3A, Nudt16A, hDcp2 purification
Nudt1, Nudt3A, Nudt16A, hDcp2 were purified from BL21(DE3) Escherichia coli
cells. One-liter cultures were harvested, lysed by sonication, and purified using Ni-NTA column
chromatography, gel filtration column chromatography, and ultrafiltration. Final protein
concentrations were determined from absorbance at 280 nm using appropriate extinction
coefficients (Table 3-1).
3.1.3 Oligonucleotides
Oligonucleotides were purchased from Integrated DNA Technologies and used for cloning
(Table 3-2), DNA Binding (Tables 3-3, 3-5) and RNA binding (Table 3-4).

Table 3-2|Oligonucleotides used for cloning
Name
NudC (NcoI)
NudC (BamHI)
Nudt12 (NdeI)
Nudt12 (BamHI)

Sequence
5’-GCG CGCCAT GGA TCG TAT AAT TGA AAA ATT AGA TC- 3’
5’-CGC GCG CGG ATC CTC ACT CAT ACT CTG CCC GAC- 3’
5’-GCG GCG CAT ATG ATG TCT TCT GTA AAA AGA AGT CTG AAG CAA G-3’
5’-GCG GCG GGA TCC TTA GAG ATT AGG ATT TAT TCT AAT CCA GTG- 3’

Table 3-3|DNA oligonucleotides used by binding assays
Name
Sequence
5’-GGTTCTGCGGGTGGCGGTACTA[Cy3] -3’
3’ Cy3
[HF]DNA45 (TYE45) 5’-[TYE563]TGGCGACGGCAGCGAGGCACCGATCACATGTTTTTTTTTTTTTTT-3’
5’-[HEX]TGGCGACGGCAGCGAGGCACCGATCACATGTTTTTTTTTTTTTTT- 3’
[HF]DNA45 (HF45)
[FAM]DNA18 (F18) 3’-[FAM]ACCGCTGCCGTCGCTCCG- 5’
[FAM]DNA38 (F38) 3’-[FAM]ACCGCTGCCGTCGCTCCGTTTTTTTTTTTTTTTTTTTT-5’
5’-[Cy5]TTTTTTTTTTTTTTT-3’
[Cy5]dT15
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GA9
C18
DNA29

5’-GAGAGAGAGAGAGAGAGA-3’
5’-CCCCCCCCCCCCCCCCCC-3’
5'-GCTCCCCGTTCATCGATTGGGGAGCTTTT-3’

Table 3-4|RNA oligonucleotides used by binding assays
Name
[FAM]RNA36
RNA18
RNA36
[Cy5]U15
RNA29

Sequence
5’-[FAM]UAGUACCGCCACCCUCAGAACCUUUUUUUUUUUUUU-3
5’-GCCUCGCUGCCGUCGCGA-3’
5’-UAGUACCGCCACCCUCAGAACCUUUUUUUUUUUUUU- 3’
5’-[Cy5]UUUUUUUUUUUUUUU-3’
5'-GCUCCCCGUUCAUCGAUUGGGGAGCUUUU-3'

3.1.4 Duplex Nucleic Acids
Duplex DNA strands were made by DNA annealing from two complementary singlestranded DNA (ssDNA) strands to yield a heteroduplex formation (Table 3-5).

Table 3-5|Partially Duplex DNAs used for Binding Assays
Name
HF45:comp15
HF45:comp20
HF45:comp25
HF45:comp30
HF45:comp35

Sequence
3’-ACCGCTGCCGTCGCT
[HEX]TGGCGACGGCAGCGAGGCACCGATCACATGTTTTTTTTTTTTTTT-3’
3’-ACCGCTGCCGTCGCTCCGTG
[HEX]TGGCGACGGCAGCGAGGCACCGATCACATGTTTTTTTTTTTTTTT-3’
3’-ACCGCTGCCGTCGCTCCGTGGCTAG
[HEX]TGGCGACGGCAGCGAGGCACCGATCACATGTTTTTTTTTTTTTTT-3’
3’-ACCGCTGCCGTCGCTCCGTGGCTAGTGTAC
[HEX]TGGCGACGGCAGCGAGGCACCGATCACATGTTTTTTTTTTTTTTT-3’
3’-ACCGCTGCCGTCGCTCCGTGGCTAGTGTACAAAAA
[HEX]TGGCGACGGCAGCGAGGCACCGATCACATGTTTTTTTTTTTTTTT-3’

Experiments described in Chapter 8 make use of fluorescently labelled nucleic acids,
properties of which have been listed below (Table 3.6).

49

Table 3-6|Fluorophores
Name
[FAM]
[Cy5]
[HEX]

Excitation
peak (nm)
495
649
535

Emission
peak (nm)
520
670
556

3.1.5 Longer RNA transcripts
Reaction mixture containing final concentrations of 1 mM GTP, 1.25 mM CTP, 1.25 mM
UTP, 1.25 mM ATP, 2.5 mM NAD+ (or NADH, NADPH, NADP+),4 mM ARCA mix, 1 µg DNA
template, 2 µl T7 RNA Polymerase Mix was made to a total volume of 20 µl. Initial reactions used
the provided CluC vector DNA template. Subsequently, gel extracted HindIII digested pET24dNudC was used as DNA template for in vitro ncinRNA transcription. The mixture was incubated
at 37 °C for 30 minutes followed by DNase I treatment, after which it was incubated 37 °C for
another 15 minutes. Newly synthesized RNA was precipitated using LiCl solution after incubation
at -20 °C for 30 minutes and centrifuged at 4 °C for 15 minutes. The RNA was rinsed with cold
ethanol and finally stored in a final volume of 50 µl 0.1 mM EDTA. This entire protocol was
followed from HiScribe T7 ARCA mRNA Kit (New England Biolabs).
3.2

Enzyme Assays

3.2.1 NAD Hydrolysis: Colorimetric
To test the enzymatic activity of Nudix hydrolases on NAD+, NADH, NADP+ and
NADPH, a colorimetric assay was used. Standard phosphate concentrations were made using
dilutions of 0.5 mM KPO4 made up to a total volume of 25 µl. Reactions containing 50 mM Tris
pH 8.5, 2 mM MgCl2, 1 mM DTT, NAD+ or NADH and Nudix hydrolase and made up to a total
volume of 40 µl. The reactions were incubated at 37 °C for 30 minutes, 1 unit of calf intestinal
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alkaline phosphatase (CIAP) was added and incubated at 37 °C for another 30 minutes. Samples
were terminated by adding 200 µl of the malachite green reagent (3 volumes 0.045% (w/v)
malachite green: 1 volume 4.2% ammonium molybdate in 4N HCl: 0.01 volume 10% Tween 20),
followed immediately by 25 µl of 35% sodium citrate. Absorbance at 630 nm was recorded on
Varian Cary 50 UV-Vis Spectrophotometer and net phosphate produced from a reaction was
calculated from the phosphate standard curve. Colorimetric assays could not be used to measure
the enzymatic activity of Nudix hydrolases on 6DNAD, as it was purified in phosphate containing
buffer.
3.2.2 NAD Hydrolysis: HPLC
Following the limitations on the colorimetric assay, an HPLC assay was designed to
analyze the enzymatic activity of Nudix hydrolases on NADH and its isomeric form, 6DNAD.
Standard solutions containing 100 µM AMP, ADP, ATP, NADH and 6DHNAD were made up to
a total volume of 50. Each sample was then injected onto a Waters Xterra C18 cartridge column
(4.6 × 150 mm2) run isocratically at 1 ml/min with 10 mM Phosphate buffer pH 7.5, coupled to a
waters 600E pump and Waters 2487 detector. The elution of the components was observed at both
260 and 340 nm. Samples containing 500 mM Tris pH 8.5, 2 mM MgCl2, varying concentrations
of substrate (NAD+, NADH or 6DNAD) and made up to a total volume of 500 µl. Reaction
mixtures containing additional Nudix hydrolases were incubated at 37 °C for 30 minutes, for
optimal activity or varying time points for time course experiments. To terminate any further
reaction, the samples were incubated 4 °C for 2 minutes and then filtered using a centrifugal filter
device. 50 μl of each sample was run on the instrument under identical conditions. Substrate and
products were identified and quantified by comparison of retention time and UV absorbance from
the initial standard curve, respectively.
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3.2.3 NAD Hydrolysis: Ratiometric Florescence
To test the enzymatic activity of NudC on the toxic isomer of NADPH, a novel assay was
designed with reaction mixtures containing 50 mM Tris pH 8.5, 2 mM MgCl2, 50 µM NADH and
0.74 nM NudC were incubated at 37°C. Following a brief incubation period, varying
concentrations of 6DHNADP was added to one cuvette. As a negative control for inner filter effect,
equal volumes of water were added to another cuvette. Emission was simultaneously observed at
460 nm (Ex. 260 nm, 340 nm) on a Varian Cary Eclipse Fluorescence Spectrophotometer. This
innovative assay may be used extensively in the future to study either the kinetics of NADH
cleaving Nudix hydrolases on ncinRNA or to identify possible inhibitors of the same class of
enzymes.
3.2.4 NAD Hydrolysis: LC/MS
No enzyme mixtures containing 500 mM Tris pH 8.5, 2 mM MgCl2, either NAD+ or NADH
or ncinRNA were made to a total volume of 200 µl. Reaction mixtures containing additional Nudix
hydrolases were incubated at 37 °C for 30 minutes. Before injecting the sample into LCMS-2020
Single Quadrupole Liquid Chromatograph Mass Spectrometer, the protein was filtered using a
centrifugal device. Samples containing ncinRNA were also analyzed on the LCMS-2020. In vitro
transcribed ncinRNAs were run on an agarose gel and gel extracted following EZNA Gel
Extraction Kit - Omega Bio-tek protocol. The activity of nudix hydrolases on agarose gel extracted
ncinRNA was also analyzed on the LCMS-2020. Proteins were precipitated out of the samples
before injection into the LCMS using 50:50 phenol:chloroform solution. Stationary phase used
was a 1.7 µm EVO C18 column, while the mobile phase was ammonium formate pH6 and
Methanol. Injection volumes were varied between 5-20 µl for optimal results. Total Ion Count
(TIC) was collected for m/z ranging from 100 to 1000. Photodiode Array (PDA) was collected
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between 190-700 nm. Selected Ion Monitoring (SIM) for NAD+ (m/z: 662, 664), NADH (m/z:
664, 666), AMP (m/z: 346, 348), NMN (m/z: 332, 334) and NMNH (m/z: 334, 336) were selected
both in negative and positive ionization mode respectively.
3.2.5 Nucleic Acid Binding: EMSA
To test the binding between DNA or RNA and NudC, a more traditional approach using
gel shift assays was taken. Mixtures containing single and double stranded fluorescently labelled
oligonucleotides and NudC were made to a final volume of 10 µl with 50 mM Tris pH 8.5 were
incubated on ice for 20 minutes. A 12 % native gel was pre run at 4°C at 120 V for 30 minutes.
Samples were mixed 6:1 with a 6X Loading Dye (0.75 % Bromophenol Blue, 0.25 % Xylene
Cyanole FF and 10 ml 40% w/v Dextrose) and run on the pre-run native gel at 4°C at 100 V for
60 minutes. Gel shifts were a UV illuminator.
3.2.6 Nucleic Acid Binding: Fluorescence Intensity
To test the binding between DNA or RNA and Nudix hydrolases, a fluorescence-based
assay was designed. Assays were plated in 384 well black plates (ThermoFisher Scientific). Assay
conditions were kept at 50 mM Tris pH7.5, 5 mM MgCl2. Additionally, negative controls
contained 1 mM DTT, 0.1 mg/ml BSA, 0.01% Tween and fluorescently labelled RNA substrate,
whereas experimental conditions contained fluorescently labelled RNA substrate and Nudix
hydrolase. Fluorescence (Ex. wavelength= 485 nm, Em. wavelength= 520 nm for FAM labelled
oligonucleotides and Ex. wavelength= 640 nm, Em. wavelength= 670 nm for Cy5 labelled
oligonucleotides) was measured on FLUOstar Omega (BMG LABTECH) at 25°C. The observed
fluorescence (Fobs) was fit to Eq. 1.
Fobs = FD ∗ (D𝑇 − ED) + Fc ∗ ED;

(Eq. 1)
(Kd + E𝑇 ∗n+ Dt)2 −(4∗E𝑇 ∗n∗Et)

where ED = (Kd + E 𝑇 ∗ n + Dt) − √

2

53

)

and ET is the concentration of Nudix hydrolase with DT being the total oligonucleotide= 20
nM or 40 nM or 80 nM; Kd is the dissociation constant, Fs is a coefficient relating probe
concentration to Fobs (i.e. oligo alone), Fc is a similar coefficient relating Fobs to the concentration
of an Enzyme-DNA complex (ED).
3.2.7 Nucleic Acid Binding: Fluorescence Polarization
To test the binding between DNA or RNA and Nudix hydrolases, a fluorescence-based
assay was designed. Assays were plated in 384 well black plates (ThermoFisher Scientific). Assay
conditions were kept at 50 mM Tris pH7.5, 5 mM MgCl2. Additionally, negative controls
contained 1 mM DTT, 0.1 mg/ml BSA, 0.01% Tween and fluorescently labelled RNA substrate,
whereas experimental conditions contained fluorescently labelled RNA substrate and Nudix
hydrolase. G-factor reference well was set with 1 nM Fluorescein in 0.01 M NaOH, while blank
well was set with 50 mM Tris pH7.5. Polarization (Ex. wavelength= 470 nm, Em. wavelength=
520 nm for FAM labelled oligonucleotides and Ex. wavelength= 640 nm, Em. wavelength= 670
nm for Cy5 labelled oligonucleotides) was measured on TECAN infinite M1000 at 25°C, with
ex/em slit widths 5 nm/10 nm. The raw data was fit to Eq. 1 (Section 3.2.6).
3.2.8 Nucleic Acid Binding: Probe Displacement Assays
Probe displacement assay was designed to estimate binding of unlabeled RNA or DNA
ligands, to test preferential binding between Nudix hydrolases and DNA or RNA. Unlabeled
oligonucleotides were added to the above described reaction mixtures to displace existing binding
between fluorescently labelled oligonucleotide and Nudix hydrolases. A decrease in the
fluorescence emission with an increase of unlabeled oligonucleotides was interpreted to mean that
Nudix hydrolase bound to the unlabeled oligonucleotides instead of the existing fluorescently
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labelled oligonucleotides. The raw data was fit to an inhibition dose response curve. IC50 values
were calculated using Eq. 2.
(Fc−Fs)

F𝑜𝑏𝑠 = F0 + (1+10((Dt−LogIC50)))

(Eq. 2)

where Dt is the concentration of unlabeled oligonucleotide titrated, both the maximum
fluorescence Fs and Fc were as defined in Eq. 1.
Dissociation constants for RNA’s were determined by assuming they act as competitive
inhibitor and fitting datasets to Eq. 3:
Fobs = FD ∗ (D𝑇 − ED) + Fc ∗ ED;

(Eq. 3)

where ED = (Kd (1 + I/Ki) + E 𝑇 ∗ n + Dt) − √

(Kd (1+X/Ki)+ E𝑇 ∗n+ Dt)2 −(4∗E𝑇 ∗n∗Et)
2

)

In Eq. 3, “I” is the concentration of unlabeled DNA/RNA, ET is the concentration of Nudix
hydrolase with DT is the total labeled oligonucleotide probe concentration, Kd is the dissociation
constant for enzyme:probe complex (calculated for Eq. 1), Fs is a coefficient relating probe
concentration to Fobs (i.e. oligo alone), Fc is a similar coefficient relating Fobs to the concentration
of the Enzyme-probe complex (ED).
3.2.9 LDH Redox
Lactate dehydrogenase (LDH) catalyzes the conversion of lactate to pyruvate and back, by
transferring a hydride. Simultaneously, the cofactor NAD+ is converted to NADH and back with
the conversion of lactate to pyruvate. The hypothesis that ncinRNA may be a substrate of both
bacterial and mammalian lactate dehydrogenase was tested. E. coli LDH was purchased from
Sigma-Aldrich (59747), bovine heart LDH was purchased from Sigma-Aldrich (L2625), while
rabbit muscle LDH was purchased from Sigma-Aldrich (L2500). Reactions containing 220 mM
Tris pH7.3, 0.2 mg E. coli or 0.368 mg bovine heart or 0.68 mg rabbit muscle LDH was initiated
with varying concentrations of lactic acid, purchased from Dot Scientific Inc. (DSL17500-500),
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containing either NAD+ or NAD+-capped RNA. The increase in the absorbance at 340 nm was
recorded in kinetic mode on Varian Cary 50 UV-Vis Spectrophotometer every 0.1 seconds for 35 minutes. The reverse reaction containing 220 mM Tris pH 9, LDH was initiated with varying
concentrations of sodium pyruvate containing either NADH or NADH-capped RNA. The decay
in the absorbance at 340 nm was recorded in kinetic mode on Varian Cary 50 UV-Vis
Spectrophotometer, under similar conditions.
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Chapter 4 Cloning & Purification of Nudix Enzymes

4.1

Summary
The cloning of bacterial nudC from DH5α cells using colony PCR and the human NUDT12

gene from pCMV-Nudt12 will be discussed in this chapter. This chapter also focusses on the
purification of mammalian Nudt1, Nudt3, Nudt12, Nudt16, Nudt20 and bacterial NudC protein.
At the time this work was done, the human Nudt12 gene had not yet been cloned in a bacterial
expression system, for consequent protein purification.
4.2

Background
The nudC gene was amplified from DH5α cells using insert-specific primers in colony

PCR. The method used for the purification of the prokaryotic NudC protein was exactly as
previously described (Frick et al., 1995). As for most nucleic acid-binding protein purifications,
NudC was precipitated with streptomycin sulfate to isolate the nucleic acids binding to the protein.
Then, the bacterial protein was purified using ion-exchange chromatography. The resin,
comprising of positively charged diethylaminoethyl cellulose (DEAE-C), interacts with negatively
charged proteins. The protein is then eluted from the resin by increasing the salt concentration of
the solvent, to compete for binding to the tertiary amine. Subsequently, the solubility of the NudC
protein was altered with the addition of ammonium sulfate. The precipitate from this fractionation
containing the NudC protein was then further extracted using gel filtration (GF) chromatography.
GF chromatography is a size-exclusion based chromatography technique, that separates the desired
protein from other contaminating proteins and nucleic acids.
The mammalian Nudix proteins, Nudt1, Nudt3, Nudt16, Nudt20 and Nudt12 however had
a polyhistidine tag on either their N- or the C- terminal domain. The His-tagged proteins were
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purified following protocols described in earlier studies (Frick et al., 2010). Each protein was
purified using IMAC (Immobilized metal affinity chromatography), where the Histidine residues
chelates the Nickel ion, which is immobilized on an IMAC ligand, nitrilotriacetic acid (NTA). It
is assumed that other proteins lacking the His-tag do not bind with the ligand and may be removed
by washing the NTA column with an imidazole containing buffer. Following the NiNTA step,
each Nudix protein was further enriched by GF chromatography. These proteins were then
concentrated using ultrafiltration and used for all future assays discussed in Chapter 5 though
Chapter 9.
4.3

Results

4.3.1 Cloning nudC from DH5α
E. coli nudC gene was amplified using PCR from DH5α colonies, with primers (Integrated
DNA Technologies, Coralville, IA) containing NcoI and BamHI restriction sites (underlined).
BamHI primer: 5’-CGC GCG CG▼G ATC CTC ACT CAT ACT CTG CCC GAC-3’
NcoI primer: 5’-GCG CGC▲CAT GGA TCG TAT AAT TGA AAA ATT AGA TC-3’
The PCR product was then cut with NcoI and BamHI and ligated into a similarly digested
pET24d plasmid (Novagen). The plasmid map of the desired construct was made using the
program ApE- A plasmid Editor (http://jorgensen.biology.utah.edu/wayned/ape/) (Fig. 4-1).

Figure 4-1| Plasmid map of pET24d-nudC construct
The nudC insert (PCR product) was digested with NcoI and
BamHI and ligated into a similarly treated pET24d vector. The
resulting construct was then transformed in DH5α cells for
increased insert stability and subsequently into BL21 (DE3)
cells for protein expression.
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The nudC gene studied by Frick et al., in 1995 was amplified from E. coli K-12 MG1655
strain, while the nudC gene studied in this thesis has been amplified from DH5α cells. Surprisingly,
when the sequences of the two genes were aligned, the 33rd residue was found to be different (Fig.
4-2).

Figure 4-2| Sequence similarity between NudC from E. coli DH5α and MG1655

The nudC insert amplified from DH5α colonies has a hydrophobic alanine at the 33rd position, as
opposed to the nudC gene encoded by the MG1655 strain of E. coli K-12, which has an arginine,
as shown in red. The highlighted sequence is the highly conserved Nudix motif,
GXXXXXEXXXXXUAXREXXEEXGU
4.3.2 Purification of NudC
Single colonies of BL21 (DE3) cells harboring pET24-nudC plasmid were inoculated into
3 ml of LB medium containing 100 μg/ml kanamycin. After the cells grew to an OD600 of 0.6, they
were transferred to 1 liter of fresh medium containing kanamycin. After the cells reached an OD600
of 0.6 again, they were induced with 1 mM isopropyl-β-D-thiogalactoside (IPTG). The induced
cells were harvested by centrifugation and the cell pellet was suspended in buffer A (50 mM Tris,
pH 7.5, 1 mM EDTA and 1 mM dithiothreitol), sonicated for 5 minutes and the crude extract was
clarified using centrifugation (15,000 g).
4.3.2.1 Streptomycin Sulfate
The protein was first precipitated with nucleic acids using a 10% streptomycin sulfate
solution added slowly to a final concentration of 1%.
4.3.2.2 DEAE Chromatography
The pellet containing the protein was collected by centrifugation (15,000 g, 30 min) and
resuspended in buffer A. This solution was then loaded onto a DEAE Sepharose column and the
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NudC protein was eluted over a 0-500 mM NaCl gradient (Fig. 4-3). Successful NudC protein
purification was confirmed by the well-separated bands of the protein ladder loaded in lane 1,
aligning with the estimated size (27 kDa) of the NudC protein in lanes 7-13.

Figure 4-3| Purification of NudC DEAE Chromatography

SDS gel electrophoresis of the fractions eluted over DEAE column. Lane 1: Pre-stained protein
Marker, Lane 2: Crude Extract, Lane 3: Streptomycin sulfate supernatant, Lane 4: Streptomycin
sulfate pellet, Lanes 5-14: DEAE fractions eluted with a 0-200 mM NaCl gradient.
4.3.2.3 Gel Filtration Chromatography
6.69 g of solid ammonium sulfate (50%) was added to 23 ml of the DEAE fraction
containing the NudC protein, and the precipitate was collected by centrifugation and discarded.
Next, 7.18 g of solid ammonium sulfate (90% saturation) was added to the supernatant and the
precipitate containing the protein was dissolved in 7.5 ml of buffer A and loaded onto a Gel
Filtration (GF) column. NudC was eluted with 50 mM Tris, 1 mM EDTA, 0.1 mM dithiothreitol,
and 50 mM NaCl. The fractions containing the NudC protein (lanes 10-13) were combined,
concentrated by ultrafiltration and stored at a final concentration of 74 µM (Fig. 4-4)..

60

Figure 4-4| Purification of NudC GF Chromatography

SDS gel electrophoresis of the fractions eluted over GF column. Lane 1: Pre-stained protein
Marker, Lane 2: 50% ammonium sulfate pellet, Lane 5: 90% ammonium sulfate pellet, Lanes 613: GF fractions eluted with 50 mM NaCl.
4.3.3 Cloning NUDT12
NUDT12 gene was amplified using PCR from pCMV-NUDT12, with primers (OriGene
Technologies Inc, Rockville, MD) containing BamHI and NdeI restriction sites (underlined).
BamHI primer: 5’-GCG GCG G▼GA TCC TTA GAG ATT AGG ATT TAT TCT AAT CCA GTG-3’
NdeI primer: 5’-GCG GCG CA▲T ATG ATG TCT TCT GTA AAA AGA AGT CTG AAG CAA G-3’
The PCR product was then cut with NotI and ligated into a similarly digested pET33
plasmid (Novagen) (Fig. 4-5).

Figure 4-5| Plasmid map of pET33-NUDT12 construct
The NUDT12 insert (PCR product) was digested with NdeI
and BamHI and ligated into a similarly treated pET33 vector.
The resulting construct was then transformed in DH5α cells
for increased insert stability and subsequently into BL21
(DE3) cells for protein expression.
This is the first report to successfully express the
human NUDT12 gene in a bacterial expression system, for successful protein purification.
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4.3.4 Purification of Nudt12
Single colonies of strain BL21(DE3) cells harboring pET33-NUDT12 plasmid were
inoculated into 3 ml of LB medium containing 100 μg/ml kanamycin. After the cells grew to an
OD600 of 0.6, they were transferred to 1 liter of fresh medium containing kanamycin. After the
cells reached an OD600 of 0.6 again, they were induced with 1 mM isopropyl-β-D-thiogalactoside
(IPTG). The induced cells were harvested by centrifugation and the cell pellet was suspended in
buffer A (20 mM Tris pH 8, 0.5 M NaCl, 5 mM imidazole), sonicated for 5 minutes and the crude
extract was collected by centrifugation.
4.3.4.1 NiNTA Chromatography
The crude extract was loaded onto a 1 ml Ni-NTA column and the fractions were eluted
over a 5-500 mM imidazole gradient (Fig. 4-6). Successful Nudt12 protein purification was
confirmed by the well-separated bands of the protein ladder loaded in lane 1, aligning with the
estimated size (52 kDa) of the Nudt12 protein in lanes 10-12.

Figure 4-6| Purification of Nudt12 Ni-NTA
Chromatography
SDS gel electrophoresis of the fractions eluted
over Ni-NTA column, Lane 1: Pre-stained
protein Marker, Lane 2: Flow Through, Lane 3:
5 mM Imidazole wash, Lane 4: 40 mM
Imidazole wash, Lanes 5-8: Elutions with 40
mM Imidazole, Lanes 9-12: Elutions with 500
mM Imidazole.
4.3.4.2 Gel Filtration Chromatography
Nudt12 elutions collected over the Ni-NTA column with 500 mM Imidazole was loaded
into a GF column and fractions were eluted with 50 mM Tris, 1 mM EDTA, 0.1 mM dithiothreitol,
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and 50 mM NaCl. The fractions containing the Nudt12 protein were combined, concentrated by
ultrafiltration and stored at a final concentration of 39 µM (Fig. 4-7).

Figure 4-7| Purification of Nudt12 GF
Chromatography
SDS gel electrophoresis of the fractions
eluted over GF column, Lane 1: Prestained protein Marker, Lane 2: Load,
Lanes 3-13: GF elutions with 50 mM
NaCl.
4.3.5 Purification of Nudt1
Purchased

plasmid

containing

NUDT1 were transformed into BL21 (DE3) cells for protein expression. Single colonies of these
transformed cells were inoculated into 3 ml of LB medium containing 100 μg/ml Kanamycin.
After the cells grew to an OD600 of 0.6, they were transferred to 1 liter of fresh medium containing
Kanamycin. After the cells reached an OD600 of 0.6 again, they were induced with 1 mM isopropylβ-D-thiogalactoside (IPTG). The induced cells were harvested by centrifugation and the cell pellet
was suspended in buffer A (20 mM Tris pH 8, 0.5 M NaCl, 5 mM imidazole), sonicated for 5
minutes and the crude extract was collected by centrifugation.
4.3.5.1 NiNTA Chromatography
The crude extract was loaded onto a 1 ml Ni-NTA column and the fractions were eluted
over a 5-500 mM imidazole gradient (Fig. 4-8). Successful Nudt1 protein purification was
confirmed by the well-separated bands of the protein ladder loaded in lane 1, aligning with the
estimated size (22 kDa) of the Nudt1 protein in lanes 7-12.
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Figure 4-8| Purification of Nudt1 NiNTA Chromatography
SDS gel electrophoresis of the fractions
eluted over Ni-NTA column, Lane 1: Prestained protein Marker, Lane 2: Flow
Through, Lane 3: 5 mM Imidazole wash,
Lane 4-5: Elutions with 5 mM Imidazole,
Lanes 6-9: Elutions with 40 mM
imidazole, Lanes 10-15: Elutions with 500
mM Imidazole.
4.3.5.2 Gel
Filtration
Chromatography
Elutions of Nudt1 (6 ml) collected over the Ni-NTA column with 40-500 mM Imidazole
was loaded into a GF column and fractions were eluted with 50 mM Tris, 1 mM EDTA, 0.1 mM
dithiothreitol, and 50 mM NaCl. The fractions containing the Nudt1 protein were combined and
concentrated by ultrafiltration (Fig. 4-9).

Figure 4-9| Purification of Nudt1 GF
Chromatography
SDS gel electrophoresis of the fractions
eluted over GF column, Lane 1: Prestained protein Marker, Lane 2-15: GF
elutions with 50 mM NaCl.
4.3.6 Purification of NUDT3
Purchased plasmid containing NUDT3A were transformed into BL21 (DE3) cells for
protein expression. Single colonies of these transformed cells were inoculated into 3 ml of LB
medium containing 100 μg/ml Kanamycin. After the cells grew to an OD600 of 0.6, they were
transferred to 1 liter of fresh medium containing kanamycin. After the cells reached an OD600 of
0.6 again, they were induced with 1 mM isopropyl-β-D-thiogalactoside (IPTG). The induced cells
were harvested by centrifugation and the cell pellet was suspended in buffer A (20 mM Tris pH 8,
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0.5 M NaCl, 5 mM imidazole), sonicated for 5 minutes and the crude extract was collected by
centrifugation.
4.3.6.1 NiNTA Chromatography
The crude extract was loaded onto a 1 ml Ni-NTA column and the fractions were eluted
over a 5-500 mM imidazole gradient (Fig. 4-10). Successful Nudt3 protein purification was
confirmed by the well-separated bands of the protein ladder loaded in lane 1, aligning with the
estimated size (20 kDa) of the Nudt3 protein in lanes 11-14.

Figure 4-10| Purification of Nudt3 NiNTA Chromatography
SDS gel electrophoresis of the fractions
eluted over Ni-NTA column, Lane 1: Prestained protein Marker, Lane 2: Sonicated
cells, Lane 3: Crude extract, Lane 4: Flow
through, Lane 5: 5 mM Imidazole wash,
Lane 6: 40 mM Imidazole wash, Lane 7-12:
Elutions with 40 mM Imidazole, Lanes 1315: Elutions with 500 mM Imidazole.
4.3.6.2 Gel Filtration Chromatography
Elutions containing the Nudt3A protein (5 ml) collected over the Ni-NTA column with 500
mM Imidazole was loaded into a GF column and fractions were eluted with 50 mM Tris, 1 mM
EDTA, 0.1 mM dithiothreitol, and 50 mM NaCl. The fractions containing the Nudt1 protein were
combined and concentrated by ultrafiltration (Fig. 4-11).

Figure 4-11 |Purification of Nudt3A GF
Chromatography
SDS gel electrophoresis of the fractions eluted
over GF column, Lane 1: Pre-stained protein
Marker, Lane 2-8: GF elutions with 50 mM NaCl.
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4.3.7 Purification of NUDT16
Purchased plasmid containing NUDT16 were transformed into BL21 (DE3) cells for
protein expression. Single colonies of these transformed cells were inoculated into 3 ml of LB
medium containing 100 μg/ml kanamycin. After the cells grew to an OD600 of 0.6, they were
transferred to 1 liter of fresh medium containing kanamycin. After the cells reached an OD600 of
0.6 again, they were induced with 1 mM isopropyl-β-D-thiogalactoside (IPTG). The induced cells
were harvested by centrifugation and the cell pellet was suspended in buffer A (20 mM Tris pH 8,
0.5 M NaCl, 5 mM Imidazole), sonicated for 5 minutes and the crude extract was collected by
centrifugation.
4.3.7.1 NiNTA Chromatography
The crude extract was loaded onto a 1 ml Ni-NTA column and the fractions were eluted
over a 5-500 mM Imidazole gradient (Fig. 4-12). Successful Nudt16 protein purification was
confirmed by the well-separated bands of the protein ladder loaded in lane 1, aligning with the
estimated size (21 kDa) of the Nudt16 protein in lanes 11-14.

Figure 4-12| Purification of Nudt16 Ni-NTA Chromatography

SDS gel electrophoresis of the fractions eluted over Ni-NTA column, Lane 1: Pre-stained protein
Marker, Lane 3: Crude extract, Lane 4: Flow through, Lane 5: 5 mM Imidazole wash, Lane 6-7:
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Elutions with 5 mM Imidazole, Lane 8-10: Elutions with 40 mM Imidazole, Lanes 11-15: Elutions
with 500 mM Imidazole.
4.3.7.2 Gel Filtration Chromatography
Elutions containing the Nudt16 protein (3 ml) collected over the Ni-NTA column with 500
mM Imidazole was loaded into a GF column and fractions were eluted with 50 mM Tris, 1 mM
EDTA, 0.1 mM dithiothreitol, and 50 mM NaCl. The fractions containing the Nudt16 protein were
combined and concentrated by ultrafiltration (Fig. 4-13).

Figure 4-13| Purification of Nudt16 GF Chromatography

SDS gel electrophoresis of the fractions eluted over GF column, Lane 1: Pre-stained protein
Marker, Lane 2-15: GF elutions with 50 mM NaCl.
4.3.8 Purification of NUDT20
Purchased plasmid containing NUDT20 was transformed into BL21 (DE3) cells for protein
expression. Single colonies of these transformed cells were inoculated into 3 ml of LB medium
containing 100 μg/ml Kanamycin. After the cells grew to an OD600 of 0.6, they were transferred
to 1 liter of fresh medium containing Kanamycin. After the cells reached an OD600 of 0.6 again,
they were induced with 1 mM Isopropyl-β-D-thiogalactoside (IPTG). The induced cells were
harvested by centrifugation and the cell pellet was suspended in buffer A (20 mM Tris pH 8, 0.5
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M NaCl, 5 mM Imidazole), sonicated for 5 minutes and the crude extract was collected by
centrifugation.
4.3.8.1 NiNTA Chromatography
The crude extract was loaded onto a 1 ml Ni-NTA column and the fractions were eluted
over a 5-500 mM Imidazole gradient (Fig. 4-14). Successful Nudt20 protein purification was
confirmed by the well-separated bands of the protein ladder loaded in lane 1, aligning with the
estimated size (49 kDa) of the Nudt20 protein in lanes 10-11.

Figure 4-14| Purification of Nudt20 Ni-NTA Chromatography

SDS gel electrophoresis of the fractions eluted over Ni-NTA column, Lane 1: Pre-stained protein
Pre-stained protein Marker, Lane 2: crude extract, Lane 3: Flow through, Lane 4: 5 mM Imidazole
wash Lanes 5-7: Elutions with 40 mM Imidazole, Lanes 8-13: Elutions with 500 mM Imidazole.

4.3.8.2 Gel Filtration Chromatography
Elutions containing the Nudt20 protein (2 ml) collected over the Ni-NTA column with 500
mM Imidazole was loaded into a GF column and fractions were eluted with 50 mM Tris, 1 mM
EDTA, 0.1 mM dithiothreitol, and 50 mM NaCl. The fractions containing the Nudt20 protein were
combined and concentrated by ultrafiltration (Fig. 4-15).
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Figure 4-15| Purification of Nudt20 GF Chromatography

SDS gel electrophoresis of the fractions eluted over GF column, Lane 1: Pre-stained protein Prestained protein Marker, Lane 2-15: GF elutions with 50 mM NaCl.

Finally, all the purified and concentrated proteins were run on a denaturing SDS
polyacrylamide gel (Fig. 4-16). I assume that the two bands for NudC, at ~ 25 kDa and ~ 50 kDa
are because NudC exists as a homodimer.

Figure 4-16| SDS PAGE of Nudix Proteins
Lane 1: Pre-stained protein Pre-stained protein Marker (120, 85,
50, 35, 25, 15 kDa), Lane 2: Nudt1 (0.1 µg), Lane 3: Nudt3A (0.1
µg), Lane 4: Nudt16 (0.1 µg), Lane 5 (0.1 µg): Nudt20 (Dcp2)
(0.1 µg), Lane 6: Nudt12 (0.1 µg), Lane 7: NudC (0.1 µg).
4.4

Discussion
Clones expressing the human decapping Nudix proteins

Nudt3, Nudt16 and Nudt20 were purchased and retransformed into BL21 (DE3) cells for protein
expression. Nudt1, a Nudix proteins that does not bind nucleic acids, was also purchased from and
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retransformed for successful protein expression. This is the first report of successfully cloning the
human NAD-cleaving Nudt12 protein into a bacterial expression system. These mammalian Nudix
proteins were purified using NiNTA chromatography, then gel filtration chromatography. The
bacterial nudC gene was cloned from DH5α cells using colony PCR and the NudC protein was
purified using DEAE chromatography, then gel filtration chromatography. All Nudix proteins
were then concentrated using ultrafiltration and used for all future assays discussed in chapter 5
though chapter 9.
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Chapter 5 NudC and Nudt12 cleave Toxic Dinucleotides

5.1

Summary
In this chapter, our data supports for the first time that NAD-cleaving Nudix hydrolases,

bacterial NudC and its functional homolog in humans, Nudt12 may be ‘housecleaning’ enzymes,
cleansing the cell of toxic isomeric forms of NADH. Our results suggest that both the bacterial and
human NADH-cleaving nudix proteins can hydrolyze 6DHNAD, with the human Nudt12 protein
preferring 6DHNAD considerably over NADH.
The HPLC-based assay described in this chapter is an alternative to the colorimetric assay
usually used to test the activity of NAD-cleaving Nudix hydrolases. The colorimetric assay
quantifies the activity of this class of proteins in a two-step protocol, first the Nudix hydrolase
catalyzed cleavage of NAD to NMN and AMP and second, the release of inorganic phosphates
from AMP by phosphatase. As suspected, this discontinuous colorimetric assay has its drawbacks.
Also, the 6DHNAD, sourced from the Moran Lab, was purified in a phosphate rich buffer, making
this assay even more challenging. Thus, we designed a more efficient protocol to study the activity
of NADH-cleaving Nudix proteins on such toxic isomeric substrates.
Experiments were set up as described in Section 3.2.2.
5.2

Background
The Moran Lab (Beaupre et al., 2015) first discovered that isomeric forms of NAD(P)H

molecules that are reduced at either the 2 or 6 position of the nicotinamide ring instead of the
metabolically active 4-position arises from catalytic oxidation. Subsequently it was shown that this
isomer of NADH, 6DHNAD is an inhibitor of several essential metabolic enzymes (Moran GR et
al., 2017) and hence deemed as toxic NADH isomeric forms. In vivo, these isomers of β-NADH
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were discovered unexpectedly as a substrate for the enzyme, renalase. In vitro, these isomeric
forms of ß-NADH arise from its non-specific borohydride reduction, resulting in different
positions of the hydride on either the 2 (2D(H)NAD) or the 6 (6DHNAD) position of the
nicotinamide ring instead of the usual 4 position.
The E. coli genome encodes for the MutT pyrophosphohydrolase (or NudA) protein, the
progenitor of the Nudix family (Treffers et al., 1954; Bhatnagar et al., 1988). This enzyme
hydrolyzes both canonical and mutagenic nucleoside triphosphates, most commonly the toxic form
of dGTP: 8-oxo-dGTP, preventing its misincorporation during DNA replication (Maki et al.,
1992). Soon after, the E. coli genome was discovered to also encode for NudC (Frick et al., 1995)
and its functional homolog Nudt12 in humans (Abdelraheim et al., 2003). They are members of a
subclass of the Nudix protein family, that cleave dinucleotides, such as NADH, NAD(P)H,
NAD(P)+, ADP-ribose and AppA to yield two nucleoside monophosphates. This subclass of Nudix
proteins are found to have a marked preference for the reduced form of NAD, NADH. It should
be noted that for the regeneration of each molecule of NADH, the cell spends energy. Why the cell
would express a protein that hydrolyzes not only an important cofactor in cellular metabolism but
also an energy rich molecule has remained a mystery.
Similar to MutT (NudA), ever since the discovery of NADH-cleaving Nudix proteins, it
has been suggested they may be involved in ‘housecleaning activities’ cleansing the cellular
environment of potentially deleterious metabolites (Bessman et al., 1996). However, this
hypothesis has never been tested.
5.3

Results
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5.3.1 Both NADH and 6DHNAD are substrate for NudC and Nudt12
NADH-cleaving Nudix hydrolases cleave the phosphodiester bond in its substrate, NADH
to yield two products, AMP and NMNH. Typical to this subclass of enzymes, this reaction is
catalyzed in an alkaline environment and in the presence of divalent cations. To test the catalytic
activity of this class of Nudix proteins on its substrates, colorimetric assays were set up to quantify
the amount of phosphate hydrolyzed. Each reaction contained 1 mM DTT, 2 mM MgCl2 and 1
mM NAD substrate incubated with ~ 40 µM Nudix protein NudC or Nudt12 at 37°C for 30
minutes. The volume was made up to 50 µl with 50 mM Tris pH8.5. Hydrolysis reactions were
then terminated by boiling the sample at 100 °C for 2 minutes. 1 unit of Calf Intestinal Alkaline
Phosphates (CIAP) sourced from ThermoFisher Scientific (Catalog no. 18009019) was added to
the reaction mixture and incubated at 37°C for an additional 30 minutes. Fresh Malachite Green
(MG) reagent was prepared, consisting of three parts of 0.045% solution of MG, 1 part of 4.2%
solution of Ammonium Molybdate in 4.0 N HCl and 0.01 part ~ 10% Tween-20 solution. To
quantify the amount of phosphate released, colorimetric assays were set up in 96-well plates
containing MG reagent. 35% sodium citrate solution was added into each sample, almost
immediately to raise the pH. A standard curve with various amounts of inorganic phosphate was
measured with the freshly prepared MG reagent as well. OD at 625 nm was recorded for each well,
on a Varian Cary 50 UV-Vis Spectrophotometer. Net phosphate released for each reaction was
calculated using the standard curve. To calculate the amount of phosphate hydrolyzed, released
phosphate concentrations was subtracted from the initial 2 mM phosphate concentration and
normalized using GraphPad Prism (v.6). Each normalized response was plotted against substrate
concentration and fit to the Michealis-Menten equation.
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Figure 5-1| Effect of NAD-cleaving Nudix proteins on NAD substrates

Various concentrations of either NAD+ (blue) or NADH (red) ranging between 0.1 – 10 mM was
incubated with 38 µM Nudix hydrolases, (A) NudC and (B) Nudt12 at 37 °C for 30 minutes,
followed by another similar incubation with phosphatase. Absorbances of the complex formed was
observed at 625 nm, divided by incubation time and plotted against NAD substrate concentration.
The amount of phosphate released was then plotted for (C) NudC and (D) Nudt12 against substrate
concentration and fir to a Michealis-Menten curve using GraphPad Prism v.6.
The amount of phosphate released from each reaction was calculated using the phosphate
standard curve. Typical of NAD-cleaving Nudix proteins, both the bacterial NudC and the human
Nudt12 preferred the reduced NAD substrate over its oxidized form. Similar experiments were set
up with 6DHNAD. Since the 6DHNAD had been isolated under phosphate-rich conditions, the
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initial OD at 625 nm, even without the addition of Nudix hydrolases was beyond the scope of this
colorimetric assay. Since this assay failed to yield any definitive results for the NAD-cleaving
hydrolytic activity of Nudix proteins on 6DHNAD, we proceeded to design a new assay using
HPLC.
To correctly identify the samples on a HPLC chromatogram, standard solutions of 100 µM
AMP, ADP, ATP, NADH and 6DHNAD were made up to a total volume of 50 µl and injected
into a Waters Xterra C18 cartridge column (4.6 × 150 mm2) run isocratically at 1 ml/min with 10
mM Phosphate buffer pH7.5, coupled to a waters 600E pump and Waters 2487 detector. The
elution of each sample was observed at both 260 and 340 nm (Fig. 5-2A).

Figure 5-2| HPLC Standards
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(A) Retention and absorbance of 100 µM solutions of AMP (blue), ADP (red), ATP (green),
6DHNAD (purple) and NADH (orange) at 260 nm (B) Area under the curves of each peak from
(A) were plotted against their sample name and will be used to quantify the rate of substrate
depletion using GraphPad Prism (v.6).
It should be noted that the chromatogram of 100 µM 6DHNAD (purple) is identical to that
observed for 100 µM 6NMNH, with a peak absorbance at 2.56 mins and 28.1 mins elution time
(Fig. 5-2A). The initial peak at 2.56 min is not characteristic of 6DHNAD. Areas under each peak
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on the chromatogram was quantified using GraphPad Prism (v.6) and plotted against sample name
(Fig. 5-2B). The retention time of each sample has been recorded under peak X.
To quantify the rate of product formation, serially diluted concentrations of the product,
AMP was run under identical conditions for standardization. The elution of each sample elution
was observed at 260 nm (Fig. 5-3A).

Figure 5-3| AMP Standard on HPLC

(A) 25 µM (blue) , 50 µM (red), 75 µM (green) and 100 µM (purple) of AMP were run on the
HPLC under identical conditions and elution of the components was monitored at 260 nm (B)
Areas under the curve for each sample from (A) eluting at 1.36 minutes was plotted against
concentration to obtain a standard curve using GraphPad Prism (v.6).
It is assumed that the perfect linear response observed in the standard curve for AMP may
be replicated for standardizing NADH (Fig. 5-3B).
1 µM NADH was incubated with 74 nM NudC at 37 °C, in the presence of 2 mM MgCl2
and 1 mM DTT made up to a final volume of 500 µl with 50 mM Tris pH8.5. 50 µl was removed
from the reaction mixture at varying time points, ranging from 5-30 minutes and run on the HPLC
under identical conditions (Fig. 5-4A). The elution of components was observed at 260 nm for
quantification of NADH depletion, eluting at 28.1 minutes and AMP formation, eluting at 1.3
minutes, both consistent with the sample standardization (Fig. 5-4B).
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Figure 5-4| Time course HPLC assay of NudC hydrolysis of NADH

(A) 1 µM ß-NADH incubated with 74 nM NudC at 37°C. 50 µl of the reaction mixture was taken
out at varying time points and run on the HPLC. The elution of products was observed at 260 nm
(B) The area under the curves for the substrate, ß-NADH at 28.1 min elution time (blue) and
product, AMP at 1.3 min elution time (red) were plotted using GraphPad Prism (v.6).
Similarly, 1 µM 6DHNAD was incubated with 74 nM NudC under otherwise identical
conditions as described above (Fig. 5-5A). The elution of components was observed at 260 nm for
quantification of 6DHNAD depletion (Fig. 5-5B), eluting at 28.1 minutes and AMP formation,
eluting at 1.3 minutes. The second product from NudC hydrolytic cleavage, 6NMNH also absorbs
at 260 nm and elutes at 2.6 minutes (Fig. 5-5A).

Figure 5-5| Time course HPLC assay of NudC hydrolysis of 6DHNAD

(A) 1 µM 6DHNAD was incubated with 74 nM NudC at 37°C. 50 µl of the reaction mixture was
taken out at varying time points and run on the HPLC. The elution of products was observed at
260 nm (B) The area under the curves for the substrate, 6DHNAD at 28.1 min elution time (blue)
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and product, AMP at 1.3 min elution time (red) and 6DHNMN at 2.56 min elution time
(green)were plotted using GraphPad Prism (v.6).

This experiment was the first evidence of enzymatic activity of NADH-cleaving Nudix
hydrolases on toxic isomeric forms of NADH.
Confirming that the NAD-cleaving NudC has hydrolytic activity on 6DHNAD, we
quantified the disappearance of the substrates, NADH and 6DHNAD (Fig. 5-6A) and the rate if
appearance of product, AMP (Fig. 5-6B) with incubation time. Quantification for each was done
using areas under the curve. Surprisingly, it was demonstrated that the rates for both substrate
disappearance and product appearance was almost three folds higher for the isomeric form,
6DHNAD compared to the canonical substrate of the enzyme, NADH.
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Figure 5-6| Analysis of HPLC analysis of NudC hydrolysis
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(A) Areas under the curve for the substrate disappearance were plotted against incubation time
and the slopes were calculated using GraphPad Prism (v.6). It was observed to be almost three
folds higher for 6DHNAD (105 A260units min-1) over NADH (31 A260units min-1) (B) Areas under
the curve for product, AMP, formation transformed to (C) concentration (µM) were plotted against
incubation time and the slopes were calculated using GraphPad Prism (v.6). Each slope is an
indication of the rate at which product is formed, calculated using GraphPad Prism (v.6). AMP
formation was observed to be more than two folds higher for 6DHNAD (33 A260units min-1) over
NADH (14 A260units min-1).
Confirming the activity of NudC on 6DHNAD, varying concentrations of the substrate was
incubated with 74 nM NudC at 37 °C, in the presence of 2 mM MgCl2 and 1 mM DTT made up to
a final volume of 500 µl with 50 mM Tris pH8.5. Each reaction was terminated at 10 mins of
incubation and the samples were treated as described above to filter out the protein and injected
into the instrument under identical conditions. Varying concentrations of NADH (Fig. 5-7A) and
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6DHNAD (Fig. 5-7B) ranging from 0.78 to 100 µM was incubated with NudC and the elutions of
samples were observed at 260 nm. Surprisingly, both substrates NADH and 6DHNAD eluted at a
similar time point, ~ 28 minutes. Products from each reaction was quantified using area under
curve and plotted against substrate concentration for both NADH (blue) and 6DHNAD (red) (Fig.
5-5C). Fitting the data to a Michealis-Menten equation yielded similar Vmax values, but an almost
two-times lower Km for 6DHNAD compared to NADH.

Figure 5-7| HPLC assay of NudC hydrolysis of NADH and 6DHNAD
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Serially diluted concentrations of 100 µM (A) NADH and (B) 6DHNAD was incubated with 74
nM NudC at 37°C for 10 minutes. The elution of components was observed at 260 nm, the
substrate NADH and at 28.1 min elution time and product, AMP at 1.3 min elution time and
6NMNH at 2.56 min elution time (C) The areas under the curve for the product (D) transformed
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to AMP concentration were plotted against substrate concentration and fit to the Michaelis-Menten
equation using GraphPad Prism (v.6) to obtain a Vmax and Km.
HPLC analysis of both substrates, NADH and 6DHNAD hydrolyzed by NudC revealed
comparable Vmax values (2.1 vs 2.0 (x 104) units), while a two-fold higher Km for NADH (41 µM)
was observed compared to 6DHNAD (17 µM) (Fig. 5-5C). Whether either isomer of NADH is a
more preferable substrate for NudC cannot be concluded from this experiment. The reproducibility
of this assay along with the precise quantitation of substrates and products is still to be determined.
Next, we tested the hydrolytic activity of Nudt12, the human NADH-cleaving Nudix
hydrolase on NADH and its toxic isomer, 6DHNAD. Varying concentrations of the substrate was
incubated with 38.5 nM Nudt12 at 37 °C, in the presence of 2 mM MgCl2 and 1 mM DTT made
up to a final volume of 500 µl with 50 mM Tris pH8.5. Each reaction was terminated at 10 mins
of incubation and the samples were treated as described above to filter out the enzyme and injected
into the instrument under identical conditions.
Varying concentrations of NADH (Fig. 5-8A) and 6DHNAD (Fig. 5-8B) ranging from 0.78
to 100 µM was incubated with the human Nudt12 protein and the elutions of samples were
observed at 260 nm. Products from each reaction was quantified using area under curve and plotted
against substrate concentration for both NADH (blue) and 6DHNAD (red) (Fig. 5-5C). Fitting the
data to a Michealis-Menten curve yielded similar vmax values, but a surprising five-folds lower km
for 6DHNAD compared to NADH.
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Figure 5-8| HPLC assay of Nudt12 hydrolysis of NADH and 6DHNAD
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Serially diluted concentrations of 100 µM (A) NADH and (B) 6DHNAD was incubated with 38.5
nM Nudt12 at 37°C for 10 minutes. The elution of components was observed at 260 nm, the
substrate NADH and at 28.1 min elution time and product, AMP at 1.3 min elution time and
6NMNH at 2.56 min elution time (C) The areas under the curve for the product were (D)
transformed to concentration (µM) and plotted against substrate concentration and fit to a
Michaelis-Menten plot using GraphPad Prism (v.6) to obtain a Vmax and Km.
In case of the human NADH-cleaving Nudix hydrolase, Nudt12 similar Vmax values
(15,000 A260 Units min-1) were observed, with an impressive five-fold difference in Km for NADH
(100 µM) over 6DHNAD (19 µM) (Fig. 5-8C). The difference in the kinetic parameters may not
be enough to conclude that 6DHNAD is a more preferred substrate for Nudt12 over NADH in vivo
just yet. Reproducibility and precision of this HPLC-based assay is still to be determined.
5.4

Discussion
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The purpose of NAD-cleaving activity of an energy-rich molecule of Nudix hydrolases has
always been a concern. This chapter is the first report of experimental evidence of the hydrolytic
‘housecleaning’ activity of bacterial NudC and human Nudt12 on the toxic isomer of NADH.
Moran et al., demonstrated the renalase catalyzed reduction of NADH to both 2DHNAD and
6DHNAD. However, it was only hypothesized that renalase may oxidize these inhibitory isomers
of NADH to form NAD+. Whether these isomers exist in vivo is still to be determined. This study
shows that NAD-cleaving Nudix proteins have a strong preference to hydrolyze the toxic isomers,
over NADH, displaying a clear biochemical role for this class of Nudix enzymes.
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Chapter 6 A Continuous Assay to Monitor NADH Hydrolysis

6.1

Summary
Since the foundation of this project, we wanted to design a more continuous approach to

study the activity of NAD-cleaving Nudix proteins on its substrates. NADH is a fluorescent
molecule, with a fluorescence emission at 460 nm, when excited at both 260 nm and 340 nm.
Bacterial NAD-cleaving Nudix hydrolase, NudC cleaves the phosphodiester bond in its substrate
to yield AMP, which has an absorbance maximum at 260 nm and NMNH, with an absorbance
maximum at 340 nm. In this chapter, we designed a continuous assay to observe the hydrolytic
cleavage of NADH, using its fluorescent properties.
In this chapter, we also designed a novel Fluorescence Ratiometric (FR)-based assay to test
the hydrolytic activity of NADH-cleaving Nudix hydrolases on the toxic isomeric form of
NADPH, 6DHNADP. 6DHNADP too, like 6DHNAD, was purified under phosphate rich
conditions making the previously discussed colorimetric assay challenging. 6DHNADP too has a
fluorescence emission at 460 nm, albeit relatively low compared to canonical NADH, when
excited at 260 nm and 345 nm. The low fluorescence of the toxic isomer made the continuous
fluorescence-based assay difficult as well. Hence, we designed a novel FR-based assay to study
the interaction between the donor fluorescent molecule, in this case NADH and its acceptor
fluorescent competitor, 6DHNADP.
Although this chapter may not quantify the kinetics of the reaction between 6DHNADP
and NudC, this new assay could be used to study the energetics of protein: ligand interactions.
All experiments were set up as described in Section 3.2.3.
6.2

Background
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Isomeric forms, the 2-dihyhdroNAD (2DNADP) and 6- dihydroNAD (6DHNADP) differs
from β-NADPH in the position of the hydride on the nicotinamide moiety. These non-canonical
substrates have been identified as a substrate for the renalase protein, in vivo. It has been
demonstrated that these molecules can arise from non-specific borohydride reduction of β-NADP+
or tautomerization of β-NADPH, in vitro.
6.3

Results

6.3.1 A continuous fluorescence assay to monitor NADH hydrolysis
50 µM NADH was incubated either 37 nM and 74 nM NudC at 37°C for 30 minutes, in
the presence of 2 mM MgCl2 and 1 mM DTT made up to a final volume of 500 µl with 50 mM
Tris pH 8.5. A change in the fluorescence excitation spectrum (230-450 nm) was observed (Fig.
6-1), when fluorescence emission wavelength was set to 460 nm. With the formation of products
and depletion of substrate as NudC cleaved NADH, a considerable decrease in fluorescence
excitation at 260 nm was observed. The change in fluorescence excitation at 340 nm was assumed
to be insignificant, compared to the decay in the excitation spectra at 260 nm.

Figure 6-1| Excitation spectra of NADH ± NudC
Excitation spectra of 50 µM NADH (blue), or NADH
incubated with 37 nM (green) and 74 nM (red) NudC,
when emission wavelength is 460 nm. The data was
collected on a Cary Eclipse fluorescence
spectrophotometer with Ex/Em slit widths of 5 nm/5
nm.
Next, we examined the kinetics of this
fluorescence change to monitor the enzymatic activity of NudC on NADH. 50 µM NADH was
incubated with 37 nM NudC at 37 °C for 30 minutes, in the presence of 2 mM MgCl2 and 1 mM
DTT made up to a final volume of 500 µl with 50 mM Tris pH 8.5. Fluorescence excitation of the
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reaction mixture was observed when emission wavelength was 460 nm, on Varian Cary Eclipse
Fluorescence Spectrophotometer with Em/Ex Slit widths 5/10 nm. A decrease in fluorescence
excitation at 260 nm was observed as the substrate depleted and led to product formation, when
fluorescence emission was set at 460 nm. The fluorescence excitation at 340 nm did not change
significantly (Fig. 6-2). This was a novel assay that observed the continuous depletion of NADH
by Nudix hydrolysis.
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Figure 6-2| Time dependent effect of NudC on NADH fluorescence
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(A) The emission spectra at 460 nm, when 50 µM NADH is incubated with 37 nM NudC. The
sample is excited at two wavelengths, 260 nm (red) and 340 nm (blue). The data was collected on
a Cary Eclipse fluorescence spectrophotometer with Ex/Em slit widths of 5 nm/5 nm. Lines are
smooth curves generated by GraphPad Prism (v.6) (B) The ratio of the fluorescence emissions at
340 nm and 260 nm is plotted against incubation time to observe an increase in the ratio (340/260)
Since a decay in the fluorescence intensities when excited at both wavelengths is observed,
a ratio of the two fluorescence intensities with incubation gives a better measure of product
formation. The intensity when excited at 340 nm is assumed to be comparatively stable compared
to when the sample is excited at 260 nm, with product formation. Hence, with progressing
incubation time, the ratio (340/260) continues to increase.
6DHNADP was obtained from Dr. Graham Moran’s lab. In vitro, it was synthesized in a
phosphate rich buffer, making Nudix hydrolase cleavage analysis using colorimetric assays
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challenging. We proceeded to use this newly designed fluorescence assay to quantify the
enzymatic activity of NADH-cleaving Nudix hydrolases on 6DHNADP. To initiate these
experiments, a UV absorbance, excitation (Em. wavelength= 460 nm) and emission (Ex.
Wavelength= 345 nm) spectra of 50 µM 6DHNADP was recorded on Varian Cary Eclipse
Fluorescence Spectrophotometer with Em/Ex Slit widths set to 5/10 nm. In comparison, the same
was done for 50 µM NADH, with excitation wavelength= 340 nm and emission wavelength= 460
nm (Fig. 6-3).

Figure 6-3| Optical properties of 6DHNADP
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(A) Absorbance spectra (B) Excitation spectra when em. wavelength= 460 nm and (C) Emission
spectra when ex. Wavelength of 340 nm for NADH and 345 nm for 6DHNADP of 50 µM ßNADH (red) and 6DHNADP (blue). Lines are smooth curves generated by GraphPad Prism (v.6).
Even though the UV absorbances of the two substrates are comparable, the fluorescence
excitation and emission of 6DHNADP were considerably lower compared to the canonical
substrate, NADH. To further test the hydrolytic activity of NudC on 6DHNADP, reaction mixtures
containing 250 µM 6DNAD was incubated with 37 nM and 74 nM NudC at 37°C for 30 minutes,
in the presence of 2 mM MgCl2 and 1mM DTT, made up to a total volume of 500 µl with 50 mM
TrisCl pH8.5. Fluorescence emission spectra was collected on Varian Cary Eclipse Fluorescence
Spectrophotometer with Em/Ex Slit widths set to 5/10 nm, when excitation wavelength= 345 nm
(Fig. 6-4A).
87

Figure 6-4| Emission spectra of 6DHNADP ± NudC
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(A) Emission spectra of 50 µM 6DHNADP (blue), incubated with 37 nM (red) and 74 nM (green)
NudC, when excitation wavelength= 345 nm. Since the fluorescence emission decay of the raw
data did not look impressive, (B) Area under curves were plotted against concentration of enzyme
using GraphPad Prism (v.6) to show the hydrolytic activity of NudC on 6DHNADP.
The fluorescence emission at 460 nm decayed with substrate depletion and product
formation (Fig. 6-4B), however not significantly as the fluorescence emission of the substrate was
considerably low to begin with.
Having confirmed that NudC has enzymatic activity on 6DHNADP, we repeated the
continuous fluorescence assay as described above, to monitor its hydrolysis. 50 µM 6DHNADP
was incubated with 37 nM NudC at 37°C for 30 minutes, in the presence of 2 mM MgCl2 and 1
mM DTT made up to a final volume of 500 µl with 50 mM Tris pH 8.5. Fluorescence excitation
of the reaction mixture was observed when emission wavelength= 460 nm, on Varian Cary Eclipse
Fluorescence Spectrophotometer with Em/Ex Slit widths set to 10/10 nm. Even with product
formation, we failed to observe any significant change in the fluorescence excitation at 260 nm
and 345 nm, when fluorescence emission was set at 460 nm (Fig. 6-5), for initial time points.
However, when the substrate was incubated with NudC for 30 minutes, a decay in the emission
spectrum was observed.
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Figure 6-5| Effect of NudC on 6DHNADP fluorescence
The excitation spectra of 50 µM 6DHNADP
incubated with 37 nM NudC. Excitation at 260 nm
(red) and 345 nm (blue) was observed when
emission wavelength= 460 nm. Lines are smooth
curves generated by GraphPad Prism (v.6). 12 nM
NudC was added at each time point, although no
visible change was observed in the emission
spectrum.
Since 6DHNADPH did not have an
impressive fluorescence emission and the assay could not be used for kinetic analysis of NudC
activity on 6DHNADP, we designed another assay exploiting fluorescence to check for Nudix
hydrolytic activity on 6DHNADP.
6.3.2 Competitive inhibition by 6DHNADP
As the Nudix hydrolases acted on the substrate, a decrease in fluorescence emission (Ex.
Wavelength= 260 nm) was observed with the production of NMNH. Two identical cuvettes were
set up for this assay, each containing 50 µM NADH and 74 nM NudC at 37°C, in the presence of
2 mM MgCl2 made to a final volume 500 µl with 50 mM Tris pH8.5. Following a very brief
incubation period, varying concentrations of 6DHNADP was added to one cuvette, while equal
volumes of water was added to rule out Inner Filter Effect. The emission spectrum at 460 nm was
collected on Varian Cary Eclipse Fluorescence Spectrophotometer with Em/Ex Slit widths set to
5/10 nm, when excited at both 260 nm and 340 nm. The hypothesis was confirmed as the
fluorescence emission continued to decay for the first cuvette compared to that of the negative
control, which remained constant (Fig. 6-6A).
Inner Filter Effect was accounted for and the raw fluorescence data was corrected using
equation 3:
𝐹𝑐𝑜𝑟𝑟 = 𝐹𝑜𝑏𝑠 10

𝐴𝑒𝑥 +𝐴𝑒𝑚
2

(Eq. 3)
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Where Fobs and Fcorr is the fluorescence emission before and after it has been corrected for
inner filter effect respectively, Aex and Aem are absorbance at 260 nm and 460 nm respectively
(Fig. 6-6B).

Figure 6-6| Effect of 6DHNADP on NudC-induced NADH fluorescence changes
B
600
C o n tr o l_ E x 3 4 0 /E m 4 6 0
400
6 D H N A D P _ E x 3 4 0 /E m 4 6 0
200

C o n tr o l_ E x 2 6 0 /E m 4 6 0
6 D H N A D P _ E x 2 6 0 /E m 4 6 0

0
0

20

40

In te n s ity ( a .u )

F lu o r e s c e n c e ( R F U )

A

300
C o n tr o l
+ 5 0 M 6 D H N A D P

200
100
0
0

60

20

40

60

T im e ( m in )

T im e ( m in )

(A) Continuous fluorescence assay, monitoring the excitation spectra of 50 µM NADH incubated
with 37 nM NudC at 37°C. After ~2 mins of incubation time, 12.5 µM 6DHNADP was added to
one cuvette and its fluorescence excitation at 260 nm (blue) and 340 nm (red) was observed. Equal
volume of water was added to the other (control) cuvette, and excitation at 260 nm (green) and
340 nm (purple) was observed when emission wavelength= 460 nm (B) The raw fluorescence
excitation data at 260 nm was corrected for inner filter effect as described above.
Next, the change in fluorescence (ΔF) was calculated between the two excitation
wavelengths, 260 nm and 340 nm for the above experiment, by taking the difference between the
two values, using GraphPad Prism (v.6). Change in fluorescence, ΔF was then plotted against
incubation time (Fig. 6-7A) and corrected for inner filter effect using Eq. 3 (Fig. 6-7B), also plotted
against incubation time.
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Figure 6-7| Normalized Effect of 6DHNADP on NudC-induced NADH fluorescence
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(A) ΔF was plotted against incubation time for both the reaction inhibited with 6DHNADP (red)
and the control reaction with water (blue) (B) The ΔFluorescence excitation data was then
corrected for inner filter effect as described above and plotted against incubation time (min).
Since the slope of Nudix hydrolase cleavage is significantly inhibited by the addition of
12.5 µM 6DHNADP, the above experiment was repeated under identical conditions, with varying
concentrations of 6DHNADP ranging between 0.98-16.7 µM 6DHNADP (Fig. 6-8). The velocities
for each reaction (v) were calculated using the Varian Cary Eclipse Fluorescence software. Next,
the velocities were transformed by dividing each with the velocity of NADH cleavage by NudC in
the absence of any 6DHNADP (vO), yielding v/vO. These resulting fractions were plotted against
concentration of 6DHNADP and fit to a equation 4 using GraphPad Prism (v.6).
V𝑖
𝑉𝑜

=

(K𝑚 +S)

(Eq. 4)

I
Ki

K𝑚 (1+ )+S

In Eq. 4, Vi is observed rate in the presence of inhibitor, Vo is observed rate in the absence
of inhibitor, Km is the Michaelis-Menten constant (100 µM), Ki is the inhibition constant, S is the
substrate (NADH) concentration (50 µM) and “I” is the concentration of 6DHNADP titrated into
each assay.
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Figure 6-8| Effects of various concentration
of 6DHNADP on NudC-induced NADH
fluorescence decrease
v/vO were plotted against the concentration of
6DHNADP, fit to competitive inhibition
(relative activity) model and the Ki of 2.5 µM,
50 µM NADH is hydrolyzed with 74 nM NudC.
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another experimental evidence that NudC has
enzymatic ‘housecleaning’ activity on the toxic isomer of NADPH, 6DHNADP.
6.4

Discussion
This chapter discuses a novel FR-based assay developed, exploiting the fluorescence of

NADH. This assay may be used extensively in the future to study either the kinetics of NADHcleaving Nudix hydrolases on ncinRNA. ncinRNA could be in vitro transcribed from fluorescently
labelled oligonucleotides and used in this FR-based protocol.

92

Chapter 7 NudC & Nudt12 Cleave NAD-capped RNA

7.1

Summary
In this chapter, we have designed and optimized an analytical approach using LC/MS to

demonstrate the successful in vitro transcription of ncinRNAs. This protocol puts the concern as
to whether NAD-capped RNAs or NAD alone is being studied to rest. Through this experiment,
we confirm that the NAD moiety is indeed attached to the terminal end of the RNA transcripts
through the adenine end. We also use this LC/MS-based approach to study the hydrolytic cleavage
of bacterial and human Nudix hydrolases on NAD-capped RNA. This study demonstrates the
activity of NAD-cleaving Nudix hydrolases on ncinRNAs, confirming that NAD-capped RNAs
might be their substrate in vivo, and not NAD as previously thought. The protocol discussed in this
chapter may be used to further study in depth the energetics of Nudix hydrolytic cleavage of
ncinRNA or even study the activity of other NAD-cleaving Nudix hydrolases, such as NPY1 on
ncinRNAs.
7.2

Background
The existence of covalently modified NAD+/NADH on the terminal end of both

prokaryotic (Chen et al., 2009) and eukaryotic (Julius et al., 2018) mRNAs in vivo is still a mystery.
It has been suggested by Cahová et al. (2015) that the role of such non-canonical modifications on
the 5’- end of mRNAs is to stabilize the nucleic acid transcript, similar to the role of the m7G cap
on eukaryotic RNA transcripts.
The NAD+ is thought to be attached on the adenine side to the terminal end of the RNA
transcript (Höfer et al., 2016; Grudzien-Nogalska et al. 2019). It has been hypothesized that these
in vitro transcribed ncinRNAs undergo ribonucleolytic cleavage, after hydrolysis by NADH93

cleaving Nudix proteins. The bacterial NudC (Höfer et al., 2016) and human Nudt12 (GrudzienNogalska et al., 2019) hydrolyzes the phosphodiester bond in the NAD+ moiety to yield free NMN
and a 5’-monophosphorylated RNA strand. Grudzien-Nogalska et al. (2019) have demonstrated
the degradation of ncinRNAs using radiolabeled NAD+-RNA, showing the activity of NADHcleaving Nudix proteins.
All experiments have been set up as described in Section 3.2.4.
7.3

Results

7.3.1 In vitro transcription of ncinRNA
All in vitro transcription reactions were set up as described in Section 3.1.5. Briefly,
pET24-NudC plasmid constructed in Section 4.3.1 was miniprepped, following EZNA® Plasmid
Mini Kit I- Omega Bio-tek and treated with Thermo Scientific Fermentas FastDigest HindIII at
37°C for 15 minutes. The digested vector (~ 6047 bp) was then gel extracted and consequently
used as the DNA template for in vitro transcription reactions (Fig. 7-1)

Figure 7-1| Agarose gel electrophoresis of HindIII digested
pET24d-NudC
Lane 1: Lambda DNA/HindIII Marker, Lane 3: Miniprep of pET24dNudC Lane 5-8: pET24d-NudC digested with HindIII. The HindIII
digested bands from lane 5 through lane 8 were gel extracted and used
as the DNA template for in vitro transcription of ncinRNA.
We used T7 RNA polymerase to synthesize RNA with non-canonical initiating nucleotides
(ncin) such as NAD+, NADH, NADP+ and NADPH. The DNA template used for each ncinRNA
transcription is NsiI digested pET24a vector. Five similar reactions were set up with the gel
extracted DNA, ~ 2.5 mM NAD+, ~ 2.5 mM NADH, 2.5 mM NADPH, 2.5 mM NADP+ and 4

94

mM ARCA mix, 1-1.5 mM NTPs and T7 RNA Polymerase. Resulting in vitro transcribed 7mGcapped and ncinRNA were run on an agarose gel (Fig. 7-2A).

Figure 7-2| Synthesis of ncinRNA by phage T7 RNA polymerase
(A) T7 RNA polymerase was used to
synthesize RNA initiating with 3’-OMe m7GpppA or the NCINs NAD+,
NADH, NADP+ and NADPH and
purified using gel electrophoresis. (B)
Absorbance spectrum of each RNA
product after LiCl and gel-purification
(note characteristic 340 nm absorbance
of reduced nicotinamide). (C) Spectra
of products produced when NADH
was added after the RNAP reaction
was
terminated,
but
before
purification. (D) Demonstration that
neither NAD+ nor NADH co-purify
with NADH-capped RNA.
Each in vitro transcribed ncinRNA was then gel extracted from a RNase free agarose gel
and the absorbance of each gel-extracted ncinRNA was then observed between 250-400 nm and
then normalized (Fig. 7-2B). Control reactions to confirm that free NAD+/NADH is not observed
in our future experiments, leftover from the transcription reaction, were carried out as well. NAD+
or NADH was added once the transcription reaction was completed, following DNAse treatment.
Absorbance at 260 nm for in vitro transcribed RNA was observed, however no absorbance at 340
nm was recorded (Fig. 7-2C). Free NAD+ and NADH were precipitated with LiCl solution and no
UV absorbance was detected, confirming that NAD alone does not precipitate with in vitro
transcribed ncinRNA (Fig. 7-2D).
Free NADH has a 10:4 ratio of their UV absorbances at 260 nm and 340 nm, respectively.
It was hypothesized that NADH-capped RNA should have a different UV absorbance ratio at the
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two wavelengths, assuming that the NADH moiety has an RNA tail, which absorbs at 260 nm,
attached to its terminal end.
7.3.2 Different lengths of NAD(H)-RNA run differently on the LCMS
NAD+-capped RNA was in vitro transcribed from two different DNA templates, to yield a
final mRNA transcript of ~ 200 bp (green) and ~ 1000 bp (purple) respectively. Also, free NAD+
and NAD+ and AMP solutions were used as a standard to test the elution of samples for future
LC/MS experiments (Fig. 7-4).

Figure 7-3| LC/MS analysis of NAD+, AMP, and NAD+-capped RNA
NAD+-capped RNA was in vitro
transcribed from two different DNA
templates, to yield a final mRNA
transcript of 258 bp (green) and 806
bp (purple) respectively. Each
NAD+-capped RNA was injected into
the LC/MS to test the hypothesis that
the RNA strand attached to the NAD+
moiety affects its elution time on the
instrument. As a control, 1 µM
solutions of NAD+ alone and AMP
were run on the LC/MS under
identical conditions. The shorter RNA transcript (green) elutes at 2.756 minutes while the longer
RNA transcript elutes at 5.112 minutes. NAD+ alone, being a smaller molecule than when attached
to RNA, elutes at 2.052 minutes, while AMP elutes at 1.46 minutes. The normalized absorbances
of each sample at 260 nm has been plotted against elution time using GraphPad Prism (v.6).
It should be noted that both the NAD+-capped RNA transcripts tested have an elution time
(2.7 to 5.1 minutes) later than free NAD+ (2.0 minutes), further confirming our hypothesis that
when NAD is attached to the terminal end of the RNA transcript. The PDA data showing
absorbance between 252-271 nm is characteristic of other nucleotides present in the RNA strand,
demonstrating the successful in vitro transcription of ncinRNA.
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7.3.3 NudC and Nudt12 cleave NADH-capped RNA
1 mM NADH was treated with NAD-cleaving Nudix hydrolase at 37 °C for 15 minutes,
the proteins filtered out and the elution of products was observed at both 260 nm and 340 nm. We
hypothesized that when the NADH moiety is attached to the terminal end of the RNA transcript,
it should have a different elution time compared to free NADH observed. In vitro transcribed
NADH-capped RNA was run on an agarose gel under RNase free conditions, gel extracted and
then injected into the LC/MS. Gel extracted NADH-capped RNA was also treated with both the
bacterial NudC and human Nudt12, under similar conditions described above. The sample was
treated with Tris-equilibrated phenol to precipitate the protein, then with 50:50 phenol:chloform
mixture and finally with chloroform to remove any traces of phenol. This method will be referred
to as the “Sevag” method, in future experiments. Removing any residual phenol was essential
because phenol, being an aromatic compound, absorbs at 260 nm as well. The products of
hydrolysis, NMNH has an absorbance maximum at 340 nm, and AMP has an absorbance
maximum at 260 nm while the substrate NADH absorbs both at 260 nm and 340 nm.
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Figure 7-4| Effect of NudC on NADH and NADH-capped RNA
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(A) 1 mM NADH alone (blue) and treated with NudC (red) at 37 °C for 15 minutes was centrifuged
to remove any traces of protein then injected into the LC/MS instrument, and the elution of
products were observed at 260 nm and 340 nm. The products, NMNH (red) elutes at 1.16 minutes,
AMP (red) elutes at 1.42 minutes while both unhydrolyzed NADH (red) and NADH alone (blue)
elutes at 2.05 minutes. The normalized PDA data of NMNH, AMP and NADH has been recorded.
(B) Gel extracted NADH-capped RNA alone (blue) and treated with NudC at 37 °C for 15 minutes
and subsequently Sevag treated, then injected into the LC/MS and the elution of products is
observed at both 260 nm and 340 nm, with the products NMNH (red) eluting at 1.24 minutes, 5’monophosphorylated RNA (red) eluting at 1.684 minutes, while both unhydrolyzed NADHcapped RNA and NADH-capped RNA alone elute at 3.096 minutes. The normalized Photodiode
Array (PDA) data of NMNH, 5’- monophosphorylated RNA and NADH-capped RNA has been
recorded.
The above data suggests that the NADH moiety is indeed attached to the terminal end of
the RNA transcript, because it elutes at a later time point (3.096 minutes) when compared to free
NADH which elutes at 2.42 minutes. As predicted, NMNH hydrolyzed from NADH-capped RNA
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(Fig. 7-6B) elutes at a similar time point (1.24 minutes) as that off NMNH hydrolyzed from free
NADH (1.16 minutes) (Fig. 7-6A), while 5’- monophosphorylated RNA elutes at a later time point
(1.684 minutes) compared to free AMP (1.42 minutes) under otherwise identical conditions. The
spectra of each peak (Fig. 7-6 inserts) further confirms the successful in vitro transcription of
NADH-capped RNA, having an uncharacteristic 260:340 absorbances when compared to
canonical NADH.

Figure 7-5| Effect of Nudt12 on NADH and NADH-capped RNA
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(A) 1 mM NADH alone (blue) and treated with Nudt12 (red) at 37 °C for 15 minutes was
centrifuged to remove any traces of protein then injected into the LC/MS instrument, and the
elution of products were observed at 260 nm and 340 nm. The products, NMNH (red) elutes at
1.16 minutes, AMP (red) elutes at 1.42 minutes while both unhydrolyzed NADH (red) and NADH
alone (blue) elutes at 2.05 minutes. The normalized PDA data (absorbance spectra) of NMNH,
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AMP and NADH has been recorded. (B) Gel extracted NADH-capped RNA alone (blue) and
treated with Nudt12 at 37 °C for 15 minutes and subsequently Sevag treated, then injected into the
LC/MS and the elution of products is observed at both 260 nm and 340 nm, with the products
NMNH (red) eluting at 1.23 minutes, 5’- monophosphorylated RNA (red) eluting at 1.69 minutes,
while both unhydrolyzed NADH-capped RNA and NADH-capped RNA alone elute at 3.03
minutes. The normalized Photodiode Array (PDA) data of NMNH, 5’- monophosphorylated RNA
and NADH-capped RNA has been recorded.
Similar to the NudC hydrolysis of NADH-capped RNA, the above data confirms that the
NADH moiety is indeed attached to the terminal end of the RNA transcript, because it elutes at a
later time point (3.03 minutes) when compared to free NADH which elutes at 2.42 minutes. As
predicted, NMNH hydrolyzed from NADH-capped RNA elutes at a similar time point (1.228
minutes) as that off NMNH hydrolyzed off free NADH (1.16 minutes), while 5’monophosphorylated RNA elutes at a later time point (1.688 minutes) compared to that of free
AMP (1.42 minutes), under otherwise identical conditions.
We also further analyzed the above results on the mass spectrometer (MS), which collected
m/z ranging between 100 to 1000, in both positive and negative ionization mode. However, to
avoid noisy MS data, we used Selected Ion Monitoring (SIM) mode to select for our expected
molecules. The MS data show that NudC cleaves NADH to NMN and AMP (Fig. 7-7A), and that
free AMP is not released from the hydrolysis of NADH-capped RNA, confirming that NADH is
covalently attached to the terminal end of the RNA transcript (Fig. 7-7B).
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Figure 7-6| LC/MS analysis of NudC reaction products

(A) 1 mM NADH treated with NudC at 37 °C for 15 minutes was injected into the LC/MS
instrument and the elution of products was observed at both 260 nm (blue) and 340 nm (red).
Selected Ion Monitoring (SIM) was selected for m/z= 666 (orange) for NADH, 346 (purple) for
AMP and 335 (green) for NMNH in positive ionization mode and overlaid with the LC
chromatogram using GraphPad Prism (v.6) (B) Gel extracted NADH-capped RNA, treated with
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NudC, then Sevag treated was injected into the LC/MS instrument and the elution of the products
were observed at 260 nm (blue) and 340 nm (red). SIM was selected for m/z= 666 (orange) for
NADH, 346 (purple) for AMP and 335 (green) for NMNH in positive ionization mode.
The MS data overlays well with the absorbance data suggesting the NudC degradation of
in vitro transcribed NADH-capped RNA. Identical experiments were repeated with Nudt12 and
NADH (Fig. 7-8A) and NADH-capped RNA (Fig. 7-8B); 10 µl sample was injected into the
LC/MS after either filtering out or removing the Nudt12 protein using the Sevag protocol.
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Figure 7-7| LC/MS analysis of Nudt12 reaction products

(A) 1 mM NADH treated with Nudt12 at 37 °C for 15 minutes was injected into the LC/MS
instrument and the elution of products was observed at both 260 nm (blue) and 340 nm (red).
Selected Ion Monitoring (SIM) was selected for m/z= 666 (orange) for NADH, 346 (purple) for
AMP and 335 (green) for NMNH in positive ionization mode and overlaid with the LC
chromatogram using GraphPad Prism (v.6) (B) Gel extracted NADH-capped RNA, treated with
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Nudt12, then Sevag treated was injected into the LC/MS instrument and the elution of the products
were observed at 260 nm (blue) and 340 nm (red). SIM was selected for m/z= 666 (orange) for
NADH, 346 (purple) for AMP and 335 (green) for NMNH in positive ionization mode. The MS
data shows that free AMP is not released from the hydrolysis of NADH-capped RNA, confirming
that NADH is modified to the 5’- end of the RNA transcript.
7.3.4 NudC and Nudt12 cleave NAD+-capped RNA
In vitro transcribed NAD+-capped RNA was run on an RNase-free agarose gel, gel
extracted, incubated with NudC at 37 °C for 15 minutes and then Sevag treated. 10 µl of the
resulting sample was then injected into the LCMS instrument. 1 mM NAD+ alone was treated
under identical conditions and injected into the LCMS as well. As assumed, unhydrolyzed NAD+capped RNA eluted much later than unhydrolyzed free NAD+. Products of each hydrolysis were
confirmed by both LC (260 nm) and MS data, which identified the substrate NAD+ (purple), and
the products, AMP (green) and NMN (red) (Fig. 7-9A). However, when NAD+-capped RNA was
hydrolyzed with NudC, although NAD+ (purple) and NMN (red) were identified, the SIM failed
to recognize AMP, further confirming that the NAD modification on the 5’- end of RNA transcripts
is through the adenine side. The LC chromatogram however identified three peaks at 260 nm, first
for NMN, second for the hydrolyzed nucleotides form the terminal end and third for unhydrolyzed
substrate, NAD+-capped RNA. (Fig. 7-9B)
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Figure 7-8| LC/MS analysis of NudC reaction products

(A) 1 mM NAD+ treated with NudC at 37 °C for 15 minutes was injected into the LC/MS
instrument and the elution of products was observed at both 260 nm (blue). Selected Ion
Monitoring (SIM) was selected for m/z= 664 (orange) for NAD+, 346 (purple) for AMP and 333
(green) for NMN in positive ionization mode and overlaid with the LC chromatogram using
GraphPad Prism (v.6) (B) Gel extracted NAD+-capped RNA, treated with NudC, then Sevag
treated was injected into the LC/MS instrument and the elution of the products were observed at
260 nm (blue). SIM was selected for m/z= 664 (orange) for NAD+, 346 (purple) for AMP and 333
(green) for NMN in positive ionization mode.
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A major concern our NAD+ data however is that the MS data for m/z= 664 does not align
with the peaks observed on the chromatogram at 260 nm. A control with NAD+ hydrolyzed by
NudC shows masses for both products, AMP and NMN. (Fig. 7-10A). The MS data shows that
free AMP is not released from the hydrolysis of NAD+-capped RNA, supporting the contention
that NAD+ is modified to the 5’- end of the RNA transcript (Fig. 7-10B).
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Figure 7-9| LC/MS analysis of Nudt12 reaction products

(A) 1 mM NAD+ treated with Nudt12 at 37 °C for 15 minutes was injected into the LC/MS
instrument and the elution of products was observed at 260 nm (blue). Selected Ion Monitoring
(SIM) was selected for m/z= 664 (orange) for NAD+, 346 (purple) for AMP and 333 (green) for
NMN in positive ionization mode and overlaid with the LC chromatogram using GraphPad Prism
(v.6) (B) Gel extracted NAD+-capped RNA, treated with Nudt12, then Sevag treated was injected
into the LC/MS instrument and the elution of the products were observed at 260 nm (blue). SIM
was selected for m/z= 664 (orange) for NAD+, 346 (purple) for AMP and 333 (green) for NMN in
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positive ionization mode. The MS data shows that free AMP is not released from the hydrolysis
of NAD+-capped RNA, confirming that NAD+ is modified to the 5’- end of the RNA transcript.
7.4

Discussion
A major concern for previous studies on in vitro transcribed ncinRNAs has been the

confirmation that NAD is indeed attached to the terminal end of the RNA transcripts. Also,
previous studies have demonstrated the Nudix hydrolysis of ncinRNA using radioactivity and gel
shift assays. However, the experiments discussed in this chapter ensures that in vitro transcribed
ncinRNA and not free NAD is being studied. Our results confirm previous studies, that NAD
attaches itself through the adenine side on the terminal end of RNA transcripts. However, this
LC/MS-based assay is a more analytical approach to validate the in vitro transcription of
ncinRNAs. Our results also confirm that the biochemical role of NAD-cleaving Nudix hydrolases
may be to hydrolyze ncinRNAs instead off energy-rich molecules such as NADH. This analytical
approach may be used to further study the kinetics of other NAD-cleaving Nudix hydrolases
among prokaryotes and eukaryotes, on ncinRNAs.
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Chapter 8 Energetics of Nudix-Nucleic Acid Binding

8.1

Summary
Since the discovery of Nudix hydrolases, the superfamily has been divided into classes

based on their substrate specificity (Srouji et al., 2017) having activity over a range of substrates
such as deoxynucleotides, nucleotide sugars, dinucleoside polyphosphates and dinucleotide
coenzymes. The E. coli enzyme, NudC and its functional homolog in humans, Nudt12 are
members of one such subclass of the Nudix family, that cleave dinucleotides, such as NADH,
NADPH, NADP+, ADP-ribose and AppA to yield two nucleoside monophosphates. Since the first
purification of the bacterial NudC protein (Frick et al., 1995), it was found to co-precipitate with
nucleic acids. Later with the discovery of the NAD-capped RNA and the decapping function of
NudC on such covalently modified RNAs, it may be hypothesized that NudC interacts with nucleic
acids. Over the years, several other mammalian proteins have been reported to have mRNA
decapping activity, which may be argued to be directly interacting with their nucleic acid
substrates. Both the bacterial NudC and Nudt12 proteins have a Zinc-finger domain, known for
interacting with nucleic acids, in their amino acid sequences. However, the energetics of the direct
interaction between nucleic acids and bacterial and human nudix proteins has never been shown
until now. In this chapter, our results confirm that the human Nudt12 protein specifically binds to
only RNA. This surprising result has been confirmed by gel shift, fluorescence polarization and
emission, and probe displacement assays. The human Nudt12 protein also has a clear preference
to bind NAD+-capped RNA over NADH-capped RNA and 7mG-capped RNA, confirming that
ncinRNAs might be the real substrates for Nudt12 in vivo. Our results demonstrate previously
unknown features of the human NAD-cleaving Nud12 protein.
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8.2

Background
The E. coli genome encodes for a mutT mutator gene, the progenitor of the family

expressing the MutT pyrophosphohydrolase (NudA) protein (Treffers et al., 1954; Bhatnagar et
al., 1988). The enzyme was found to catalyze the hydrolysis of canonical and mutagenic nucleoside
triphosphates, most commonly the toxic form of dGTP, 8-oxo-dGTP, preventing its
misincorporation during DNA replication (Maki et al., 1992). Nudt1 is its functional homologue
in humans and plays a vital role in removing mutagenic dNTPs to prevent A:T to C:G transversion,
by hydrolyzing the 8-oxo dGTP to 8-oxo dGMP (Nakabeppu Y, 2001). Since the early discovery
of E. coli NudC, nucleic acids were found to co-precipitate with the protein, suggesting its
interaction (Frick et al., 1995). With the recent discovery of the cofactor nicotinamide adenine
dinucleotide (NAD+) as a transcriptional modification of prokaryotic mRNA (Chen et al., 2009),
it has been suggested that NudC is involved in RNA decapping, eventually triggering its decay
(Cahová et al., 2014). Its functional homolog in mouse, Nudt12 has also been shown to decap both
canonical capped mRNA, between the β- and γ- phosphate moieties and NAD+-capped RNA in
vitro (Grudzien-Nogalska et al., 2017). Although, evidence is yet to be shown for direct interaction
between these decapping Nudix hydrolases and their oligonucleotide substrates.
Following the discovery of the hydrolytic activity of MutT, it was believed that the protein
bound to the nucleic acid. However, it was later shown that MutT only interacted with its
mutagenic nucleotide substrate, 8-oxo dGTP, holding onto the product, 8-oxo dGMP with an
exceptionally high affinity (Massiah et al., 2003). In stark contrast, MutY, an E. coli adenine
glycosylase initiates the repair of A:oxoG to C:G by removing the mismatched adenine moiety
from the entire DNA backbone (Fromme et al., 2004).
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The cofactor, NAD+ at the terminal end of bacterial mRNA resembles the eukaryotic cap
and has been shown to stabilize some mRNAs in E. coli in the same manner as the 7mG cap found
on eukaryotic mRNAs. This is where the Nudix phosphohydrolase NudC plays an important role
to decap NAD+-capped RNA, by cleaving the phosphoanhydride bond in the cap, thereby
triggering RNA decay.
Confined to the cytoplasm, phylogenetic assignment classified Nudt3 as a DIPP
(diphosphoinositol polyphosphate phosphohydrolase). Nudt3 has also been demonstrated as an
mRNA decapping enzyme (McLennan et al., 2006; Song et al., 2013; Kiledjian et al., 2016).
Nudt16 has been reported to be localized in the cytoplasm as well, with 5’-end U8 snoRNA
decapping activity (Grzela et al., 2018). Human Nudt12 is a NADH diphosphatase, found to be
localized in the peroxisome (Abdelraheim, et al., 2003). Nudt20, more commonly referred to as
Dcp2 is a member of the Nudix hydrolase superfamily of enzymes and was the first eukaryotic
mRNA decapping enzyme to be discovered (Wang Z et al., 2002). It removes the 7mG cap from
the 5’-end of eukaryotic mRNA. Similar to Nudt16, Nudt20 also hydrolyzes the α-β-phosphate
bond of the mRNA cap, whereas Nudt3 can hydrolyze both α-β- and β-γ-phosphates with similar
activity (Grudzien-Nogalska et al., 2017). Thus, we reasoned that for human Nudt3, Nudt12,
Nudt16 and Nudt20 (Dcp2) and the bacterial NudC Nudix proteins to be active RNA decapping
enzymes, there has to be direct interaction between the proteins and their nucleic acid substrates.
Supporting this hypothesis, it has been reported that Nudt20 (Dcp2) in budding yeast has
an additional well conserved RNA binding channel that promotes decapping by the Dcp1/Dcp2
complex. The interactions between the protein and its 7mG-capped RNA substrate have been
shown using gel shift assays (Deshmukh et al., 2008). Although human Nudt3 and Nudt16 are
functional RNA decapping enzymes, they do not have any domain additional to the Nudix catalytic
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site. E. coli RNA decapping enzyme, NudC has been shown to have a positively charged area
adjacent to the NAD+ binding domain, suggesting its interaction with nucleic acids (Höfer et al.,
2016). Its functional homolog in humans, Nudt12 also has an additional Ankyrin repeat domain,
essential for NAD+-capped RNA decapping activity (Grudzien-Nogalska et al., 2019).
Additionally, both NudC and Nudt12 have Zinc-finger domains, suggesting yet another possible
binding site for nucleic acids.
In this study, we developed and optimized a fluorescence polarization (FP) assay to
quantify affinity between RNA decapping Nudix hydrolases and nucleic acids. Fluorescence
polarization is a property of most fluorophores. Often times, polarization is a more preferred
measurement to study ligand interactions, being less reliant on environmental changes, such as pH
and temperature. Fluorescence polarization (P) is defined from fluorescence intensities of both
parallel (F||) and perpendicular (F⊥) light with respect to the plane of linearly polarized excitation
light (Eq. 5). Anisotropy (r) is also another method of detecting ligand interactions without being
dependent on the concentrations of the fluorophore (Eq. 6).
𝐹 −𝐹⊥

𝑃 = (𝐹||+𝐹 )
||

(Eq. 5)

⊥

𝐹 −𝐹⊥

𝑟 = (𝐹 ||+2𝐹 )
||

(Eq. 6)

⊥

where F|| is the fluorescence intensity parallel to the linearly polarized excitation light
and F⊥ is the fluorescence intensity perpendicular to the linearly polarized excitation light.
Since the fluorescence intensities cancel each other out in the above equation for
measurement of polarization, unlike the calculation of fluorescence intensities in section 3.2.6,
fluorescence polarization does not depend on the concentration of fluorophore in the assay.
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Surprisingly, our data shows that the human NADH-cleaving Nudix hydrolase, Nudt12
exclusively binds RNA and not DNA. We further validated these results by designing another FP
assay to displace the bound protein-nucleic acid complex with either DNA or RNA. Nudt12 also
has an incredibly high affinity to bind in vitro transcribed NAD+-capped RNA compared to
NADH-capped RNA and 7mG capped RNA. This is the first study to demonstrate the kinetics of
the interactions between human and bacterial RNA decapping Nudix hydrolases and nucleic acids.
8.3

Results
The Nudix proteins used to test their nucleic acid binding are the bacterial NudC and the

mammalian Nudt12, Nudt1, Nudt3, Nudt16 and Nudt20 proteins (Fig. 4-16).
8.3.1 Interaction between Nudix hydrolase and fluorescently labelled DNA
A gel shift assay was designed to test the interaction between fluorescently labeled DNA
and Nudix proteins (Fig. 8-1). Samples containing either [HF]DNA45 alone or with Nudt1
(MutH1), Nudt3, Nudt12, Nudt16, Nudt20 (Dcp2) and NudC were made to ta total volume of 10
µl with 50 mM TrisCl pH 8.5, incubated on ice for 20 minutes and then run on a 12% nondenaturing polyacrylamide gel at 4°C at 100 V for 60 minutes. Fluorescence was observed with a
UV trans-illuminator. [HF]45 was used alone as a negative control. A ‘band shift’ was assumed to
be because of a complex forming between fluorescently labeled DNA and the interacting proteins,
Nudt3, Nudt16, Nudt20 (Dcp2) or4 NudC. NS3h protein, used as a positive control observed a
clear band shift, while DNA interacting Nudix proteins shifted with a more smear-like appearance.
Surprisingly, a ‘band shift’ was not observed with Nudt12 and Nudt1 (MutH1), which was used
as a known negative control.
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Figure 8-1| Interaction between Nudix
hydrolases and [HF]DNA45 using native
PAGE
Lanes 1: 1 µM [HF]DNA45, 2: [HF]DNA45 and
NS3h, 3: [HF]DNA45 and NudC, 4: [HF]DNA45
and Nudt12, 5: [HF]DNA45 and Nudt20 (Dcp2),
6: [HF]DNA45 and Nudt16, 7: [HF]DNA45 and
Nudt3, 8: [HF]DNA45 and Nudt1
The above non-denaturing polyacrylamide
gel was then stained with coomasie blue dye
solution to confirm the overlay of the Nudix proteins with each ‘gel shift’ (Fig. 8-2). Lane 1,
containing fluorescent DNA alone did not stain with coomasie blue solution. Lane 2, containing
the positive control protein, NS3h and lanes 3, 5, 6, 7 and 8 containing Nudix proteins showed a
protein band or smear in accordance to where the gel shift was assumed to be. Lanes 4 and 8
containing Nudt1 and Nudt12 proteins respectively did not observe a gel shift with the DNA, but
still had a band for protein in Fig. 8-2.

Figure 8-2| Interaction between Nudix
hydrolases and [HF]DNA45 using native
PAGE
The non-denaturing polyacrylamide gel was
stained with Coomasie blue stain and the
proteins in each lane were observed. Lanes 1:
1 µM [HF]DNA45, 2: [HF]DNA45 and NS3h,
3: [HF]DNA45 and NudC, 4: [HF]DNA45
and Nudt12, 5: [HF]DNA45 and Nudt20
(Dcp2), 6: [HF]DNA45 and Nudt16, 7: [HF]DNA45 and Nudt3, 8: [HF]DNA45 and Nudt1
Since the desired ‘gel shift’ results could not be replicated using numerous non-denaturing
polyacrylamide gels, we proceeded to design two fluorescence-based assays. Interactions between
fluorescently labelled nucleic acids and the Nudix proteins are assumed to be at equilibrium, to
estimate binding affinity/dissociation constant (Lohman et al., 1992; Smolik et al., 2014).
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Fluorescently labeled DNA, [FAM]DNA18 was titrated with serially diluted concentrations of
Nudix proteins. The first point in each titration is the intensity of 20 nM [FAM]DNA18 alone, in
the absence of any protein. If the fluorescence emission increases, then it was assumed to be
because of binding between [FAM]DNA18 and the protein (Lohman et al., 2012; Hwang et al.,
2014). Non-specific interaction was ruled out by the addition of Bovine serum albumin (BSA)
with [FAM]DNA18. The fluorescence emission was measured on FLUOstar Omega (BMG
LABTECH), with a gain= 100. The increase in fluorescence emission (Ex. wavelength= 485 nm,
Em. Wavelength= 520 nm) suggests the binding of [FAM]DNA18 with Nudt3, Nudt16, Nudt20
(Dcp2) and NudC (Fig. 8-3A). However, with Nudt1(MutH1) and Nudt12, both the fluorescence
emission and polarized values remain unchanged, even with the addition of protein, suggesting
that there is no interaction between the oligonucleotide and protein. The fluorescence emission
data were fit Eq. 1 (Section 3.2.6) to calculate the dissociation constants (Kd) (Fig. 8-3B). Similar
results were obtained in repeat experiments.

Figure 8-3| Effect of Nudix hydrolases on the fluorescence intensity of [FAM]DNA18

(A) 20 nM [FAM]DNA18 was titrated with various concentrations of Nudix proteins and
fluorescence emission was observed at 520 nm when excited at 485 nm. The raw fluorescence
data, measured on FLUOstar Omega (BMG LABTECH) were fit Eq. 1 where Fs= 230.5, Fc= 507.5
and n= 11 are shared values among all data sets. (B) A summary of the best fit dissociation
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constants (Kd) determined by GraphPad Prism. Kd for Nudt1= Not defined, Nudt3= 28, Nudt12=
Not defined, Nudt16= 3.5, Nudt20= 36, NudC= 22 nM.
Although the above results suggest that Nudix hydrolases bind probe DNA to enhance its
fluorescence intensity, we designed a fluorescence-based polarization assay to further validate the
binding between DNA or RNA and Nudix hydrolases. When a fluorophore is excited by polarized
light, fluorescence polarization of the molecule is inversely proportional to its rotational speed
(Lakowicz, 2006). If the polarization increased with the titration of fluorescently labeled DNA to
Nudix hydrolases, then it was assumed that the fluorescently labeled DNA interacted with the
protein. The increase in polarization is presumed to be because of a significantly lower rate of
rotation compared to the free [FAM]DNA18. Unlike fluorescence intensity, polarization is not
dependent on the concentration of fluorophore. Fluorescence polarization at 520 nm when excited
at 470 nm was measured on TECAN infinite M1000. G-factor reference well was set with 1 nM
Fluorescein in 0.01 M NaOH= 180, while blank well was set with 50 mM Tris pH7.5. Polarization
values were data were fit Eq. 1 (Section 3.4.6) (Fig. 8-4A) to calculate the dissociation constants
(Kd) (Fig. 8-4B).
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Figure 8-4| Effect of Nudix hydrolases on the polarization of [FAM]DNA18

(A) 20 nM [FAM]DNA18 was titrated with each Nudix protein and polarization measured on
TECAN infinite M1000, at 520 nm emission, when excited at 485 nm. The polarization values
were fit Eq. 1 (Section 3.2.6), where Fs= 230, Fc= 296 and n= 25 are shared values among all data
sets. (B) A summary of the best fit dissociation constants determined by GraphPad Prism. Nudt1=
Not defined, Nudt3= 29, Nudt12= Not defined, Nudt16= 52, Nudt20= 3.1, NudC= 70 nM.
We also ruled out the hypothesis that the proteins may be interacting with the fluorophore
alone and not the nucleic acids. However, no enhancement in fluorescence intensity or polarization
(Em. 520 nm, Ex. 485 nm) was observed with the titration of 20 nM fluorescein with the Nudix
hydrolases.
Next, we wanted to examine whether the interaction between Nudix proteins and nucleic
acids was specific for the [FAM]-labeled probe, by using another fluorescently labeled DNA
probe, Cy5 labeled dT15 and its RNA counterpart, Cy5 labeled rU15. The fluorescently labeled
nucleic acid probes were titrated with each Nudix protein. The first point in each titration is the
intensity of fluorescently labeled oligonucleotide alone, in the absence of any protein. If the
fluorescence intensity increases with the titration of [Cy5]dT15 with the proteins, then it was
assumed to be because of binding between [Cy5]dT5 and the Nudix hydrolases (Lohman et al.,
2012; Hwang et al., 2014). Non-specific binding was ruled out by the addition of Bovine serum
albumin (BSA) to [Cy5]dT15. The fluorescence emission was measured on FLUOstar Omega
117

(BMG LABTECH), with a gain= 100. The increase in fluorescence intensity (Ex. wavelength=
640 nm, Em. Wavelength= 670 nm) suggests the binding of [Cy5]dT15 with Nudt3, Nudt16,
Nudt20 (Dcp2) and NudC. However, even with the addition of Nudt1(MutH1) and Nudt12, both
the fluorescence intensity and polarization remain unchanged, suggesting that there is no
interaction between the oligonucleotide and protein. The fluorescence intensity data (Fig. 8-5A)
were fit to Eq. 1 (Section 3.4.6) to calculate the Kd (Fig. 8-5B). Similar results were obtained in
repeat experiments.

Figure 8-5| Effect of Nudix hydrolases on the fluorescence intensity of [Cy5]dT15

(A) Fluorescence intensity values, measured on FLUOstar Omega (BMG LABTECH), were fit to
Eq. 1 (Section 3.2.6), where Fs= 461.3, Fc= 2099 and n= 11.3 are shared values among all data sets
(B) A summary of the best-fit dissociation constants (Kd) obtained. Kd for Nudt1= Not defined,
Nudt3= 11.841, Nudt12= Not defined, Nudt16= 2.957, Nudt20= 6.394, NudC= 7.308 nM.
The polarization of the same titration samples as described above, were measured at 520
nm when excited at 470 nm, on TECAN infinite M1000. G-factor reference well was set with 1
nM Fluorescein in 0.01 M NaOH= 180, while blank well was set with 50 mM Tris pH7.5. If the
fluorescence polarization increased with the titration of [Cy5]dT15 into Nudix hydrolases, then an
interaction between the DNA and the protein is confirmed. The polarization values (Fig. 8-6A)
were data were fit Eq. 1 (Section 3.2.6) to calculate the dissociation constants (Kd) (Fig. 8-6B).
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Figure 8-6| Effect of Nudix hydrolases on the polarization of [Cy5]dT15

(A) The raw polarization, measured on TECAN infinite M1000, were fit to Eq. 1 (Section 3.2.6),
where Fs= 23.52, Fc= 35.08 and n=11.3 are shared values among all data sets and (B) a summary
of the dissociation constants (Kd) using GraphPad Prism (v.6). Kd for Nudt1= Not defined, Nudt3=
7.432, Nudt12= Not defined, Nudt16= 6.561, Nudt20= 35.328, NudC= 8.695 nM.
The fluorescence intensity and polarization experiments were conducted on two
independent instruments, with both supporting the contention that some Nudix hydrolases interact
with DNA. Data also suggest that the fluorophore on the oligonucleotide does not affect the
interaction. Surprisingly, amongst the mammalian decapping Nudix hydrolases tested, only the
human Nudt12 protein did not bind DNA.
8.3.2 Interaction between Nudix hydrolase and fluorescently-labeled RNA
Next, we wanted to study the interaction between RNA and Nudix hydrolases.
Fluorescently labeled RNA probe, [FAM]RNA36 was titrated with serially diluted concentrations
of Nudix proteins. The first point in each titration is the intensity of 20 nM [FAM]RNA36 alone,
in the absence of any protein. If the fluorescence intensity increased with the amount of protein
added to [FAM]RNA36, then it was assumed to be because of binding between [FAM]RNA36
and the Nudix hydrolases (Lohman et al., 2012; Hwang et al., 2014). Non-specific binding was
ruled out by the addition of bovine serum albumin (BSA) with [FAM]RNA36. The fluorescence
emission was measured on FLUOstar Omega (BMG LABTECH), with a gain= 100. The increase
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in fluorescence emission (Ex. wavelength= 485 nm, Em. Wavelength= 520 nm) suggests the
binding of [FAM]RNA36 with Nudt3, Nudt12, Nudt16, Nudt20 (Dcp2) and NudC (Fig. 8-7A).
However, with Nudt1(MutH1), both the polarization and intensity values remain unchanged, even
with the addition of protein, suggesting that there is no interaction between the oligonucleotide
and protein. The fluorescence emission data were fit to Eq. 1 (Section 3.2.6) to calculate the Kd
(Fig. 8-7B).

Figure 8-7| Effect of Nudix hydrolases on the fluorescence intensity of [FAM]RNA36

(A) The raw fluorescence intensity data, measured on FLUOstar Omega (BMG LABTECH), were
fit Eq. 1 (Section 3.2.6), where Fs= 222, Fc= 979 and n= 5 are shared values among all data sets.
(B) A summary of the dissociation constants (Kd). Kd for Nudt1= Not defined, Nudt3= 1.606,
Nudt12= 13.528, Nudt16= 13.495, Nudt20= 16.844, NudC= 19.400 nM.
Fitting the enhancement in fluorescence emission (Em. 520 nm, Ex. 485 nm) to a binding
model, confirmed the interaction between the human Nudt12 protein and RNA. Next, 20 nM, 40
nM and 80 nM [FAM]RNA 36 were titrated with serially diluted concentrations of Nudix proteins
(Fig. 8-8). The first point in each titration is the fluorescence intensity of 20 nM or 40 nM
[FAM]RNA36 alone, in the absence of any protein. Again, it was assumed that any increase in
fluorescence emission and polarization is due to binding between [FAM]RNA36 and the protein.
Non-specific binding was ruled out by the addition of Bovine serum albumin (BSA) with
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[FAM]RNA36. The fluorescence emission was measured on FLUOstar Omega (BMG
LABTECH), with a gain= 100. Both the fluorescence and polarization values remain unchanged,
with the addition of Nudt1(MutH1) to [FAM]RNA36, suggesting that there is no interaction
between the oligonucleotide and protein.
We couldn’t include the fluorescence intensity data for 80 nM [FAM]RNA36 titrated with
Nudix proteins, because the readings with our instrument maxed out at that particular
concentration of fluorophore. However, since polarization intensity is not dependent on the
concentration of fluorophore, we could replicate the desired results. The polarization intensity was
measured at 520 nm when excited at 470 nm, on TECAN infinite M1000. As stated above, the Gfactor reference well was set with 1 nM Fluorescein in 0.01 M NaOH= 180, while the blank well
was set with 50 mM Tris pH7.5. The raw polarization values data were fit were fit Eq. 1 (Section
3.2.6) to calculate the Kd and the sites of binding (N). Both the Kd and N, assumed to be constant
at equilibrium, were shared among the three data sets for each protein. Since the polarization
intensity does not depend on concentration of the fluorophore, the maximum polarization of the
complex between the protein and the RNA (Fc) and the initial polarization of [FAM]RNA36 alone
(Fs) were shared for each protein as well.

121

Figure 8-8| Effect of Nudix hydrolases on the polarization of different concentrations of
[FAM]RNA36

[FAM]RNA36

was titrated with various concentrations of (A) Nudt1 (MutH1) (B) Nudt3 (C)
Nudt12 (D) Nudt16 (E) Nudt20 (Dcp2) and (F) NudC and an increase in polarization at 520 nm,
measured on TECAN infinite M1000, was observed when excited at 485 nm. The data were fit to
Eq. 1 (Section 3.2.6), where [FAM]RNA36= 20 nM (blue) or 40 nM (red) or 80 nM (green). Kd
and N, assumed to be constant at equilibrium, were shared among the data sets.
We also wanted to test the hypothesis that the enhancement of fluorescence and
polarization intensities observed with the titration of fluorescently labeled RNA to Nudix protein,
was not depended on the fluorophore [FAM] used in previous experiments. Hence, another
fluorescently labeled RNA, [Cy5]rU15 was titrated with serially diluted concentrations of Nudix
proteins (Fig. 8-9). The fluorescence emission was measured on FLUOstar Omega (BMG
LABTECH), with a gain= 100. If an increase in fluorescence emission (Ex. wavelength= 640 nm,
Em. Wavelength= 670 nm) was observed, then binding of [Cy5]rU15 with Nudt3, Nudt12,
Nudt16, Nudt20 (Dcp2) and NudC was assumed. The fluorescence emission data was then fit to
Eq. 1 using GraphPad Prism (v.6) to calculate a Kd and for each protein-probe combination.
However, with Nudt1(MutH1), both the polarization and fluorescence values remain unchanged,
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even with the addition of protein, suggesting that there is no interaction between the
oligonucleotide and protein. Similar results were obtained in repeat experiments (Fig. 8-9).

Figure 8-9| Effect of Nudix hydrolases on the fluorescence intensity of [Cy5]rU15
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The raw fluorescence data, measured on FLUOstar Omega (BMG LABTECH), were fit to Eq. 1
(Section 3.2.6), where Fs= 474.4, Fc= 2096 and n=11.3 are shared values among all data sets and
(B) a summary of the dissociation constants (Kd) using GraphPad Prism (v.6). Kd for Nudt1= Not
defined, Nudt3= 17.487, Nudt12= 10.939, Nudt16= 27.925, Nudt20= 17.394, NudC= 9.718 nM.
The polarization intensity of the same titration samples as described above, were measured
at 670 nm when excited at 640 nm, on TECAN infinite M1000. G-factor reference well was set
with 1 nM Fluorescein in 0.01 M NaOH= 180, while blank well was set with 50 mM Tris pH7.5.
The polarization emission data was fit to Eq. 1 with GraphPad Prism (v.6), to calculate the Kd for
each interaction between [Cy5]rU15 and the Nudix hydrolases.
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Figure 8-10| Effect of Nudix hydrolases on the polarization of [Cy5]rU15
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(A) The raw polarization measured on TECAN infinite M1000, were fit to Eq. 1 (Section 3.2.6),
where Fs= 24, Fc= 35 and n= 13 are shared values among all data sets. (B) A summary of the
dissociation constants (Kd) using GraphPad Prism (v.6). Kd for Nudt1= Not defined, Nudt3= 22,
Nudt12= 11, Nudt16= 12, Nudt20= 11, NudC= 14 nM.
These initial experiments confirmed that the fluorophore does not affect the interaction
between the RNA and the nudix proteins, further showing that the human Nudt12 protein
specifically binds to only RNA and not DNA (Fig. 8-10).
8.3.3 A probe-displacement assay to monitor RNA/DNA binding to Nudix hydrolases
Next, a probe displacement assay was designed using unlabeled RNA, to test preferential
binding between Nudix hydrolases and DNA or RNA. 20 nM [FAM]RNA36 was titrated with 5
nM Nudix hydrolases to replicate the previously observed enhanced fluorescence and polarization
intensity at 520 nm, when excited at 485 nm. An increase in fluorescence emission suggested the
interaction of the Nudix hydrolase with the nucleic acid. This enhanced fluorescence polarization
(Fig. 8-11) and of the bound [FAM]RNA36 was displaced from various Nudix hydrolase complex
using unlabeled RNAs, either RNA36 (Fig. 8-11A) or RNA18 (Fig. 8-11B). If a decrease in the
fluorescence and polarization with an increasing titration of RNA36 or RNA18 was observed, then
it was assumed that Nudix hydrolase interacted with the unlabeled oligonucleotides instead of the
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existing [FAM]RNA36. Supportive data has been shown for NudC, Nudt3, Nudt12, Nudt16 and
Nudt20 (Dcp2). However, with Nudt1 (MutH1), the fluorescence values remain unchanged,
suggesting yet again that there is no interaction between RNA18 or RNA36 and the protein. The
fluorescence intensity values were fit to Eq. 2 using GraphPad Prism (v.6), as described in Section
3.2.8.

Figure 8-11| Displacement of [FAM]RNA36 from Nudix hydrolases with RNA18 and
RNA36

The polarization measured on TECAN infinite M1000, at 520 nm when excited at 485 nm when
20 nM [FAM]RNA36 was titrated with 5 nM Nudix hydrolase and subsequently displaced using
various concentrations of (A) RNA36. The raw data were fit to Eq. 2 (Section 3.2.8) to yield IC50
values for Nudt1= Not defined, Nudt3= 39.43, Nudt12= 25.42, Nudt16= 42.60, Nudt20= 12.84,
NudC= 11.21 nM. (B) RNA18. The raw data was fit to inhibition dose response curve using
GraphPad Prism (v.6) to yield IC50 values for Nudt1= Not defined, Nudt3= 27, Nudt12= 30
Nudt16= 37, Nudt20= 18, NudC= 11 nM.
This data suggests that the length of the RNA does not affect its interaction with the
proteins. Both RNA18 and RNA36 displaced the existing enhanced fluorescence emission of
[FAM]RNA36-Nudix hydrolase complex, with the proteins not preferring any length of
oligonucleotide more than the other. Another pair of unlabeled oligonucleotides, RNA29 and its
deoxynucleotide counterpart, DNA29 were chosen to disrupt the binding between [FAM]RNA36
and Nudix hydrolases, to further validate the specificity of the human Nudt12 protein binding RNA
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only, over DNA (Fig. 8-12). The fluorescence emission at 520 nm when excited at 485 nm was
measured on FLUOstar Omega (BMG LABTECH), with a gain= 100. If a decrease in the
fluorescence emission was observed, then it was assumed that the Nudix hydrolases bound the
unlabeled oligonucleotide instead of [FAM]RNA36. The fluorescence emission data was fit to Eq.
2 using GraphPad Prism (v.6), as described in Section 3.2.8.

Figure 8-12| Displacement of [FAM]RNA36 from Nudix hydrolases with RNA29 and
DNA29

The fluorescence emission, measured on FLUOstar Omega (BMG LABTECH), at 520 nm when
excited at 485 nm when 20 nM [FAM]RNA36 was titrated with 5 nM Nudix hydrolase and
subsequently displaced using various concentrations of (A) RNA29. The raw data were fit to Eq.
2 (Section 3.2.8) to yield IC50 values for Nudt1= Not defined, Nudt3= 133, Nudt12= 63, Nudt16=
184, Nudt20= 108 and NudC= 292 nM. (B) DNA29. The raw data were fit to Eq. 2 (Section 3.2.8)
to yield IC50 values for Nudt1= Not defined, Nudt3= 147, Nudt12= Not defined, Nudt16= 158,
Nudt20= 152 and NudC= 258 nM. The DNA oligonucleotide, DNA29 fails to displace the
enhanced fluorescence of [FAM]RNA36 already bound to Nudt12, further confirming that Nudt12
exclusively binds RNA and not DNA.
This experiment confirmed that irrespective of having the same sequence, the
deoxynucleotide version (DNA29) failed to interact with the human Nudt12 protein, while its RNA
complement, RNA29 displaced the existing interaction between [FAM]RNA36 with the Nudt12.
To further test the hypothesis that Nudt12 exclusively binds RNA and not DNA, the enhanced
fluorescence and polarization intensity of [FAM]RNA36 bound with Nudt12 was displaced with
126

unlabeled DNA nucleotides GA9, C18 and RNA nucleotides RNA18 and RNA36 under identical
conditions. To test the reproducibility of the data, various concentrations of [FAM]RNA36 bound
to Nudt12 were displaced with appropriate concentrations of unlabeled oligonucleotides. The
fluorescence enhancement (Em. 520 nm, Ex. 485 nm) was measured on FLUOstar Omega (BMG
LABTECH), with a gain= 100. If a decrease in the enhanced fluorescence emission was observed,
then it was assumed that the human Nudt12 protein interacted with the unlabeled oligonucleotide
titrated into the sample. The fluorescence emission data was fit to Eq. 3 (Section 3.2.8) to calculate
inhibition constant (Ki).

5 ’- [F A M ]U A G U A C C G C C A C C C U C A G

B

F lu o re s c e n c e (R F U )

A A C C U U U U U U U U U U U U U U -3 ’

5000
4000
3000

K i = 0 .7 ± 0 .2
15000
20

10000

10
5000

5

0
1

2000

10

100

1000

R N A 1 8 (n M )

1000
1

10

100

5 ’- G C C U C G C U G C C G U C G C G A - 3 ’

1000

R N A /D N A ( n M )
GA9
5 ’- ( d ) G A G A G A G A G A G A G A G A G A - 3 ’

C 18
5 ’- ( d ) C C C C C C C C C C C C C C C C C C - 3 ’
R N A18
5 ’- (r ) G C C U C G C U G C C G U C G C G A - 3 ’

C
F lu o re s c e n c e (R F U )

A

F lu o re s c e n c e (R F U )

Figure 8-13| Displacement of [FAM]RNA36 from Nudt12 with GA9, C18, RNA18 and
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The fluorescence emission, measured on FLUOstar Omega (BMG LABTECH), at 520 nm when
excited at 485 nm when (A) 5 nM [FAM]RNA36 was titrated with 1 nM Nudt12 and displaced
using various concentrations of DNAs GA9 (blue), C18 (red) and RNAs RNA18 (green) and
RNA36 (purple). The DNA oligonucleotides, GA9 and C18 failed to displace the enhanced
fluorescence of the [FAM]RNA36 bound to Nudt12 complex. The data were fit to Eq. 2 (Section
3.2.8) to yield IC50 values for GA9= Not defined, C18= Not defined, RNA18= 6.8 and RNA36=
8.2 nM. Next, the enhanced fluorescence emission at 520 nm when 5 nM [FAM]RNA36 was
titrated with 1 nM Nudt12 (blue), 10 nM [FAM]RNA36 was titrated with 2.5 nM Nudt12 (red)
and 20 nM [FAM]RNA36 was titrated with 5 nM Nudt12 (green) and displaced using various
concentrations of (B) RNA18 and (C) RNA36. In (B) and (C), the raw data was fit to Eq. 3 (Section
3.2.8)
Since the fluorescence emission is dependent on the concentration of the fluorophore
titrated in each experiment, the initial fluorescence of [FAM]RNA36 titrated with Nudt12 is
indicative of the concentration of [FAM]. Ki, assumed to be constant at equilibrium is shared
among the three data sets for each titration of unlabeled oligonucleotide. The length of the
‘competing’ unlabeled oligonucleotide does not affect the interactions between the RNA and
Nudt12.
8.3.4 In vitro transcription of ncinRNA
To test if Nudt12 binds to ncinRNA (non-canonical initiating nucleotide RNA), we used
T7 RNA polymerase to synthesize RNA with non-canonical initiating nucleotides (ncin) such as
NAD+, NADH, NADP+ and NADPH. The DNA template used for each ncinRNA transcription is
NsiI digested pET24-nudC vector, obtained as described in Section 3.1.5.
Each band was excised out of the gel (Fig.7-2) and gel extracted. The gel purified NAD+capped RNA was phenol:chloroform treated and then injected into a LCMS-2020. Elution of each
sample was observed, ions were collected for m/z ranging from 100 to 1000, and photodiode array
spectra was collected between 190-700 nm.
NAD+-capped RNA eluted at much later at 4.5 minutes, compared to free NAD+ which
eluted at 2.0 minutes under identical assay conditions (Fig. 8-14). It was assumed that since the
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NAD+ was covalently attached to the terminal end of the RNA transcript, it would elute at a later
time point compared to free NAD+.

Figure 8-14| LC of in vitro transcribed NAD+-capped RNA
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LC data (260 nm) of both free NAD+ (blue) and NAD+-capped RNA (red) to illustrate their
different elution times on the instrument under identical conditions and the normalized PDA of
both NAD+ and NAD+-capped RNA
Similarly, in vitro transcribed NADH-capped RNA was gel extracted, treated according to
the Sevag protocol and injected into the LCMS instrument. As a control, NADH alone was run on
the LCMS instrument under identical conditions. It was assumed again that NADH-capped RNA
would elute at a much later time point on the chromatogram compared to free NADH (Fig. 8-15).
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Figure 8-15| LC of in vitro transcribed NADH-capped RNA
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LC data (260 nm, 340 nm) of both NADH alone (blue) and NADH-capped RNA (red) to illustrate
their different elution times on the instrument under identical conditions and the normalized PDA
data of both samples as well.
The ratio of the absorbance at 260 nm to 340 nm of NADH-capped RNA is not
characteristic of free NADH, suggesting the presence of an RNA tail attached to a NADH moiety.
8.3.5 Nudt12 prefers to bind NAD+-capped RNA
To test the hypothesis whether Nudt12 binds ncinRNA, the enhanced fluorescence and
polarization intensity of [FAM]RNA36 bound with Nudt12 was displaced with unlabeled
ncinRNA (Fig. 8-16). Similar results were observed in repeat experiments. If the existing
fluorescence emission of the [FAM]RNA36-Nudt12 complex decreased with the titration of
unlabeled ncinRNA, then it was assumed that Nudt12 was interacting with ncinRNA instead of
[FAM]RNA36. Concentrations of ncinRNAs were determined from their absorbance at 260 nm.
Fluorescence emission was measured on FLUOstar Omega (BMG LABTECH), with a gain= 100
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(Em. 520 nm, Ex. 485 nm). The fluorescence data were fit to Eq. 2 (Section 3.2.8) to yield IC50
values.

Figure 8-16| Displacement of [FAM]RNA36 from Nudt12 with ncinRNA (fluorescence
emission)

The fluorescence emission, measured on FLUOstar Omega (BMG LABTECH), at 520 nm when
excited at 485 nm when 20 nM [FAM]RNA36 was titrated with 5 nM Nudt12 was displaced using
various concentrations of ncinRNAs, NAD+-capped RNA (red) and NADH-capped RNA (green).
The raw data were fit to Eq. 2 (Section 3.2.8) and IC50 values were found to be similar for 7mG
and NADH capped RNA (10 µg/ml), but an impressive 300 fold lower for NAD+-capped RNA
(0.04 µg/ml).
The same experiment was repeated to observe a decrease in polarization (Em. 520 nm, Ex.
485 nm) of the [FAM]RNA36-Nudt12 complex, being displaced with in vitro transcribed capped
RNA. The polarized intensities measured on TECAN infinite M1000 (Fig. 8-17) were fit to Eq. 2
(Section 3.2.8). G-factor reference well was set with 1 nM Fluorescein in 0.01 M NaOH= 180,
while blank well was set with 50 mM Tris pH 7.5.
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Figure 8-17| Displacement of [FAM]RNA36 from Nudt12 with ncinRNA (polarization).

Polarization measured on TECAN infinite M1000, at 520 nm when excited at 485 nm when (A)
20 nM [FAM]RNA36 was titrated with 5 nM Nudt12 was displacement using various
concentrations of ncinRNAs, NAD+-capped RNA (red) and NADH-capped RNA (green). Data
were fit to Eq. 2 (Section 3.2.8) and IC50 values were found to be much higher for 7mG (0.2 µg)
and NADH-capped RNA (~ 0.4 µg), but an impressive 100 fold lower for NAD+-capped RNA
(0.002 µg).
8.4

Discussion
Ever since the purification of the first NAD-cleaving nudix hydrolase, bacterial NudC, it

has been shown to precipitate with nucleic acids. Since then, other prokaryotic and eukaryotic
Nudix hydrolases have been shown to have RNA decapping activity on non-methylated,
monomethylated and ncinRNAs. The crystal structure solved for NudC showed a positively
charged residue adjacent to the NAD-binding pocket, for a possible site to bind nucleic acids. The
sequences of both bacterial NudC and human Nudt12 shows a 110-161 amino acid residue,
comprising of a zinc-finger domain, known to interact with nucleic acids. However, the direct
interaction between such Nudix proteins and their nucleic acid substrates have never been studied
before. This chapter for the first time, clearly demonstrates an interaction between Nudix
decapping proteins and nucleic acids. Surprisingly, our results also show that the human NADcleaving Nudt12 protein exclusively binds to RNA, and not DNA. These results were confirmed
by both gel shift assays and a more quantitative approach using fluorescence polarization and
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emission assays, as wells as probe displacement assays. Our results also show that Nudt12 prefers
to bind NAD+-capped RNA strongly than either NADH-capped or 7mG-capped RNA. It may be
concluded from these studies that the in vivo substrate for NAD-cleaving Nudix hydrolases might
be NAD+-capped RNA and not NADH, as previously thought. The optimized fluorescence
polarization and emission-based assays may be used to either screen a library of inhibitory
compounds against the Nudix proteins or to study interactions between yeast NPY1 and nucleic
acids.
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Chapter 9 Lactate Dehydrogenase Reduce NAD-capped RNA

9.1

Summary

Ever since the identification of non-canonical covalent modifications on the terminal end
of both prokaryotic and eukaryotic RNA transcripts, their existence in vivo has been a mystery. In
this chapter, we test the idea that the NAD modification might not just be to stabilize the RNA
transcripts but to function as an important cofactor to several metabolic enzymes. Our results
demonstrate that NAD-capped RNA might not only be a cofactor to NAD-utilizing metabolic
enzyme, such as LDH but also the more preferred cofactor compared to NAD alone. For the first
time, the studies discussed in this chapter establishes a clear biochemical role of such ncinRNAs
in vivo, making way for a possibly new class of ribonucleoproteins or even ribozymes.
9.2

Background

Lactate dehydrogenase (LDH) is an important enzyme in anaerobic respiration, the
conversion of pyruvate into lactate in the absence oxygen. This pathway is crucial for the essential
generation of ATP and the regeneration of NAD+ from NADH. Simultaneously, during the Cori
cycle, lactate dehydrogenase can reduce NAD+ back, by transferring a hydride from lactate to
pyruvate. We hypothesized that the biochemical role of the cofactors NAD+ or NADH attached to
the terminal end of in vitro transcribed RNAs could be instrumental in such metabolic redox
reactions.
In vivo, L-lactate dehydrogenase is found in five forms of isoenzymes, each having a
slightly different structure and spread over various tissues like the heart and the skeletal muscle.
NADPH and NADP+ were used as negative controls that do not assist the activity of L-lactate
dehydrogenase. Interestingly, ncinRNA was found to be a substrate of the same enzyme. This
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finding is supported further by the fact that lactate dehydrogenase is an mRNA binding enzyme,
specifically found to interact with GM-CSF mRNA 3’UTR (Rigby et al., 2002).
L-lactate dehydrogenase catalyzes the conversion of pyruvate to lactate and back, by
transferring a hydride between the two molecules. NADH is oxidized to NAD+, while pyruvate is
reduced to lactate, during the redox reaction. The pyridine ring of NAD+ has a more stable
configuration than NADH, making NADH absorb at both 260 nm and 340 nm, while NAD+ only
absorbs at 260 nm. Hence, this assay was designed to monitor the decay in the absorbance at 340
nm, with the reduction of pyruvate to lactate. The reverse redox reaction was studied as well, with
an increase in the absorbance at 340 nm.
All experiments were set up as described in Section 3.2.8.
9.3

Results

9.3.1 Minimizing LDH assays
The recombinant bacterial lactate dehydrogenase has been cloned from chicken heart.
Recombinant E. coli (chicken heart) L-LDH catalyzes the reduction of pyruvate to lactate, and the
subsequent oxidation of NADH. Each reaction mixture containing 60 µM NADH, 4.65 nM
chicken heart LDH was made to a final volume of either 1 ml (Fig 9-2A) or 0.05 ml (Fig 9-2B)
with 220 mM Tris Cl pH 7.3. Each reaction was then initiated with various concentrations of
pyruvate to observe a decay in the absorbance at 340 nm, as NAD+ was produced from NADH.
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Figure 9-1| Initiating the LDH reactions with pyruvate
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stock solution, either in a
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cuvette. The decay in absorbance at 340 nm was recorded for 3 minutes. Initial rates were observed
to be dependent on substrate concentration which were and plotted using GraphPad Prism (v.6).
In vitro transcription yields only 50 µl of ncinRNA product. Hence, the replication of the
LDH assay in a much smaller volume (50 µl) was essential to test the activity of such ncinRNAs
in similar redox reactions.
9.3.2 NADH-capped RNA is a substrate of recombinant E. coli lactate dehydrogenase
We tested the hypothesis that in vitro transcribed ncinRNA may be a substrate for L-lactate
dehydrogenase. Identical reactions containing 220 mM Tris Cl pH 7.3, 1 mM Sodium pyruvate,
20 µM substrate (NADH or NADH-capped RNA and NADPH or NADPH-capped RNA) was
initiated with 4.65 nM of lactate dehydrogenase and the absorbance at 340 nm, 25°C was collected
every 0.1 seconds on Varian Cary 50 UV-Vis Spectrophotometer for 3 minutes. The concentration
of the chicken heart LDH used in each assay was calculated using its molecular weight (43 kDa).
NADPH was chosen as a negative control because it has previously been reported to be inactive
in aiding redox reactions catalyzed by L-lactate dehydrogenase (Holmberg et al., 1999, Zhu et al.,
2015).
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Figure 9-2| NAD-capped RNA is a substrate of recombinant E. coli lactate dehydrogenase
Reaction mixtures containing 220 mM Tris Cl pH
7.3, 1 mM Sodium pyruvate was initiated with
4.65 nM of chicken heart lactate dehydrogenase
for NADH (blue), NADH-capped RNA (purple),
NADPH (green) and NADPH-capped RNA (red)
and a decay in absorbance at 340 nm was
observed. However, the absorbance remained
constant for both NADPH and NADPH-capped
RNA, even with the addition of enzyme. Raw UV
absorbance data was plotted using GraphPad Prism (v.6).
Surprisingly, the NADH-capped RNA was found to be a substrate of the recombinant
bacterial lactate dehydrogenase and the initial rate was found to be 10 times faster than when
NADH alone as a cofactor. Since this was the first study to establish a clear biochemical role of
ncinRNAs, we proceeded to further study the kinetic parameters of ncinRNAs involved in redox
metabolic reactions (Fig. 9-1).
Reaction mixture containing 220 mM Tris pH 7.3, 150 µM NADH, 4.65 nM chicken heart
lactate dehydrogenase was initiated with varying concentrations of sodium pyruvate. With the
simultaneous reduction of pyruvate to lactate, and the oxidation of NADH to NAD+, a decay in
the absorbance at 340 nm was recorded every 0.25 seconds on Varian Cary 50 UV-Vis
Spectrophotometer for 3 minutes. Each reaction containing NADH and enzyme was made to a
total volume of 1 ml with 220 mM Tris pH 7.3, then initiated with varying volumes of a 30 mM
Sodium pyruvate solution.
To test the hypothesis that NADH-capped RNA may be a substrate for chicken heart lactate
dehydrogenase, similar experiments as described above were repeated with 45 µM NADH-capped
RNA. Each reaction containing NADH-capped RNA and enzyme was made to a total volume of
60 µl with 220 mM Tris pH 7.3, then initiated with varying volumes of a 30 mM Sodium pyruvate
solution. Each reaction was carried out in a 50 µl quartz cuvette.
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The rates for each reaction was fit to a substrate inhibition curve (Eq. 7) using GraphPad
Prism (v.6).
𝑣 = (𝐾

𝑉𝑚𝑎𝑥 𝑆

(Eq. 7)

𝑆
𝑚 +𝑆(1+ ⁄𝐾 )

Where v=

Enzyme activity in A340 min-1

S=

Substrate concentration (µM)

𝑖

Vmax= Maximum enzyme activity in A340 min-1
Km=

Michaelis-Menten constant (µM)

Figure 9-3| Initiating the recombinant E. coli LDH reaction with pyruvate
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220 mM Tris pH 7.3, 4.65 nM recombinant bacterial (chicken heart) lactate dehydrogenase,
containing either (A) 175 µM NADH or (B) 30 µM NADH-capped RNA was initiated with varying
concentrations of a 30 mM sodium pyruvate stock solution. The decay in absorbance at 340 nm
was collected at an interval of 0.5 seconds on Varian Cary 50 UV-Vis Spectrophotometer for 3
minutes. Initial rates were (C) plotted against pyruvate concentration and fit to substrate inhibition
model (Eq. 7) using GraphPad Prism (v.6) to yield a ~ 20 fold lower Km value for NADH-capped
RNA (red) compared to NADH (blue) and a ~ 20 fold higher catalytic efficiency (22 s -1µM-1) for
the ncinRNA compared to free NADH (1.4 s-1µM-1). Surprisingly, NADH-capped RNA was found
to experience more substrate inhibition compared to NADH.
Turnover number (kcat) is a measure of lactate that is converted to pyruvate per second, by
each active site on LDH and was calculated by dividing the vmax by the total LDH concentration
in each assay. Surprisingly, not only was the NADH moiety of NADH-capped RNA found to be a
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substrate for chicken heart LDH, but it had 20 times lower Km compared to that of NADH, and a
higher catalytic efficiency (kcat/Km) as well. Also, a more pronounced substrate inhibition is
observed when NADH-capped RNA catalyzes the redox reaction, compared to free NADH.
9.3.3 NADH-capped RNA is a substrate of bovine heart lactate dehydrogenase
The subunits of lactate dehydrogenase can be divided between M (muscle type) or H (heart
type) encoded by two distinct genes LDH-A and LDH-B, respectively (Alegre E et al., 2015). So,
we tested the hypothesis that in vitro transcribed ncinRNA may be a substrate for both subunits of
mammalian L-lactate dehydrogenase, from these two different sources: heart and muscle. Identical
reactions containing 220 mM Tris Cl pH 7.3, 1 mM Sodium pyruvate, ~ 50 µM substrate (NADH
or NADH-capped RNA and NADPH or NADPH-capped RNA) was initiated with 506 pM heart
lactate dehydrogenase and the absorbance at 340 nm, 25°C was collected every 0.1 seconds on
Varian Cary 50 UV-Vis Spectrophotometer for 3 minutes. NADPH was chosen as a negative
control because it has previously been reported to be inactive in aiding redox reactions catalyzed
by L-lactate dehydrogenase (Holmberg et al., 1999, Zhu et al., 2015). The bovine heart lactate
dehydrogenase was purchased from Sigma-Aldrich (L2625).
Reaction mixture containing 220 mM Tris pH 7.3, ~50 µM NADH, 506 pM bovine heart
lactate dehydrogenase was initiated with varying concentrations of sodium pyruvate. With the
simultaneous reduction of pyruvate to lactate, and the oxidation of NADH to NAD+, a decay in
the absorbance at 340 nm was recorded every 0.1 seconds on Varian Cary 50 UV-Vis
Spectrophotometer for 3 minutes. The concentration of the mammalian heart LDH used in each
assay was calculated using its molecular weight (36.4 kDa). Each reaction, containing the NADH
and enzyme was made to a total volume of 60 µl with 220 mM Tris pH 7.3, then initiated by adding
varying concentrations of sodium pyruvate.
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Figure 9-4| Initiating the heart LDH reaction with pyruvate
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220 mM Tris pH 7.3, 506 pM bovine heart lactate dehydrogenase, containing either (A) 50 µM
NADH or (B) 30 µM NADH-capped RNA was initiated with varying concentrations of a 30 mM
sodium pyruvate stock solution. The decay in absorbance at 340 nm was collected at an interval
of 0.5 seconds on Varian Cary 50 UV-Vis Spectrophotometer for 3 minutes. Initial rates were (C)
plotted against pyruvate concentration and fit to substrate inhibition model (Eq. 7) using GraphPad
Prism (v.6) to yield a significantly (~ 20 folds) lower Km and a higher (~ 50 folds) higher kcat/Km
for ncinRNA compared to free NADH.
Surprisingly, not only was the NADH moiety of NADH-capped RNA found to be a
substrate for mammalian heart lactate dehydrogenase, but it was a more preferred cofactor
compared to that of NADH, with an almost 20 folds lower Km and ~ 50 folds higher catalytic
efficiency for ncinRNA. A similar trend in substrate inhibition to that experienced by recombinant
bacterial LDH is observed in this case as well. It is important to note that both enzymes used are
the heart isozymes of L-lactate dehydrogenase.
9.3.4 NADH-capped RNA is a substrate of rabbit muscle lactate dehydrogenase
Similar to experiments described in section 9.3.2, we tested the hypothesis that ncinRNA
may be a substrate for the muscle subunit of L-lactate dehydrogenase, as well. Identical reactions
containing 220 mM Tris Cl pH 7.3, 1 mM Sodium pyruvate, 50 µM substrate (NADH or NADHcapped RNA and NADPH or NADPH-capped RNA) was initiated with 0.963 pM muscle lactate
dehydrogenase and the absorbance at 340 nm, 25°C was collected every 0.1 seconds on Varian
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Cary 50 UV-Vis Spectrophotometer for 3 minutes. The muscle subunit lactate dehydrogenase was
sourced from Sigma-Aldrich (L2500-5KU).
Reaction mixture containing 220 mM Tris pH 7.3, ~50 µM NADH, 0.963 pM rabbit muscle
lactate dehydrogenase was initiated with varying concentrations of sodium pyruvate. With the
simultaneous reduction of pyruvate to lactate, and the oxidation of NADH to NAD+, a decay in
the absorbance at 340 nm was recorded every 0.1 seconds on Varian Cary 50 UV-Vis
Spectrophotometer for 3 minutes. The concentration of the mammalian muscle LDH used in each
assay was calculated using its molecular weight (35 kDa). Each reaction, containing the NADH or
NADH-capped RNA and enzyme was made to a total volume of 60 µl with 220 mM Tris pH7.3,
then initiated with varying volumes of a 15 mM sodium pyruvate solution.

Figure 9-5| Initiating the muscle LDH reaction with pyruvate
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220 mM Tris pH 7.3, 0.963 pM rabbit muscle lactate dehydrogenase, containing either (A) 50 µM
NADH or (B) 50 µM NADH-capped RNA was initiated with varying concentrations of a 30 mM
sodium pyruvate stock solution. The decay in absorbance at 340 nm was collected at an interval
of 0.5 seconds on Varian Cary 50 UV-Vis Spectrophotometer for 3 minutes. Initial rates were (C)
plotted against pyruvate concentration and fit to substrate inhibition model (Eq. 7) using GraphPad
Prism (v.6) to yield similar Km values, however a much higher catalytic efficiency for NADHcapped RNA (4.0 s-1µM-1) compared to free NADH (1.5 s-1µM-1).
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Thus, NADH-capped RNA not only is a substrate for the muscle subunit of lactate
dehydrogenase as well but has a more than 2 folds higher catalytic efficiency for ncinRNA
compared to free NADH. For the first time, our results demonstrate that the NADH moiety of
NADH-capped RNA may be involved in cellular redox reactions, catalyzed by both isozymes of
mammalian metabolic dehydrogenases.
From our experiments, it may be concluded that the NADH-capped RNAs, when used as
a cofactor for anaerobic reaction catalyzed by LDH-H, exhibits a more pronounced substrate
inhibition compared to NADH alone. This led to the velocity curves of NADH-capped RNAs to
escalate to a maximum velocity and then decline as the pyruvate concentration continued to
increase. However similar substrate inhibition is not observed with LDH-M catalyzing the
anaerobic

redox

reaction.

9.3.5 NAD+-capped RNA is a substrate of E. coli lactate dehydrogenase
Reaction mixture containing 220 mM Tris pH9, ~ 40 µM NAD+, 4.65 nM chicken heart
lactate dehydrogenase was initiated with varying concentrations of lactate. With the simultaneous
oxidation of lactate to pyruvate, and the regeneration of NADH from NAD+, the increase in the
absorbance at 340 nm was recorded every 0.25 seconds on Varian Cary 50 UV-Vis
Spectrophotometer for 5 minutes. Reaction samples containing NAD+ and enzyme were made to
a final volume of 60 µl, then initiated with varying volumes of a 30 mM lactic acid solution,
sourced from Dot Scientific Inc (DSL17500-500). Initial rates were found to be dependent on
substrate concentration.
To test the hypothesis that NAD+-capped RNA is a substrate for chicken heart lactate
dehydrogenase, identical experiments as described above were repeated with ~ 40 µM NAD+-
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RNA. Surprisingly enough, the NAD+ moiety of NAD+-capped RNA was found to be a substrate
for lactate dehydrogenase, even with an oligonucleotide ‘tail’.

Figure 9-6| Initiating the recombinant E. coli LDH reaction with lactate
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(A) Reaction mixtures containing 220 mM Tris pH9, ~10 µM NAD+, 4.65 nM recombinant
bacterial (chicken heart) lactate dehydrogenase was initiated with varying concentrations of a 30
mM lactate stock concentration. The increase in absorbance at 340 nm was collected at an interval
of 0.5 seconds. Each reaction was carried out in a 50 µl quartz cuvette (B) Initial rates, observed
to be dependent on substrate concentration were plotted against lactate concentration and fit to a
substrate inhibition model (Eq. 7) using GraphPad Prism (v.6) to yield similar Km values, however
a higher catalytic efficiency for NAD+-capped RNA (~ 1 s-1µM-1) compared to free NAD+ (~ 0.5
s-1µM-1).
Not only was the NAD+ moiety of NAD+-capped RNA found to be a substrate for LDH,
but it had a significantly higher catalytic efficiency (kcat/Km) as well.
9.3.6 NAD+-capped RNA is a substrate of bovine heart lactate dehydrogenase
Initial experiments demonstrated that NADH-capped RNA is a substrate of mammalian
heart lactate dehydrogenase. Next, we tested the hypothesis whether the reverse oxidation of
lactate may also be catalyzed by NAD+-capped RNA. Reaction mixture containing 220 mM Tris
pH9, 40 µM NAD+, 506 pM lactate dehydrogenase was initiated with varying concentrations of
lactate. With the simultaneous oxidation of lactate to pyruvate, and the regeneration of NADH
from NAD+, the increase in the absorbance at 340 nm was recorded every 0.25 seconds on Varian
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Cary 50 UV-Vis Spectrophotometer for 5 minutes. Reaction samples containing NAD+ and
enzyme were made to a final volume of 60 µl, then initiated with varying volumes of a 30 mM
lactic acid solution, sourced from Dot Scientific Inc (DSL17500-500). Initial rates were found to
be dependent on substrate concentration.
To test the hypothesis that NAD+-capped RNA is a substrate for bovine heart lactate
dehydrogenase, identical experiments as described above were repeated with 40 µM NAD+-capped
RNA. Surprisingly enough, the NAD+ moiety of NAD+-capped RNA was found to be a substrate
for lactate dehydrogenase, even with an oligonucleotide ‘tail’.

Figure 9-7| Initiating the heart LDH reaction with lactate
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220 mM Tris pH 9, 506 pM bovine heart lactate dehydrogenase, containing either (A) 50 µM
NAD+ or (B) 50 µM NAD+-capped RNA was initiated with varying concentrations of a 30 mM
lactate stock solution. The increase in absorbance at 340 nm as NADH was regenerated was
collected at an interval of 0.5 seconds on Varian Cary 50 UV-Vis Spectrophotometer for 3 minutes.
Initial rates were observed to be dependent on substrate concentration which were (C) plotted
against lactate concentration and fit to a substrate inhibition model (Eq. 7) using GraphPad Prism
(v.6) to yield a greater than six-folds higher catalytic efficiency for NAD+-capped RNA (~ 3 s1
µM-1) compared to free NAD+ (~ 0.5 s-1µM-1).
Our results demonstrate that NAD+-capped RNA is a substrate for mammalian heart LDH,
having a considerably higher catalytic efficiency (kcat/Km) compared to free NAD+.
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9.3.7 NAD+-capped RNA is a substrate of rabbit muscle lactate dehydrogenase
Experiments described in section 9.3.4 showed that NADH-capped RNA is a substrate of
rabbit muscle lactate dehydrogenase. So, we tested the hypothesis whether the reverse oxidation
of lactate may also be catalyzed by NAD+-capped RNA. Reaction mixture containing 220 mM
Tris pH9, ~ 40 µM NAD+, 0.963 pM lactate dehydrogenase was initiated with varying
concentrations of lactate. With the simultaneous oxidation of lactate to pyruvate, and the
regeneration of NADH from NAD+, the increase in the absorbance at 340 nm was recorded every
0.25 seconds on Varian Cary 50 UV-Vis Spectrophotometer for 5 minutes. Reaction samples
containing NAD+ and enzyme were made to a final volume of 60 µl, then initiated with varying
volumes of a 30 mM lactic acid solution. Initial rates were found to be dependent on substrate
concentration.
To test the hypothesis that NAD+-capped RNA is a substrate for rabbit muscle lactate
dehydrogenase, identical experiments as described above were repeated with ~ 40 µM NAD+capped RNA. Surprisingly enough, the NAD+ moiety of NAD+-capped RNA was found to be a
substrate for lactate dehydrogenase, even with an oligonucleotide ‘tail’.
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Figure 9-8| Initiating the muscle LDH reaction with lactate
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220 mM Tris pH 9, 0.963 pM rabbit muscle lactate dehydrogenase, containing either (A) 50 µM
NAD+ or (B) 50 µM NAD+-capped RNA was initiated with varying concentrations of a 30 mM
sodium pyruvate stock solution. The decay in absorbance at 340 nm was collected at an interval
of 0.5 seconds on Varian Cary 50 UV-Vis Spectrophotometer for 3 minutes. Initial rates were (C)
plotted against lactate concentration and fit to a substrate inhibition model (Eq. 7) using GraphPad
Prism (v.6) to yield a lower Km for NAD+-capped RNA (126 µM) compared to free free NAD+
(670 µM). A 20-folds higher catalytic efficiency for NAD+-capped RNA was also observed
compared to free NAD+.
Our experiments illustrate that NAD+-capped RNA significantly inhibits the activity of
LDH compared to free NAD+, with a significantly higher catalytic efficiency (kcat/Km) compared
to free NAD+. A more pronounced substrate inhibition was observed with the muscle isozyme of
lactate dehydrogenase, when catalyzing the aerobic reaction.
9.4

Discussion
Ever since the discovery of NAD-capped RNAs in booth prokaryotes and eukaryotes, their

function in vivo has been a concern. It has been hypothesized that similar to the methylated cap on
eukaryotic mRNA transcripts, the NAD cap may stabilize its prokaryotic RNA substrates.
However, evidence for this role is yet to be demonstrated. The results in this chapter confirm that
NAD-capped RNA not only functions as a cofactor to eukaryotic metabolic dehydrogenases, but
the enzyme LDH seems to prefer NAD-capped RNA over NAD alone. This is the first report to
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show a clear biochemical role for ncinRNAs, suggesting that ncinRNAs might be participants in
cellular redox reactions. The activity of ncinRNAs as a viable cofactor has been confirmed with
mammalian lactate dehydrogenases, as well as both its subunits (muscle and heart). In vivo, NADcapped RNAs might therefore form a new class of key ribonucleoproteins or even ribozymes
capable of catalyzing redox reactions. Several metabolic enzymes have also been reported to be
RNA binding enzymes (Table 9-1), especially at 5’-UTR site where the covalent modification of
ncinRNA is believed to occur as well.
Another interesting find from this chapter was the substrate inhibition observed for the two
different isozymes of L-lactate dehydrogenase tested. A more pronounced substrate inhibition was
observed for the aerobic conversion of lactate to pyruvate when the muscle isozyme of the enzyme
uses NAD+-capped RNA as a cofactor, whereas a similar inhibitory effect is observed when
NADH-capped RNA utilizes LDH for the reverse anaerobic reduction. The same is true for the
recombinant E. coli LDH, where the LDH gene sequence was cloned from chicken heart.
We would further like to test the activity of ncinRNAs for other RNA binding NAD-using
metabolic enzymes. Using the stopped-flow technique could also give us a better understanding of
the kinetics in such redox reactions.

Table 9-1|RNA binding metabolic enzymes
Pathway

Enzyme

RNA(s)

Glycolysis

GAPDH

Glycolysis
(anaerobic)

LDH

tRNA, rRNA, ribozymes, RNA virus UTRs
(Rigby WF et al., 1995; Garcin ED et al., 2016; Klug G et
al., 2002; Garcin ED et al., 2015; Garcin ED 2019;
Alexander GJ et al., 1999)
GM-CSF mRNA 3’UTR
(Rigby WF et al., 2002)

TCA entry

PDH

Not known
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α-KDH

Mitochondrial mRNA 5’UTR
(Grivell LA et al., 1993)
Not Known

MDH

Not Known

Pentose Phosphate

G6PDH

Amino Acid
TCA entry
Nucleotide Synthesis

GDH

GLUT1 mRNA 3’UTR
(Pekala PH et al., 1996)
mRNA, gRNA, 3’oligo (U)
(Lightowlers RN et al., 1993; Simpson L et al., 1997)
DHFR mRNA
(Bertino JR et al., 1997)

TCA

IDH

DHFR
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Chapter 10 Conclusions and Perspectives

Since the discovery of NADH-cleaving Nudix proteins, E. coli NudC, the progenitor of
this subfamily of Nudix hydrolases, its exact biochemical role has been unclear. Despite, the cell
spending energy to synthesize each molecule of NADH, bacterial NudC and human Nudt12 cleave
this energy rich molecule to yield NMN and AMP. The exact reason for this hydrolytic cleavage
reaction is yet to be completely understood. This thesis entirely focuses on studying the role of this
class of enzymes.
Following the discovery of Nudt1 (MutH1) in as early as 1994, hydrolyzing mutagenic
nucleotide pools to prevent its misincorporation into DNA, chapter 4 concentrated on a similar
hypothesis. We confirmed that both bacterial NudC and human Nudt12 Nudix hydrolases has
catalytic activity on the toxic isomeric forms of NADH, using HPLC. Experiments described in
this thesis indicate that the human Nudix protein Nudt12 prefers to hydrolyze 6DHNAD over the
nascent NADH by almost five-fold (Figure 5-7). However, additional research is required to
confirm this hypothesis for both bacterial and human NADH-cleaving Nudix hydrolases.
Furthermore, it would be interesting to see the effect of knocking out this particular subclass of
Nudix proteins might affect the levels of 6DHNAD in vivo.
A novel fluorescence assay was designed in Chapter 6 to bypass the limitations of
previously described colorimetric assays. A fluorescence-based assay to monitor the continuous
hydrolysis of NAD-cleaving Nudix proteins on its substrates was designed. This assay confirmed
that the toxic isomer of NADPH, 6DHNADP is a substrate of the bacterial Nudix hydrolase, NudC.
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Results demonstrate the ongoing hydrolysis of NADH by NudC is further inhibited by the addition
of the ‘competing’ substrate, 6DHNADP. This novel assay could be used in the future to study the
activity of NADH-cleaving Nudix hydrolases, bacterial NudC, yeast NPY1 and human Nudt12 on
ncinRNAs.
Chapter 8 is the first study to show the direct interaction between human and bacterial RNA
decapping Nudix hydrolases and their nucleic acid substrates. Since the early discovery of NudC
(Frick & Bessman, 1995), it has been demonstrated to co-purify with nucleic acids. Additionally,
both NudC and its human functional homolog, Nudt12 have Zinc-finger domains, suggesting yet
another possible binding site for nucleic acids. Nudt3 (McLennan et al., 2006; Song et al., 2013;
Kiledjia et al., 2016), Nudt16 (Grzela et al., 2018) and Nudt20, more commonly referred to as
Dcp2 (Wang et al., 2002) have all been demonstrated to have mRNA decapping activity. However,
interactions between DNA or RNA and these RNA decapping Nudix hydrolases have not been
studied before. In this chapter, we developed and optimized a fluorescence polarization (FP) assay
to quantify affinity between RNA decapping Nudix hydrolases and nucleic acids. Surprisingly, our
data shows that the human Nudt12 protein exclusively binds RNA and not DNA. We further
validated these results by designing another FP assay to displace the bound RNA-protein complex
with either unlabeled DNA or unlabeled RNA. We also show that Nudt12 has an incredibly high
affinity to bind in vitro transcribed NAD+-capped RNA compared to NADH-capped RNA and
7

mG capped RNA. Future work would include repeating similar FP assay using ncinRNAs

transcribed using fluorescently modified nucleotides, to study the energetics of direct interaction
between both bacterial and human RNA decapping Nudix proteins and fluorescently labeled
ncinRNAs.
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Previous studies have demonstrated that NudC (Cahová et al., 2015) and Nudt12
(Grudzien-Nogalska et al., 2019) have deNADding activity on NAD+-RNA, using radiolabeled in
vitro transcribed ncinRNA. Both these Nudix proteins cleave the phosphodiester bonds in the
NAD+ moiety to yield free NMN and 5’- monophosphorylated RNA. In Chapter 7, we in vitro
synthesized ncinRNAs, NAD+-RNA and NADH-RNA and optimized a more quantitative
analytical approach using LC/MS to study the hydrolytic activity of NudC and Nudt12 on their
substrates. Zhang et al. (2016) showed similar results, although this technique can be replicated to
study the energetics of deNADding by the functional homolog of these proteins in yeast, Npy1.
Since the identification of NAD+ as a covalent modification on the terminal end of RNA
transcripts in bacteria (Chen et al., 2009; Cahova et al., 2015), yeast (Walters et al., 2017) and
humans (Jiao, et al., 2017), its significance has been questioned. It has been hypothesized by
Cahova et al. (2015), that the NAD+ cap might play a similar role in stabilizing bacterial RNA
transcripts as the m7G cap does to eukaryotic mRNA transcripts. In Chapter 9, we hypothesized
that ncinRNAs might be participants in cellular redox reactions. To test this hypothesis, two
isoforms of lactate dehydrogenase: recombinant E. coli L-lactate dehydrogenase, rabbit muscle Llactate dehydrogenase and bovine heart L-lactate dehydrogenase were used to test its redox activity
on both pyruvate and lactate using either NADH or NADH-RNA and NAD+ or NAD+-RNA
respectively. To our surprise, we found that not only can ncinRNAs assist in redox metabolic
reactions, but they might be better cofactors compared to their free NAD+ or NADH forms. This
is the first study to demonstrate a clear biochemical role for ncinRNAs. We think that NAD+capped RNAs might therefore form a new class of key ribonucleoproteins or even ribozymes
capable of catalyzing redox reactions, in vivo. Additionally, several metabolic enzymes including
lactate dehydrogenase, used as an example in this thesis, have also been reported to be RNA
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binding enzymes, especially at 5’-UTR site where the covalent modification of ncinRNA is
believed to occur as well. It would be exciting to test the aiding effect of ncinRNAs in redox
reactions catalyzed by other RNA binding metabolic enzymes mentioned in Table 9-1.
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